Page last updated: 2024-10-29

ifosfamide and Cancer of Lung

ifosfamide has been researched along with Cancer of Lung in 737 studies

Research Excerpts

ExcerptRelevanceReference
"This Phase II trial of paclitaxel/ifosfamide included patients with bi-dimensionally measurable metastatic breast cancer in second or third relapse, following anthracycline-containing regimens; ECOG PS < 2, and adequate hepatic, cardiac, renal, and hematological functions."9.08Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer. ( Amorim, WC; Ferreira-Filho, AF; Guimaraes, RC; Morici, AC; Murad, AM; Schwartsmann, G, 1997)
"This Phase I/II study investigates increasingly high doses of ifosfamide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in patients with metastatic soft tissue sarcoma (STS)."9.08A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. ( Arseniev, L; Bokemeyer, C; Franzke, A; Hartmann, JT; Kanz, L; Link, H; Metzner, B; Schmoll, HJ; Schöber, C, 1997)
"To investigate the value of contrast-enhanced computed tomography (CECT) radiomics features in predicting the efficacy of epirubicin combined with ifosfamide in patients with pulmonary metastases from soft tissue sarcoma."8.12Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features. ( Jiang, X; Li, M; Ma, ST; Miao, L; Wang, YM; Zhang, HH, 2022)
"This case shows us that operation on late stage cardiac angiosarcomas can alleviate a patient's symptoms; postoperative paclitaxel monotherapy was insufficient and ifosfamide and epirubicin plus recombinant human endostatin has a limited effect on late stage cardiac angiosarcoma."7.91The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report. ( Davies, H; Jiang, L; Shi, K; Xu, X, 2019)
"The aim of this retrospective study was to evaluate the feasibility and efficacy of response to continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for patients with recurrent or refractory osteosarcoma."7.81Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study. ( He, AN; Huang, YJ; Min, DL; Shen, Z; Sun, YJ; Yao, Y, 2015)
"To determine demographic data, prognostic factors and outcome of childhood osteosarcoma treated with a carboplatin-based chemotherapeutic protocol at Chiang Mai University."7.79Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand. ( Charoenkwan, P; Choeyprasert, W; Natesirinilkul, R; Sittipreechacharn, S, 2013)
"This study assessed the therapeutic effect of and adverse reactions to pirarubicin (THP) chemotherapy in osteosarcoma patients with lung metastasis, and analyzed the relationship between THP therapeutic effect and expression of p-glycoprotein and topoisomerase-II."7.76Therapeutic effect of pirarubicin-based chemotherapy for osteosarcoma patients with lung metastasis. ( Chen, P; Lin, F; Sun, Y; Wang, Z; Yao, Y; Zhao, H, 2010)
"We report a patient with primary lung adenocarcinoma who had Ewing's sarcoma and was successfully treated with ifosfamide."7.74[A case of primary lung adenocarcinoma accompanied by Ewing's sarcoma successfully treated with ifosfamide]. ( Arai, H; Fukumura, H; Kudo, M; Masuda, M; Nakajima, K; Oshiro, H; Rino, Y; Wada, N; Watanuki, Y; Yamanaka, S; Yukawa, N, 2008)
"Cyclophosphamide (CTX) and ifosfamide (IFX) are alkylating agents used to treat osteosarcoma (OS)."7.73Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. ( Duan, X; Jia, SF; Kleinerman, ES; Koshkina, N, 2006)
"Ifosfamide, Carboplatin and Etoposide (ICE) therapy was used to treat 4 patients, 2 with refractory osteosarcoma, and one each with relapsed brain tumor and newly diagnosed brain tumor."7.70[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)]. ( Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M, 1998)
"Generalized and partial seizures with secondary generalization were observed during ifosfamide-mesna (IFO) treatment in a patient with lung epidermoid carcinoma."7.69[Epileptic seizures and treatment with ifosfamide-mesna]. ( Farisse, P; Somma-Mauvais, H; Viallat, JR, 1994)
" A 16-year-old girl with metastatic osteosarcoma experienced recurrent bouts of symptomatic pancreatitis 24 hours after treatment with ifosfamide administered as a single agent."7.69Acute pancreatitis after ifosfamide therapy. ( Adamson, PC; Balis, FM; Blaney, SM; Izraeli, S, 1994)
"From January 1990 to December 1995 we treated 35 patients (pts) with bone and soft tissue sarcoma with ifosfamide (IFM)."7.69[The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas]. ( Ishii, T; Kitoh, M; Satoh, T; Tatezaki, S; Umeda, T; Yonemoto, T, 1997)
"Forty seven patients with inoperable adenocarcinoma and large cell carcinoma of the lung were treated with a combination of cisplatin (25 mg/m2), ifosfamide (1."7.68[Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung]. ( Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Mori, T; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A, 1991)
"A 13-year-old boy with unresectable pulmonary metastatic osteosarcoma, which was refractory to high dose methotrexate, adriamycin, cisplatin and combination of bleomycin, cyclophosphamide and actinomycin D, was treated by aggressive chemotherapy including the combination of ifosfamide (1 g/m2 x day 1-4), Carboplatin (100 mg/m2 x day 1-4) and Vindesine (4 mg/m2 x day 1)."7.68[Successful treatment of metastatic and refractory osteosarcoma by ifosfamide, carboplatin and vindesine: case report]. ( Fujita, H; Ishimoto, K; Kiyokawa, N; Kyo, K; Mizuno, T; Takada, K; Yabuta, K, 1991)
"The mesna, doxorubicin, ifosfamide, dacarbazine regimen produced a 47% response rate (including 10% complete responses) in 105 eligible adults with advanced sarcoma."7.68Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma. ( Aisner, J; Antman, KH; Elias, A; Ryan, L, 1990)
"Thirty-seven patients with widely metastatic malignant melanoma were treated with one of three chemotherapy regimens, incorporating high-dose dacarbazine (DTIC)."7.67High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma. ( Carr, T; Chadwick, G; Craig, P; Jones, R; Lind, M; Morgenstern, G; Thatcher, D, 1989)
"Fifty-three patients with inoperable non-small cell bronchial carcinoma were treated at four-weekly intervals with two cytostatic drugs, doxorubicin (50 mg/m2 on day 1) and ifosfamide (2000 mg/m2 on days 1-3)."7.66[Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide]. ( Göbel, D; Matthiessen, W; Stempinski, E; Thalmann, U, 1983)
" Both have a dose-response relationship."6.68Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma. ( de Wit, R; Planting, AS; Stoter, G; van der Burg, ME; Verweij, J, 1996)
"Breast stromal sarcoma is very rare, accounting for less than 1% of mammary neoplasms, and the treatment strategy is not well established, especially regarding chemotherapy."5.37Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: report of a case. ( Inoue, K; Iwase, H; Kuriwaki, K; Sueta, A; Yamamoto, Y, 2011)
"The European Organization for Research and Treatment of Cancer (EORTC) 62012 study was a Phase III trial of doxorubicin versus doxorubicin-ifosfamide chemotherapy in 455 patients with advanced soft tissue sarcoma (STS)."5.24Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study. ( Collin, F; Daugaard, S; Fisher, C; Gronchi, A; Grünwald, V; Hogendoorn, PCW; Judson, I; Lia, M; Litière, S; Mechtersheimer, G; Messiou, C; Sciot, R; van der Graaf, W; Wardelmann, E; Young, RJ, 2017)
"Patients with high-grade soft tissue sarcomas were treated with 2 cycles of ifosfamide, mitomycin, doxorubicin, and cisplatin plus GM-CSF subcutaneous followed by 45 Gy irradiation with concurrent 2 cycles of mitomycin, doxorubicin, and cisplatin followed by surgery +/- intraoperative radiation or brachytherapy."5.22Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively. ( Haddock, M; Mahoney, M; Maples, W; Markovic, SN; O'Connor, MI; Okuno, S; Petersen, I; Shives, T; Sim, F, 2016)
"To compare three-drug chemotherapy with cisplatin, doxorubicin, and methotrexate with four-drug chemotherapy with cisplatin, doxorubicin, methotrexate, and ifosfamide for the treatment of osteosarcoma."5.13Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. ( Bernstein, ML; Betcher, D; Ferguson, WS; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, M; Healey, JH; Kleinerman, E; Krailo, MD; Link, MP; Meyers, PA; Nadel, H; Nieder, M; Schwartz, CL; Siegal, GP; Weiner, MA; Wells, RJ; Womer, RB, 2008)
"The outcome of patients with metastatic osteosarcoma treated in two consecutive trials from 1986 to 1997 was analyzed to evaluate the efficacy of carboplatin-based multiagent chemotherapy and to identify prognostic factors."5.12Metastatic osteosarcoma. ( Billups, CA; Cain, AM; Daw, NC; Jenkins, JJ; McCarville, MB; Meyer, WH; Neel, MD; Rao, BN; Rodriguez-Galindo, C, 2006)
"A phase IIb trial using liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE) in combination with ifosfamide (IFX) for patients with relapsed osteosarcoma was undertaken to determine (a) the tolerability of the combination therapy, (b) if L-MTP-PE increased the toxicity of IFX, and (c) whether IFX altered or suppressed the in vivo immune response to L-MTP-PE."5.08Combination therapy with ifosfamide and liposome-encapsulated muramyl tripeptide: tolerability, toxicity, and immune stimulation. ( Gano, JB; Jaffe, N; Jia, SF; Kleinerman, ES; Meyers, PA; Raymond, AK, 1995)
"This Phase II trial of paclitaxel/ifosfamide included patients with bi-dimensionally measurable metastatic breast cancer in second or third relapse, following anthracycline-containing regimens; ECOG PS < 2, and adequate hepatic, cardiac, renal, and hematological functions."5.08Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer. ( Amorim, WC; Ferreira-Filho, AF; Guimaraes, RC; Morici, AC; Murad, AM; Schwartsmann, G, 1997)
"This Phase I/II study investigates increasingly high doses of ifosfamide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in patients with metastatic soft tissue sarcoma (STS)."5.08A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. ( Arseniev, L; Bokemeyer, C; Franzke, A; Hartmann, JT; Kanz, L; Link, H; Metzner, B; Schmoll, HJ; Schöber, C, 1997)
"To estimate the duration of survival (S) of patients with metastatic osteosarcoma (MOS) at diagnosis treated with a multiagent, ifosfamide-containing chemotherapeutic and surgical regimen and to evaluate the toxicity of this regimen."5.08Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. ( Ayala, A; Ferguson, WS; Gieser, P; Goorin, AM; Harris, MB; Holbrook, T; Link, MP; Shochat, SJ, 1998)
"43 patients with metastasizing sarcomas were treated with a combination of either vincristin, adriamycin and cis-platinum (n = 21) or ifosfamide and cis-platinum at three weeks' intervals in each case."5.05[Chemotherapy in advanced sarcomas (author's transl)]. ( Bierbaum, W; Bremer, K; Firusian, N; Higi, M; Niederle, N; Scheulen, ME; Schmidt, CG; Seeber, S, 1981)
"A patient with a small-cell lung cancer (SCLC) developed an asymptomatic hyponatremia, with all features of the syndrome of inappropriate antidiuretic hormone secretion (SIADH), two days after the start of his first cycle of chemotherapy with vindesine, ifosfamide and cisplatin."4.80Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review. ( Paridaens, R; Vanhees, SL; Vansteenkiste, JF, 2000)
"The authors describe skin pigment changes in a 5-year-old patient receiving ifosfamide, MESNA, and etoposide for the treatment of relapsed Wilms tumor."4.78Ifosfamide-induced hyperpigmentation. ( Cornelius, AS; Murry, DJ; Teresi, ME, 1993)
"The alkylating agent ifosfamide, an analog of cyclophosphamide, has demonstrated significant activity in soft tissue sarcoma and testicular carcinoma."4.77Ifosfamide. ( Baker, LH; Zalupski, M, 1988)
"To investigate the value of contrast-enhanced computed tomography (CECT) radiomics features in predicting the efficacy of epirubicin combined with ifosfamide in patients with pulmonary metastases from soft tissue sarcoma."4.12Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features. ( Jiang, X; Li, M; Ma, ST; Miao, L; Wang, YM; Zhang, HH, 2022)
"This case shows us that operation on late stage cardiac angiosarcomas can alleviate a patient's symptoms; postoperative paclitaxel monotherapy was insufficient and ifosfamide and epirubicin plus recombinant human endostatin has a limited effect on late stage cardiac angiosarcoma."3.91The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report. ( Davies, H; Jiang, L; Shi, K; Xu, X, 2019)
"The aim of this retrospective study was to evaluate the feasibility and efficacy of response to continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for patients with recurrent or refractory osteosarcoma."3.81Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study. ( He, AN; Huang, YJ; Min, DL; Shen, Z; Sun, YJ; Yao, Y, 2015)
"We reviewed the records of 50 patients with osteosarcoma who underwent marginal resection following effective preoperative chemotherapy; 18 were treated with the MMIA (high-dose methotrexate (HD-MTX), adriamycin (ADR), ifosfamide (IFO)) and cisplatin (DDP), and 32 patients were treated with the DIA (DDP, ADR and IFO)."3.80Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes. ( Xu, M; Xu, S; Yu, X, 2014)
"To determine demographic data, prognostic factors and outcome of childhood osteosarcoma treated with a carboplatin-based chemotherapeutic protocol at Chiang Mai University."3.79Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand. ( Charoenkwan, P; Choeyprasert, W; Natesirinilkul, R; Sittipreechacharn, S, 2013)
"This study assessed the therapeutic effect of and adverse reactions to pirarubicin (THP) chemotherapy in osteosarcoma patients with lung metastasis, and analyzed the relationship between THP therapeutic effect and expression of p-glycoprotein and topoisomerase-II."3.76Therapeutic effect of pirarubicin-based chemotherapy for osteosarcoma patients with lung metastasis. ( Chen, P; Lin, F; Sun, Y; Wang, Z; Yao, Y; Zhao, H, 2010)
"We report a patient with primary lung adenocarcinoma who had Ewing's sarcoma and was successfully treated with ifosfamide."3.74[A case of primary lung adenocarcinoma accompanied by Ewing's sarcoma successfully treated with ifosfamide]. ( Arai, H; Fukumura, H; Kudo, M; Masuda, M; Nakajima, K; Oshiro, H; Rino, Y; Wada, N; Watanuki, Y; Yamanaka, S; Yukawa, N, 2008)
"Cyclophosphamide (CTX) and ifosfamide (IFX) are alkylating agents used to treat osteosarcoma (OS)."3.73Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. ( Duan, X; Jia, SF; Kleinerman, ES; Koshkina, N, 2006)
"Ifosfamide, Carboplatin and Etoposide (ICE) therapy was used to treat 4 patients, 2 with refractory osteosarcoma, and one each with relapsed brain tumor and newly diagnosed brain tumor."3.70[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)]. ( Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M, 1998)
"In three new approved indications (non Hodgkin's lymphoma, Hodgkin's lymphoma and acute lymphoblastic leukaemia) and in three previously existing indications (ovarian cancer, soft tissue sarcomas and osteogenic sarcomas), non comparative trials show that ifosfamide can induce tumour regression in patients who relapse after a first course of chemotherapy (sometimes containing cyclophosphamide)."3.70Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness. ( , 1998)
"Generalized and partial seizures with secondary generalization were observed during ifosfamide-mesna (IFO) treatment in a patient with lung epidermoid carcinoma."3.69[Epileptic seizures and treatment with ifosfamide-mesna]. ( Farisse, P; Somma-Mauvais, H; Viallat, JR, 1994)
" A 16-year-old girl with metastatic osteosarcoma experienced recurrent bouts of symptomatic pancreatitis 24 hours after treatment with ifosfamide administered as a single agent."3.69Acute pancreatitis after ifosfamide therapy. ( Adamson, PC; Balis, FM; Blaney, SM; Izraeli, S, 1994)
"Patients with advanced adenocarcinoma of the lung with measurable or assessable disease received chemotherapy with mesna, ifosfamide, carboplatin, and etoposide (MICE)."3.69Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study. ( Boerrigter, L; Mooi, WJ; Rodenhuis, S; Slebos, RJ; Top, B; van Zandwijk, N; van't Veer, L, 1997)
"Patients with lung metastases originating from an osteosarcoma of the extremity received chemotherapy (high dose methotrexate, cisplatin, doxorubicin, and ifosfamide) followed by simultaneous resection of primary and metastatic lesions and additional chemotherapy."3.69Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. ( Bacci, G; Bertoni, F; Briccoli, A; Donati, D; Ferrari, S; Forni, C; Manfrini, M; Mercuri, M; Monti, C; Zanoni, A, 1997)
"From January 1990 to December 1995 we treated 35 patients (pts) with bone and soft tissue sarcoma with ifosfamide (IFM)."3.69[The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas]. ( Ishii, T; Kitoh, M; Satoh, T; Tatezaki, S; Umeda, T; Yonemoto, T, 1997)
"The series of 9 compounds, including 3 racemates and 6 enantiomers of bromine-substituted analogues of ifosfamide (bromo-, chlorobromo- and dibromofosfamides) have been evaluated for antitumor activity against L1210 leukemia, Lewis lung carcinoma and B16 melanoma in mice."3.68Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds. ( Glazman-Kuśnierczyk, H; Matuszyk, J; Radzikowski, C, 1992)
"Forty seven patients with inoperable adenocarcinoma and large cell carcinoma of the lung were treated with a combination of cisplatin (25 mg/m2), ifosfamide (1."3.68[Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung]. ( Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Mori, T; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A, 1991)
"A 13-year-old boy with unresectable pulmonary metastatic osteosarcoma, which was refractory to high dose methotrexate, adriamycin, cisplatin and combination of bleomycin, cyclophosphamide and actinomycin D, was treated by aggressive chemotherapy including the combination of ifosfamide (1 g/m2 x day 1-4), Carboplatin (100 mg/m2 x day 1-4) and Vindesine (4 mg/m2 x day 1)."3.68[Successful treatment of metastatic and refractory osteosarcoma by ifosfamide, carboplatin and vindesine: case report]. ( Fujita, H; Ishimoto, K; Kiyokawa, N; Kyo, K; Mizuno, T; Takada, K; Yabuta, K, 1991)
"The mesna, doxorubicin, ifosfamide, dacarbazine regimen produced a 47% response rate (including 10% complete responses) in 105 eligible adults with advanced sarcoma."3.68Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma. ( Aisner, J; Antman, KH; Elias, A; Ryan, L, 1990)
"Thirty-seven patients with widely metastatic malignant melanoma were treated with one of three chemotherapy regimens, incorporating high-dose dacarbazine (DTIC)."3.67High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma. ( Carr, T; Chadwick, G; Craig, P; Jones, R; Lind, M; Morgenstern, G; Thatcher, D, 1989)
"Fifty-three patients with inoperable non-small cell bronchial carcinoma were treated at four-weekly intervals with two cytostatic drugs, doxorubicin (50 mg/m2 on day 1) and ifosfamide (2000 mg/m2 on days 1-3)."3.66[Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide]. ( Göbel, D; Matthiessen, W; Stempinski, E; Thalmann, U, 1983)
" This phase II study evaluated the efficacy and safety of IFM combination with recommended current supportive therapy for recurrent SCLC in second-line and heavily treated setting."2.87A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting. ( Fukatsu, A; Hase, T; Hasegawa, Y; Hayashi, H; Kawada, K; Kondo, M; Morise, M; Nomura, F; Sokai, A; Tanaka, I, 2018)
"Ifosfamide is a chloro-isophosphoramide prodrug activated by hepatic Cytochrome P450 enzymes."2.82Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models. ( Ahluwalia, D; Ferraro, DJ; Hart, CP; Jung, D; Liu, Q; Matteucci, MD; Sun, JD; Wang, Y, 2016)
"The European Intergroup Cooperative Ewing's Sarcoma Study investigated whether cyclophosphamide has a similar efficacy as ifosfamide in standard-risk (SR) patients and whether the addition of etoposide improves survival in high-risk (HR) patients."2.73Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. ( Cassoni, A; Craft, AW; Douglas, C; Dunst, J; Grimer, R; Hackshaw, A; Hunold, A; Jürgens, H; Köhler, G; Ladenstein, R; Lewis, I; McTiernan, A; Paulussen, M; Poremba, C; Schuck, A; Spooner, D; van den Berg, H; Whelan, J; Winkelmann, W; Zoubek, A, 2008)
"To investigate the prognostic value of systemic exposure to etoposide (Area Under the concentration Curve (AUC(VP16))) on overall survival (OS) in patients with small cell lung cancer (SCLC)."2.73Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study. ( Chabaud, S; Court-Fortune, I; Falandry, C; Fournel, C; Freyer, G; Girard, P; Ribba, B; Souquet, PJ; Tod, M; Tranchand, B; Trillet-Lenoir, V; You, B, 2008)
"Paclitaxel was given at the dose of 200 mg/m iv in 3 hours, ifosfamide (with mesna) at the dose of 3 g/m and carboplatin at an area under the curve 5, on day 1, every 21 days for a total of six cycles in responding or stabilized patients."2.71Phase II study of Taxol combined With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancer. ( Ardizzoni, A; Ariganello, O; Boni, C; Cafferata, MA; De Marinis, F; Meriggi, F; Neumaier, CE; Portalone, L; Rosso, R; Torri, V; Zaniboni, A, 2003)
"Ifosfamide is an active alkylating agent used in the first-line treatment of NSCLC."2.71Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel. ( Chen, MC; Chen, YM; Lee, CS; Lin, WC; Perng, RP; Shih, JF; Tsai, CM, 2003)
"Secondary objectives were time to disease progression, response rates, evaluation of toxicity, disease-related symptoms, World Health Organization performance status (PS), and quality of life (QoL)."2.71Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. ( Anderson, H; Ashcroft, L; Beresford, C; Burt, PA; Clemons, M; Danson, S; Dowd, I; Fairve-Finn, C; Hassan, J; Middleton, MR; O'Byrne, KJ; Ranson, M; Stout, R; Thatcher, N, 2003)
"Ifosfamide (I) has also been approved for NSCLC treatment."2.71Phase I study with dose escalation of gemcitabine and cisplatin in combination with ifosfamide (GIP) in patients with non-small-cell lung carcinoma. ( Billiart, I; Bourgeois, H; Chabrun, V; Chieze, S; Daban, A; Ferrand, V; Germain, T; Lemerre, D; Meurice, JC; Tourani, JM, 2004)
" Haematological toxicity and dosage reductions were higher with SuperMIP, which was nevertheless associated with a significantly increased absolute dose intensity."2.71A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer. ( Berghmans, T; Corhay, JL; Efremidis, A; Giner, V; Koumakis, G; Lafitte, JJ; Lecomte, J; Lothaire, P; Mommen, P; Ninane, V; Paesmans, M; Richez, M; Sculier, JP; Thiriaux, J; Van Houtte, P; Wackenier, P, 2004)
"Grade 3 thrombocytopenia was observed in five cases (36%)."2.71Combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in patients with metastatic urothelial cancer: a preliminary report. ( Kitamura, T; Kume, H; Matsumoto, S; Nishimatsu, H; Okamoto, N; Suzuki, M; Takahashi, S; Tomita, K, 2005)
"Grade 3-4 neutropenia was the dose limiting toxicity, observed in 36% of patients."2.71Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial. ( Brunetti, C; Cassano, G; Colucci, G; Galetta, D; Gebbia, V; Germano, D; Giampaglia, M; Guida, M; Izzi, G; Lorusso, V; Nettis, G; Silvestris, N; Spada, M, 2005)
"To find the maximum tolerated dose for ifosfamide in combination with paclitaxel and carboplatin in small-cell lung cancer patients (SCLC), who are resistant to cyclophosphamide, doxorubicin and etoposide (CDE)."2.70Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer. ( Beijnen, JH; Groen, HJ; Kerbush, T; Sleijfer, DT; Smit, EF; van Putten, JW; van Rijswijk, R, 2001)
" Peak concentration of 47 micrograms/ml was observed after 1 h."2.70Pharmacokinetics and toxicity of oral (-)-(S)-bromofosfamide in lung cancer patients. ( Gasiorek, M; Kobylińska, K; Kobylińska, M; Koralewski, P; Sobik, B, 2001)
"Neutropenia was the dose limiting toxicity (G1=6%, G2=11%, G3=10%, G4=7%)."2.70Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer. ( Camps, C; García, R; Maestu, I; Montalar, J; Morales, S; Segura, A; Torregrosa, D; Vadell, C; Yuste, AL, 2001)
" No toxic death was reported."2.70Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC). ( Ardizzoni, A; Baldini, E; Boni, L; Cafferata, MA; Conte, PF; Neumaier, C; Prochilo, T; Rosso, R; Tibaldi, C, 2001)
"Paclitaxel was given after the first dose of ifosfamide on Day 1."2.69A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors. ( Berkowitz, R; Bunnell, CA; Buswell, L; Muto, M; Sheets, E; Shulman, LN; Thompson, L, 1998)
" The urinary profiles of mesna and dimesna excretion were determined on days 1, 2, and 5; pharmacokinetic parameters for blood samples were determined only on day 5."2.69Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide. ( Anthony, LB; Brade, WP; Bush, DA; Frazier, MW; Goren, MP; Hande, KR; Johnson, DH; Li, JT, 1998)
"Gemcitabine was administered at a dose of 1,000 mg/m2 on days 1, 8, and 15, followed by a 1-week rest, while ifosfamide was given at a dose of 1,500 mg/m2 on days 8 through 12."2.69Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancer. ( Blatter, J; Chomy, F; Chomy, P; Drings, P; Eberhard, W; Gatzemeier, U; Khayat, D; Manegold, C; Seeber, S; Wilke, HJ, 1998)
"Ifosfamide 4 g/m2 was given for 4 h by intravenous infusion on day 2."2.69Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer. ( Thongprasert, S, 1998)
"Megestrol acetate 250 mg PO was administered throughout the duration of chemotherapy."2.69A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial. ( Craffey, M; Dowlati, A; Levitan, N; MacKay, W; McKenney, J; Remick, SC; Tahsildar, H, 1998)
" Four patients were assigned to different dosage levels, and drug toxicity was evaluated for the first 2 cycles."2.69Phase I study of a combination of irinotecan and ifosfamide in advanced primary lung cancer. ( Gohara, R; Ichiki, M; Kawayama, T; Kinoshita, M; Mitui, T; Oizumi, K; Okubo, Y; Rikimaru, T, 1999)
"The ifosfamide dose was escalated as follows: 3000 mg/m2 (level 1), 5000 mg/m2 (level 2), 7000 mg/m2 (level 3), 9000 mg/m2 (level 4)."2.69A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer. ( Arakawa, M; Chou, D; Gejyo, F; Ito, K; Kagamu, H; Sakai, K; Shimbo, T; Suzuki, E; Takahashi, M; Tanaka, H; Tanaka, J; Wakabayashi, M; Yoshizawa, H, 2000)
" The present retrospective analysis assessed two ways of dosing carboplatin: according to body surface area (mg/m2) or to the estimated targeted area under the concentration versus time curve (AUC)."2.69A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party. ( Alexopoulos, CG; Berchier, MC; Bureau, G; Giner, V; Klastersky, J; Koumakis, G; Lafitte, JJ; Lecomte, J; Mommen, P; Ninane, V; Paesmans, M; Sculier, JP; Thiriaux, J; Zacharias, C, 1999)
"The gemcitabine dose was escalated from 500 to 1200 mg/m2 on days 3 and 8 every third week."2.69Ifosfamide, vinorelbine and gemcitabine in advanced non-small cell lung cancer. A phase I study. ( De Filippis, S; Guerriero, G; Pompili, P; Rea, S; Recchia, F; Rosselli, M, 1999)
"To determine the population pharmacokinetic (PK) parameters of doxorubicin (Dox), etoposide (Eto) and ifosfamide (Ifo) in small cell lung cancer (SCLC) patients, to assess the potential relationship between those parameters and to estimate the impact of individual morphological and biological covariates on patients' PK parameters."2.69Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study. ( Ardiet, C; Boissel, JP; Court-Fortune, I; Freyer, G; Girard, P; Ligneau, B; Rebattu, P; Riou, R; Souquet, PJ; Tranchand, B; Trillet-Lenoir, V, 2000)
" Our trial failed to demonstrate a significant improvement in response or survival when patients with metastatic NSCLC were treated, in addition to ifosfamide and mitomycin, by combination of moderate dosages of cisplatin and carboplatin instead of moderate dosage of cisplatin alone."2.69Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer. ( Alexopoulos, CG; Baumöhl, J; Berghmans, T; Florin, MC; Klastersky, J; Koumakis, G; Lafitte, JJ; Mommen, P; Ninane, V; Paesmans, M; Schmerber, J; Sculier, JP; Thiriaux, J; Zacharias, C, 2000)
"Paclitaxel dose levels were 135, 170, 200, 250, and 300 mg/m2."2.68Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. ( Bitran, JD; Drinkard, LC; Golomb, HM; Hoffman, PC; Krauss, SA; Masters, GA; Samuels, BL; Vokes, EE; Watson, S, 1995)
" The dosage of paclitaxel was escalated from 75 to 225 mg/m2."2.68A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. ( Carey, RW; Elias, AD; Grossbard, ML; Jacobs, C; Jauss, S; Kwiatkowski, DJ; Lynch, TJ; Shulman, LN; Strauss, GM; Sugarbaker, DJ, 1995)
"The early stages of bronchial carcinoma are still a domain of operative treatment."2.68[Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study]. ( Klinke, F; Micke, O; Rübe, C; von Eiff, M; Wagner, W; Willich, N, 1995)
"Ifosfamide is a chiral pro-drug which is administered clinically in its racemic form."2.68Pharmacokinetics of ifosfamide and its enantiomers following a single 1 h intravenous infusion of the racemate in patients with small cell lung carcinoma. ( Chrystyn, H; Corlett, SA; Parker, D, 1995)
"Ifosfamide was therefore decreased to 1."2.68Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. ( Drinkard, LC; Golomb, HM; Hoffman, PC; Masters, GA; Samuels, BL; Vokes, EE; Watson, S, 1996)
" MIP regimen was permanently suspended in 14 patients because of toxic events."2.68Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer. ( Baud, M; Bedin, A; Chouaid, C; Febvre, M; Lebeau, B; Urban, T, 1996)
"Ifosfamide was administered at a dose of 1."2.68Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study. ( Drinkard, LC; Golomb, HM; Hoffman, PC; Krauss, SA; Masters, GA; Samuels, BL; Vokes, EE, 1996)
"The addition of IFN-alpha to induction CT appears to confer a survival benefit to SCLC patients but optimal dosing schedule has yet to be defined."2.68Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial. ( Charitopoulos, K; Dimitriadis, K; Economides, D; Maglaveras, N; Papagiannis, A; Vamvalis, C; Zarogoulidis, K; Ziogas, E, 1996)
"Phlebitis was observed in 15 of 30 patients (50%) who did not have central implantable venous systems."2.68Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma. ( Amato, S; Barbieri, M; Cuevas, M; Dominguez, M; Lacava, J; Langhi, M; Leone, B; Machiavelli, M; Ortiz, E; Perez, J; Rodriguez, R; Romero Acuña, J; Romero Acuña, L; Romero, A; Sabatini, C; Salvadori, M; Vallejo, C, 1996)
" Both have a dose-response relationship."2.68Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma. ( de Wit, R; Planting, AS; Stoter, G; van der Burg, ME; Verweij, J, 1996)
"The ongoing phase I study reported here sought to determine the maximum tolerated doses of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) and carboplatin when given at specific times in combination with ifosfamide, mesna, and filgrastim."2.68Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results. ( Palackdharry, CS, 1997)
"Gemcitabine was administered at a dose of 1,000 mg/m2 on days 1, 8, and 15 followed by a 1-week rest, while ifosfamide was given at a dose of 1,500 mg/m2 on day 8 and days 9 through 12."2.68A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer. ( Blatter, J; Chomy, F; Chomy, P; Drings, P; Eberhard, W; Gatzemeier, U; Khayat, D; Manegold, C; Seeber, S; Wilke, HJ, 1997)
" The study design and dosing schedule are discussed in this report."2.68Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer. ( Golomb, HM; Hoffman, PC; Masters, G; Mauer, AM; Vokes, EE; Watson, S, 1997)
"We have treated 26 consecutive chemotherapy-naive patients with stage IIIB/IV non-small cell lung cancer with an innovative regimen based on a 1-hour infusion of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) 125 to 250 mg/m2, ifosfamide 3 g/m2 (with mesna), and carboplatin dosed to an area under the concentration-time curve of 5, every 21 days for a total of six cycles in responding or stabilized patients."2.68Paclitaxel, ifosfamide, and carboplatin for the treatment of stages IIIB and IV non-small cell lung cancer: preliminary results. ( Alghisi, A; Bozzola, G; Marini, G; Meriggi, F; Mutti, S; Pascarella, A; Rizzi, A; Zaniboni, A, 1997)
"Paclitaxel was escalated from 75 to 225 mg/m2 in 25-mg/m2 increments."2.68Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis. ( Carey, RW; Elias, AD; Grossbard, ML; Herbst, R; Jacobs, C; Kwiatkowski, DJ; Leong, T; Lynch, C; Lynch, TJ; Skarin, AT; Strauss, GM, 1997)
"Levels of depression were lower and showed little change."2.67A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party. ( Bleehen, NM; Girling, DJ; Machin, D; Stephens, RJ, 1993)
"Ifosfamide was infused at the dose of 2 g/m2 over a 4-hour bolus infusion, followed by 2-g/m2 24-hour continuous infusions of ifosfamide, for a total of 14 or 18 g/m2 (6-8 days)."2.67Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. ( Eckardt, J; Eilber, F; Forscher, C; Fu, YS; Holmes, C; Lowenbraun, S; Rosen, G, 1994)
"The etoposide dose was escalated, with six patients receiving 300 mg/m2 total dose (level 1), six receiving 600 mg/m2 (level 2), three receiving 900 mg/m2 (level 3), and five receiving 1,200 mg/m2 (level 4)."2.67Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer. ( Comis, R; Haas, N; Kilpatrick, D; Krigel, RL; Langer, C; Padavic, K; Palackdharry, CS, 1994)
"Verapamil 480 mg day-1 was given for 3 days starting 24 h prior to chemotherapy which consisted of bolus vindesine 7 mg followed by ifosfamide/mesna 5 g m-2 over 24 h, followed by mesna alone for a further 8 h."2.67Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study. ( Cantwell, BM; Corris, PA; Harris, AL; Millward, MJ; Munro, NC; Robinson, A, 1993)
"Ifosfamide has shown promising single-agent activity in non-small cell lung cancer."2.67Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report. ( Dhingra, HH; Greenberg, J; Hong, WK; Lee, JS; Shirinian, M, 1992)
"Oral etoposide was given on days 1-5, 15-19, and 29-33."2.67A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer. ( Anderson, H; Prendiville, J; Radford, JA; Swindell, R; Thatcher, N, 1991)
"Ifosfamide was administered by intravenous drip infusion at a daily dose of 2 g/m2 for 5 consecutive days, and mesna was intravenously administered at 20% of the ifosfamide dose, three times daily for 5 consecutive days."2.67Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders. ( Fukuoka, M; Furuse, K; Ikegami, H; Kawahara, M; Kodama, N; Masuda, N; Nakamura, S; Negoro, S; Nishio, H; Ohnoshi, T, 1991)
"Thirty six patients with advanced solid tumors (24 lung: 3 oat-cell, 14 squamous, 7 adenocarcinomas, 3 soft tissue sarcomas, 6 breast carcinomas; 1 seminoma; 2 ovarian adenocarcinomas) entered a phase II study of high-dose ifosfamide (IF) administered in combination with the uroprotective agent sodium 2-mercapto-ethane-sulfonate (Mesna)."2.65Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors. ( Brema, F; Cinquegrana, A; Nobile, MT; Rosso, R; Santi, L, 1984)
" The major dose-limiting toxic effect of CIA was leukopenia."2.64Protection against chemotherapy toxicity by IV hyperalimentation. ( Bodey, GP; Copeland, EW; Dudrick, SJ; Freireich, EJ; Issell, BF; Valdivieso, M; Zaren, HA, 1978)
" A daily dosage of 50 to 60 mg/kg ifosfamide on 5 consecutive days produced the best results."2.64Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide. ( Brock, N; Burkert, H; Fichtner, E; Schnitker, J, 1976)
"Extraosseous Ewing sarcoma is a rare, poorly differentiated round-cell tumour that is part of the Ewing sarcoma family of tumours."2.61Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature. ( Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A, 2019)
"Chemotherapy for treatment of osteosarcoma was demonstrated to be effective in eradicating primary tumor and pulmonary metastases in the mid-twentieth century."2.50Historical perspective on the introduction and use of chemotherapy for the treatment of osteosarcoma. ( Jaffe, N, 2014)
" We therefore investigated the therapeutic efficacy of STI571, alone or combined with chemotherapy, in human SCLC cells or tumors xenografted into nude mice."2.43In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy. ( de Cremoux, P; Decaudin, D; Fréneaux, P; Judde, JG; Livartowski, A; Nemati, F; Pouillart, P; Poupon, MF; Sastre, X; Tran-Perennou, C, 2005)
"Synovial sarcoma is a malignant soft-tissue neoplasm, usually arising in close association with the joints and generally carrying a poor prognosis."2.43Bilateral metastatic renal synovial sarcoma. ( Matin, SF; Pollock, RE; Stage, AC, 2005)
"Myxoid liposarcoma has a relatively good prognosis but tends to recur locally."2.43Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review. ( Clarke, PM; Sandison, A; Tysome, JR, 2006)
"Ifosfamide is an old drug still considered an effective cytostatic agent in the treatment of NSCLC."2.42Ifosfamide in non-small cell lung cancer. ( Boni, C; Zanelli, F, 2003)
"Brain metastases are rare in the natural history of Wilms tumor."2.41Brain metastases in Wilms' tumor: case report and literature review. ( Grimard, L; Halton, JM; Hsu, E; MacRae, R; Nizalik, E, 2002)
"Ifosfamide has been in use for several decades and is generally considered to be one of the most effective drugs for the treatment of non-small cell lung cancer (NSCLC)."2.40Ifosfamide and docetaxel in non-small cell lung cancer. ( Büchholz, E; Drings, P; Manegold, C, 1998)
"Ifosfamide has been combined with gemcitabine in a phase I/II study."2.40Combination studies with gemcitabine in the treatment of non-small-cell lung cancer. ( Steward, WP, 1998)
"Gemcitabine has a mild toxicity profile that allows it to be combined easily in triplet combinations with other doublets."2.40Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer. ( Bunn, PA, 1999)
"Ifosfamide has been used in combination with several drugs including cisplatin, giving rise to multiple doublets and triplets including the ifosfamide-cisplatin-mitomycin regimen (Cullen's MIC regimen) that has been commonly used in Europe."2.40Ifosfamide in non-small-cell lung cancer. ( Balaña, C; Martin, C; Rosell, R, 1999)
"Paclitaxel has been used in combination with several other nonplatinum agents for the treatment of NSCLC."2.40Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer. ( Langer, CJ; Socinski, MA, 1999)
"Ifosfamide has been found to have antineoplastic activity in a variety of solid tumors."2.39The role of ifosfamide in germ cell tumors and small cell lung cancer. ( Nichols, CR, 1995)
"Ifosfamide is an analogue of cyclophosphamide that is active against a variety of solid tumors, including non-small cell lung cancer."2.39Ifosfamide in non-small cell lung cancer. ( Johnson, DH, 1996)
"Ifosfamide has the broad range of clinical activity, but its ultimate role as part of initial therapy remains to be discerned."2.38Clinical trials with ifosfamide: the Indiana University experience. ( Einhorn, LH; Loehrer, PJ; Nichols, CR; Williams, SD, 1992)
" The stability of ifosfamide and its high bioavailability have allowed its use in chronic, 7-day ambulatory IV infusions, with decreased toxicity and hospitalization."2.38Novel approaches with ifosfamide in small cell lung cancer. ( Cerny, T; De Campos, E; Lind, M; Thatcher, N, 1992)
"The role of chemotherapy in the treatment of myxofibrosarcoma is unclear."1.56Complete remission of a case of high-grade myxofibrosarcoma with lung metastases after modified MAID regimen chemotherapy. ( Cui, Y; Pan, Y; Shi, X, 2020)
"NUT carcinoma is an extremely rare disease and yet extremely aggressive with 2-year survival of only approximately 19% and median survival of 6 to 9 months."1.56Durable Complete Remission of PD-L1 Positive NUT Carcinoma Treated With Concurrent Chemotherapy and Radiation. ( Chang, JS; Pan, M, 2020)
"Malignant phyllodes tumors are rare breast neoplasms that are associated with a 6."1.51Complete remission of giant malignant phyllodes tumor with lung metastasis: A case report. ( Jung, JH; Kim, WW; Lee, J; Lee, JW; Lee, SJ; Moon, SH; Park, HY, 2019)
"Ameloblastoma is generally characterized as a benign tumor originating in odontogenic epithelium."1.51MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma: A case report. ( Li, D; Liu, Y; Qiao, L; Sun, M; Wang, L; Xu, S, 2019)
"Considering the physical condition of patient, the patient underwent surgical resection of the right lung lesion after receiving endostar combined with chemotherapy and maintained endostar alone for 47 cycles."1.46Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report. ( Dong, Y; Jiang, S; Wang, G, 2017)
"Patients with bones or brain metastases were treated with palliative radiotherapy only or combined with Doxorubicin."1.43Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast. ( Blecharz, P; Jakubowicz, J; Kulpa, J; Mituś, JW; Reinfuss, M; Walasek, T, 2016)
" The aim of this study was to assess the efficacy and safety of ifosfamide in combination with carboplatin and etoposide (ICE) in previously untreated patients with SCLC."1.42Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer. ( Koo, DH; Lee, HS; Lee, SS; Lee, YG; Lim, SY; Nam, H; Oh, S; Song, JU, 2015)
" A partial radiological response was achieved; dosage was reduced to 1."1.40Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases. ( Basso, U; Maruzzo, M; Montesco, MC; Rastrelli, M; Roma, A; Zanardi, E, 2014)
"Pediatr Blood Cancer 2015;62:274-278."1.40 ( Adiguzel, R; Andreana, PR; Arslan, Z; Ates, M; Bemis, T; Bercovitch, LG; Bögli, S; Boucherez, J; Boudouf, S; Briat, JF; Brown, BM; Busemann, A; Buters, J; Byers, JS; Cairo, MS; Carrier, F; Chalmers, JJ; Chang, E; Chen, J; Chen, Y; Christenson, MK; Cielecka-Piontek, J; Cole, PA; Cooper, BS; Davis, PH; De Silva, RA; Decato, S; DeFries, RS; Demir, V; Denic, A; Deserno, M; Dickey, AM; Diss, E; Eberlein, B; Eyerich, S; Faluvegi, G; Farlow, MR; Fletcher, JW; Francetic, T; Furlan, L; Garbacki, P; Gartung, A; Garvin, JH; Gates, L; Gaymard, F; Ghetti, B; Gibson, MP; Griffin, RG; Hamed, M; Hammad, LA; Hammond, GB; Han, J; Hann, R; Hao, N; Harrison, LA; Heidecke, CD; Hutchins, GD; Inlow, M; Irmer, H; Jani, P; Jara-Cavieres, A; Jawadi, H; Jiang, Q; Jiang, Y; Kameda, T; Keeler, EG; Kim, H; Kim, R; Kim, S; Kinney, PL; Krause, A; Kumar, V; Kwok, Y; Lam, T; Lanni, F; Le May, M; Lee, A; Lee, JF; Lee, MJ; Leontyev, IV; Li, Q; Li, X; Liu, J; Liu, NK; Lominadze, D; Lösche, M; Lu, QB; Lu, Y; Lu, Z; Mach, H; Madsen, E; Marletta, M; Marlier, ME; McDonald, BC; McKay, IS; Mckenzie, CL; Mecozzi, S; Menges, P; Meyers, D; Michaelis, VK; Montooth, KL; Moore, LR; Morgan, JK; Morris, E; Movahed, M; Nalabothula, N; Narayanan, S; Nguyen, D; Nho, K; Oken, B; Ong, TC; Osborne, LS; Paczkowska, M; Park, EK; Pennino, D; Peters, S; Potluri, LP; Qin, C; Radhakrishnan, K; Randerson, JT; Rantanen, J; Reyt, G; Ring, J; Risacher, SL; Rodriguez, M; Saykin, AJ; Schmidt-Weber, CB; Sengelaub, DR; Shatters, RG; Shen, L; Shen, V; Shindell, DT; Stuchebrukhov, AA; Swaminathan, S; Takahashi, K; Talaczyńska, A; Tallman, EF; Tan, C; Terry, SF; Trabbic, KR; Trease, AJ; Tretter, C; Uitto, J; Váradi, A; von Bernstorff, W; Voulgarakis, A; Wagenhofer, M; Wahbeh, H; Wang, EN; Wang, X; Wells, RJ; West, JD; Williams, PS; Wolff, JE; Wootla, B; Xu, B; Xu, XM; Yoder, KK; Zalewski, P; Zan, GH; Zborowski, M; Zhang, HH; Zhang, W; Zhao, J; Zoecklein, L, 2014)
"Alveolar soft part sarcomas are rarely seen and highly malignant tumors, and the prognosis of stage IV ASPS is poor."1.38[Treatment and prognosis of stage IV alveolar soft part sarcoma]. ( Yang, Y; Zhao, J, 2012)
" No significant dose-response relationship was found in terms of LRC."1.37Sequential or concomitant chemotherapy in limited stage small-cell lung cancer. ( Anchisi, S; Bieri, S; Elhfidh, M; Khanfir, K; Matzinger, O; Mirimanoff, RO; Ozsahin, M; Zouhair, A, 2011)
"Breast stromal sarcoma is very rare, accounting for less than 1% of mammary neoplasms, and the treatment strategy is not well established, especially regarding chemotherapy."1.37Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: report of a case. ( Inoue, K; Iwase, H; Kuriwaki, K; Sueta, A; Yamamoto, Y, 2011)
"We present a case of pleomorphic malignant fibrous histiocytoma arising from the left forearm in a 45-year-old man who had undergone resection and radiotherapy for a tumor 3 years previously."1.35Pleomorphic malignant fibrous histiocytoma: response of bone, lung, and brain metastases to chemotherapy. ( Hoshi, M; Ieguchi, M; Takami, M, 2008)
"A 30-year-old man was diagnosed with testicular cancer, and underwent a radical orchiectomy."1.35[A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin]. ( Egawa, S; Hatano, T; Ito, H; Kishimoto, K; Tomita, M; Wada, T; Yanada, S, 2008)
"From 1979 to 2002, 27 patients with Ewing's sarcoma (20) or PNET (7) were treated."1.34Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands. ( Boven, E; Meijer, OW; Smorenburg, CH; van Groeningen, CJ; Visser, M, 2007)
"Paclitaxel (175 mg/m(2)) was administered on day 1 and ifosfamide (2500 mg/m(2)) on day 1-2 every 3 weeks."1.34Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer. ( Ahn, JS; Ahn, MJ; Hong, YS; Hwang, IG; Kang, WK; Lee, J; Lee, SC; Lim, H; Park, BB; Park, JO; Park, K; Park, S, 2007)
"The response of adult soft tissue sarcoma (STS) to chemotherapy is uncertain."1.34[Responses of 109 adult soft tissue sarcoma patients to chemotherapy]. ( Guan, ZZ; Huang, HQ; Jiang, WQ; Li, FH; Lin, TY; Luo, HY; Qiu, MZ; Sun, XF; Wang, F; Wang, SS; Xu, F; Xu, GC; Xu, RH, 2007)
"Angiosarcomas are rare soft tissue malignancies."1.33Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature. ( Bearz, A; Berretta, M; Berretta, S; Brollo, A; Buonadonna, A; Canzonieri, V; Frustaci, S; Morra, A; Rupolo, M; Tirelli, U, 2006)
" The purpose of the study was to determine the optimal dosage and the maximal tolerated dose (MTD) of a specified schedule of gemcitabine and ifosfamide."1.33Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer. ( Aschroft, L; Baka, S; Blackhall, F; Buchholz, E; Lorigan, P; Manegold, C; Nagel, S; Schott-von-Römer, K; Thatcher, N, 2006)
"Synovial sarcoma is an extremely rare primary pulmonary tumor whose description is based on a limited number of cases."1.32[Primary pulmonary synovial sarcoma: a report and diagnosis of 2 cases]. ( Baldo Padró, X; Bernadó Turmo, L; Haro Estarriol, M; Rubio Goday, M; Sebastián Quetglas, F; Viñas Villaró, G, 2003)
"Spinal cord compression has also been rarely reported in all age groups."1.32Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent. ( Akansel, G; Arisoy, AE; Calişkan, M; Corapcioglu, F; Dillioğlugil, O; Sarper, N, 2004)
"The response rate in brain metastases was 50."1.31Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer. ( Fujita, A; Fukuoka, S; Sekine, K; Tagaki, S; Takabatake, H, 2000)
"The aim of this study was to develop a population pharmacokinetic model that could describe the pharmacokinetics of ifosfamide."1.31Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients. ( Beijnen, JH; Groen, HJ; Huitema, AD; Kerbusch, T; Mathĵt, RA; vanPutten, JW, 2001)
" Similar dose-response curves were found for both metabolites."1.30Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide. ( Brüggemann, SK; Kisro, J; Wagner, T, 1997)
"The role and value of chemotherapy for soft tissue sarcomas remain unclear."1.30[Chemotherapy for pulmonary metastases of soft tissue sarcoma]. ( Kito, M; Umeda, T, 1998)
"But pulmonary hemorrhage and respiratory failure resulted in her death 7 months after initial diagnosis."1.30Treatment of primary pure angiosarcoma of ovary with multiple lung metastases: a case report. ( Chao, KC; Juang, CM; Lai, CZ; Lu, CJ; Twu, NF; Yeng, MS, 1999)
" These results compare favourably with other combined modality studies, using multiple radiotherapy fractions with cisplatin-based combinations and dosage reduction for patients staged in more anatomical detail."1.29Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation. ( Burt, P; Hicks, F; Leahy, B; Lorigan, P; Prendiville, J; Stout, R; Thatcher, N, 1994)
"Ifosfamide was administered at the daily dose of 1200 mg/m2/24 h."1.29[Peri-operative chemotherapy during resection of pulmonary metastases of sarcoma]. ( Azorin, JF; Delepine, G; Delepine, N; Destable, MD; Pocard, M; Tremblay, B, 1994)
" The dosage of IEP in this study caused moderate toxicity."1.29Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC). ( Jiamsriponges, K; Thongprasert, S, 1993)
"A case of malignant fibrous histiocytoma (MFH) of jejunal origin with brain and lung metastases was treated by jejunal resection."1.29[A case of malignant fibrous histiocytoma of jejunal origin with marked response to cisplatin, ifosfamide and adriamycin]. ( Fujita, A; Isai, H; Kondo, M; Minase, T; Sekine, K; Tagaki, S, 1993)
" Moreover, a dose-response relationship was detectable: 1/6 patients without lung irradiation vs."1.29Lung irradiation for Ewing's sarcoma with pulmonary metastases at diagnosis: results of the CESS-studies. ( Dunst, J; Jürgens, H; Paulussen, M, 1993)
" As compared with the values obtained on day 1, on day 5 the terminal half-life and AUC values determined for IF were reduced by 30% (6."1.29Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy. ( Kurowski, V; Wagner, T, 1993)
"Ifosfamide has shown promising single-agent activity in non-small cell lung cancer (NSCLC)."1.28Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer. ( Dhingra, HH; Greenberg, J; Hong, WK; Lee, JS; Shirinian, M, 1992)
"The authors report a case of pulmonary squamous cell carcinoma which occurred after chemotherapy of non-Hodgkin's lymphoma (NHL)."1.28[Elderly non-Hodgkin's lymphoma presenting with pulmonary squamous cell carcinoma as a complication of chemotherapy for malignant lymphoma]. ( Annoh, S; Arai, N; Kaneko, H; Shirai, T; Tsukahara, T; Umeda, M, 1992)
"Cerebral metastases occurred in 20% of all patients and was the apparent sole site of relapse in 11% of the CR patients."1.28Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy. ( Burt, P; Prendiville, J; Radford, J; Ranson, M; Steward, W; Stout, R; Thatcher, N, 1991)
"Ifosfamide is a newly available analog of cyclophosphamide in the oxazaphosphorine drug class."1.28Ifosfamide vs cyclophosphamide in cancer therapy. ( Weiss, RB, 1991)
"Thirty-one patients with inoperable squamous cell carcinoma of the lung were treated with a combination of cis-platin (CDDP, 100 mg/m2 day 1), ifosfamide (IFX, 2 g/m2 day 1, 2, 3; with mesna) and vindesine (VDS, 3 mg/m2 day 1)."1.28[Cisplatin, ifosfamide and vindesine in the chemotherapy of squamous cell carcinoma of the lung]. ( Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A, 1991)
" A positive correlation was found between the elimination half-life of ifosfamide and age (r = 0."1.28The effect of age on the pharmacokinetics of ifosfamide. ( Cerny, T; Lind, MJ; Margison, JM; Thatcher, N; Wilkinson, PM, 1990)
" Treatment was repeated every 3 weeks for a maximum of six courses and no dosage reductions were allowed."1.28Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis. ( Bronchud, MH; Kamthan, AG; Lind, MJ; Ranson, MR; Steward, WP; Stout, R; Thatcher, N, 1990)
"The course of 72 patients (36 with squamous carcinoma, 25 with adenocarcinoma, two with alveolar-cell carcinoma and nine with large-cell carcinoma) could be evaluated."1.27[Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin]. ( Abel, U; Dirks, HP; Drings, P; Grimm, V; Heinrich, S; Kleckow, M; Manke, HG; Queisser, W; Stiefel, P, 1984)
" The collected experience emphasizes the many individual variables encountered in clinical practice complicating the effort of correlating pharmacokinetic data with clinical results."1.27Pharmacokinetic studies in lung cancer patients. ( Cattaneo, MT; Piazza, E; Varini, M, 1984)
"The most frequent histology was squamous cell carcinoma found in 20 patients."1.27[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma]. ( Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R, 1985)
" IFN-alpha nl alone at this dosage was shown to have some cytotoxic activity."1.27Augmentation of cytotoxicity of chemotherapy by human alpha-interferons in human non-small cell lung cancer xenografts. ( Balkwill, FR; Carmichael, J; Fergusson, RJ; Smyth, JF; Wolf, CR, 1986)
"Ifosfamide at 5 g/m2 was given as a bolus to 48 patients with advanced progressing non-small cell lung cancer."1.27Ifosfamide by bolus as treatment for advanced non-small cell lung cancer. ( Anderson, H; Hilton, A; Rahman, A; Smith, DB; Steward, WP; Thatcher, N; Webb, K, 1986)
"The etoposide combination was tolerated better."1.27Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer. ( Abel, U; Bülzebruck, H; Drings, P; Kleckow, M; Manke, HG; Stiefel, P, 1986)
"Ifosfamide and mesna were administered to 77 patients with advanced malignancies."1.27Prediction of ifosfamide/mesna associated encephalopathy. ( Blackledge, G; Blake, AE; Honigsberger, L; Kelly, KA; Meanwell, CA, 1986)
" There was a proportionate increase in the AUC for the 5-g oral dose, indicating 100% bioavailability at all three dose levels."1.27Bioavailability of ifosfamide in patients with bronchial carcinoma. ( Cerny, T; Margison, JM; Thatcher, N; Wilkinson, PM, 1986)
"Ifosfamide (Holoxan) has an effect as a single drug on testicular carcinoma and shows synergism with cisplatinum in mice."1.26The value of ifosfamide in the polychemotherapy of metastasized testicular cancer pretreated with chemotherapy. ( Clemm, C; Hartenstein, R; Wilmanns, W, 1982)
"Oral ifosfamide therapy was determined to be feasible, and further studies are justified to assess the pharmacokinetics of the optimum dosage and scheduling regimens."1.26The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma. ( McNiel, NO; Morgan, LR, 1981)
"Ifosfamide was administered to 21 patients with recurrent or disseminated lung cancer at a dose of 4."1.26Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules. ( Costanzi, JJ; Gagliano, R; Hokanson, JA; Loukas, D; Panettiere, FJ, 1978)
"153 patients with inoperable malignant tumors were treated by the so-called synchronization therapy with vincristine and ifosfamide."1.26[Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)]. ( Hartwich, G; Lutz, H; Neidhardt, B, 1978)
"12 patients with extensive metastases of malignant testicular tumors and 5 other patients with other rapidly growing metastasizing tumors were treated."1.25[Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)]. ( Jonas, U; Körner, F; Lund, S, 1975)

Research

Studies (737)

TimeframeStudies, this research(%)All Research%
pre-1990120 (16.28)18.7374
1990's312 (42.33)18.2507
2000's216 (29.31)29.6817
2010's80 (10.85)24.3611
2020's9 (1.22)2.80

Authors

AuthorsStudies
Miao, L1
Ma, ST1
Jiang, X1
Zhang, HH2
Wang, YM1
Li, M1
Conforti, F1
Pala, L1
Vivanet, G1
Corti, C1
Catania, C1
Maiettini, D1
Varano, G1
Di Venosa, B1
Curigliano, G2
Salvini, P1
Berardi, R1
Ballatore, Z1
De Pas, TM1
Miyoshi, AI1
Ueda, Y1
Kurita, T1
Kimura, T1
Yoshino, K1
Hosomi, T1
Shibasaki, N1
Otsuka, H1
Uketa, S1
Makino, Y1
Shichiri, Y1
Maroun, CA1
Khalifeh, I1
Tfayli, A1
Moukarbel, RV1
Cui, Y1
Pan, Y1
Shi, X1
Inoue, S1
Hirai, S2
Katayama, T1
Benkhaled, S1
Mané, M1
Jungels, C1
Shumelinsky, F1
Aubain, NS1
Van Gestel, D1
Pan, M1
Chang, JS1
Hui, C1
Shin, DH1
Wakeling, A1
Donaldson, SS1
Hazard, FK1
Rangaswami, A1
Hiniker, SM1
Pannu, AK1
Sharma, N1
Young, RJ1
Litière, S1
Lia, M1
Hogendoorn, PCW1
Fisher, C1
Mechtersheimer, G1
Daugaard, S1
Sciot, R1
Collin, F1
Messiou, C1
Grünwald, V1
Gronchi, A1
van der Graaf, W1
Wardelmann, E1
Judson, I1
Meazza, C2
Cefalo, G1
Massimino, M1
Daolio, P2
Pastorino, U2
Scanagatta, P2
Morosi, C1
Podda, M3
Ferrari, A3
Terenziani, M1
Spreafico, F1
Casanova, M2
Parafioriti, A1
Collini, P2
Gandola, L2
Bastoni, S1
Biassoni, V1
Schiavello, E1
Chiaravalli, S1
Puma, N1
Bergamaschi, L1
Luksch, R2
Tanaka, I1
Kawada, K1
Morise, M1
Hase, T1
Hayashi, H2
Sokai, A1
Fukatsu, A1
Kondo, M2
Nomura, F1
Hasegawa, Y1
Jiang, S1
Wang, G1
Dong, Y1
Carden, MA1
Perdahl-Wallace, E1
Greenberg, J3
McCarty, JM1
Lee, J3
Jung, HA1
Kim, Y2
Choi, S1
Han, J2
Choi, YL1
Lee, SH1
Ahn, JS2
Park, K4
Sun, JM1
Tatenuma, T1
Mizuno, N1
Jikuya, R1
Hashizume, A1
Yasui, M1
Umemoto, S1
Kawai, M1
Hiruma, T1
Kishida, T1
Jiang, L1
Xu, X1
Davies, H1
Shi, K1
Moon, SH1
Jung, JH1
Kim, WW1
Park, HY1
Lee, JW1
Lee, SJ1
Li, D1
Xu, S3
Sun, M1
Qiao, L1
Wang, L1
Liu, Y1
Yamamoto, Y3
Tsukiyama, I1
Nii, S1
Harada, R1
Watanabe, K2
Yabushita, H1
Wakatsuki, A1
Saito, H4
Hasegawa, T1
Tiseo, M2
Bordi, P1
Bortesi, B1
Boni, L4
Boni, C7
Baldini, E9
Grossi, F2
Recchia, F4
Zanelli, F4
Fontanini, G1
Naldi, N1
Campanini, N1
Azzoni, C1
Bordi, C1
Ardizzoni, A10
Choeyprasert, W1
Natesirinilkul, R1
Charoenkwan, P1
Sittipreechacharn, S1
Johnson, K1
Notrica, DM1
Carpentieri, D1
Jaroszewski, D1
Henry, MM1
Al-Hader, AA1
Jain, A1
Al-Nasrallah, N1
Einhorn, LH9
Koufos, N1
Michailidou, D1
Xynos, ID1
Tomos, P1
Athanasiadou, K1
Kosmas, C6
Tsavaris, N3
Ozdemir, O1
Ozdemir, P1
Veral, A1
Uluer, H1
Ozhan, MH1
Berghmans, T13
Lafitte, JJ14
Scherpereel, A5
Paesmans, M14
Lecomte, J11
Marco, VG1
Meert, AP6
Leclercq, N4
Sculier, JP19
Okuno, S1
Petersen, I1
Shives, T1
Mahoney, M1
Haddock, M1
Sim, F1
O'Connor, MI1
Markovic, SN1
Maples, W1
Dutour, A1
Josserand, V1
Jury, D1
Guillermet, S1
Decouvelaere, AV1
Chotel, F1
Pointecouteau, T1
Rizo, P1
Coll, JL1
Blay, JY1
Jaffe, N2
Zanardi, E1
Maruzzo, M1
Montesco, MC1
Roma, A1
Rastrelli, M1
Basso, U2
Raciborska, A1
Bilska, K1
Drabko, K1
Chaber, R1
Sobol, G1
Pogorzała, M1
Wyrobek, E1
Połczyńska, K1
Rogowska, E1
Rodriguez-Galindo, C2
Wożniak, W1
Hung, GY1
Yen, HJ1
Yen, CC1
Chen, WM1
Chen, PC1
Wu, HT1
Chiou, HJ1
Chang, WH1
Hsu, HE1
Kameda, T1
Takahashi, K1
Kim, R1
Jiang, Y1
Movahed, M1
Park, EK1
Rantanen, J1
Marlier, ME1
DeFries, RS1
Voulgarakis, A1
Kinney, PL1
Randerson, JT1
Shindell, DT1
Chen, Y2
Faluvegi, G1
Diss, E1
Nalabothula, N1
Nguyen, D1
Chang, E1
Kwok, Y1
Carrier, F1
Radhakrishnan, K1
Lee, A1
Harrison, LA1
Morris, E1
Shen, V1
Gates, L1
Wells, RJ2
Wolff, JE1
Garvin, JH1
Cairo, MS1
Eberlein, B1
Hann, R1
Eyerich, S1
Pennino, D1
Ring, J1
Schmidt-Weber, CB1
Buters, J1
Dickey, AM1
Trease, AJ1
Jara-Cavieres, A1
Kumar, V1
Christenson, MK1
Potluri, LP1
Morgan, JK1
Shatters, RG1
Mckenzie, CL1
Davis, PH1
Osborne, LS1
Francetic, T1
Le May, M1
Hamed, M1
Mach, H1
Meyers, D1
Cole, PA1
Chen, J1
Li, Q1
Zborowski, M1
Moore, LR1
Williams, PS1
Chalmers, JJ1
Cooper, BS1
Hammad, LA1
Montooth, KL1
Bögli, S1
Brown, BM1
Marletta, M1
Tretter, C1
Wagenhofer, M1
Leontyev, IV1
Stuchebrukhov, AA1
Ates, M1
Demir, V1
Adiguzel, R1
Arslan, Z1
Zan, GH1
Tan, C1
Deserno, M1
Lanni, F1
Lösche, M1
Decato, S1
Bemis, T1
Madsen, E1
Mecozzi, S1
Trabbic, KR1
De Silva, RA1
Andreana, PR1
Wahbeh, H1
Oken, B1
Uitto, J1
Jiang, Q1
Váradi, A1
Bercovitch, LG1
Terry, SF1
Liu, J1
Zhao, J3
Lee, JF1
Gartung, A1
Jawadi, H1
Zhang, W1
Lominadze, D1
Lee, MJ1
Denic, A1
Wootla, B1
Zoecklein, L1
Rodriguez, M1
Kim, S1
Nho, K1
Risacher, SL1
Inlow, M1
Swaminathan, S1
Yoder, KK1
Shen, L1
West, JD1
McDonald, BC1
Tallman, EF1
Hutchins, GD1
Fletcher, JW1
Farlow, MR1
Ghetti, B1
Saykin, AJ1
Reyt, G1
Boudouf, S1
Boucherez, J1
Gaymard, F1
Briat, JF1
Hao, N1
Gibson, MP1
Jani, P1
Wang, X1
Lu, Y1
Qin, C1
Lu, Z1
Hammond, GB1
Xu, B1
Liu, NK1
Byers, JS1
Lam, T1
Lu, QB1
Sengelaub, DR1
Xu, XM1
von Bernstorff, W1
Irmer, H1
Menges, P1
Peters, S2
Heidecke, CD1
Busemann, A1
Li, X1
Narayanan, S1
Michaelis, VK1
Ong, TC1
Keeler, EG1
Kim, H1
McKay, IS1
Griffin, RG1
Wang, EN1
Furlan, L1
Paczkowska, M1
Zalewski, P1
Garbacki, P1
Talaczyńska, A1
Krause, A1
Cielecka-Piontek, J1
Xu, M2
Yu, X2
Ibrahim, ZA1
Chan, WH1
Wong, SL1
Ong, EJ1
Narihan, MZ1
Huang, YJ1
He, AN1
Sun, YJ1
Shen, Z1
Min, DL1
Yao, Y2
Pagano, M1
Baldi, L1
Gnoni, R1
Braglia, L1
Savoldi, L2
Liu, YP1
Jin, J1
Wang, WH1
Wang, SL1
Song, YW1
Fang, H1
Ren, H1
Liu, XF1
Yu, ZH1
Li, YX1
Grignani, G2
Martín-Broto, J1
Schuler, M1
Reichardt, P1
Schönknecht, C1
Hadjamu, M1
Oechsner, M1
Andratschke, N1
Duma, MN1
Zhou, Y1
Xu, Y1
Zhong, W1
Wang, M1
Lee, HS1
Lee, YG1
Koo, DH1
Oh, S1
Nam, H1
Song, JU1
Lim, SY2
Lee, SS1
Mituś, JW1
Blecharz, P1
Walasek, T1
Reinfuss, M1
Jakubowicz, J1
Kulpa, J1
Gallo, K1
Brickman, A1
Warren, WH1
Gattuso, P1
Seder, CW1
Sun, JD1
Liu, Q1
Ahluwalia, D1
Ferraro, DJ1
Wang, Y1
Jung, D1
Matteucci, MD1
Hart, CP1
Wang, B1
Saha, D1
Basu, A1
Maiti, A1
Rodriguez, E1
Lee, AC1
Nodomi, S1
Umeda, K1
Okamoto, T1
Saida, S1
Hiramatsu, H1
Adachi, S1
Heike, T1
Ranganath, P1
Kesler, KA1
Pagliaro, LC1
Zschäbitz, S1
Lasitschka, F1
Hadaschik, B1
Hofheinz, RD1
Jentsch-Ullrich, K1
Grüner, M1
Jäger, D1
Grüllich, C1
Thornton, K1
Pesce, CE1
Choti, MA1
Paulussen, M2
Craft, AW1
Lewis, I1
Hackshaw, A1
Douglas, C1
Dunst, J2
Schuck, A1
Winkelmann, W1
Köhler, G1
Poremba, C1
Zoubek, A1
Ladenstein, R1
van den Berg, H1
Hunold, A1
Cassoni, A1
Spooner, D2
Grimer, R1
Whelan, J1
McTiernan, A2
Jürgens, H2
Azim, HA1
Elattar, I1
Loberiza, FR1
Azim, H1
Mok, T1
Ganti, AK1
Hoshi, M1
Takami, M1
Ieguchi, M1
Girard, N1
Cottin, V1
Lapalus, MG1
Tronc, F1
Cordier, JF3
Bregni, M1
Pedrazzoli, P1
Shibuya, T1
Osada, T1
Kodani, T3
Hojo, M1
Ueyama, H1
Kato, J1
Nagahara, A1
Otaka, M1
Ogihara, T1
Nagao, K1
Fujime, M1
Watanabe, S1
Pintoffl, J1
Meisinger, I1
Mayer, F1
Horger, M1
von Weyhern, C1
Kanz, L8
Hartmann, JT2
Berretta, M2
Zanet, E1
Taibi, R1
Martellotta, F1
Pavone, P1
Bearz, A2
Gobitti, C1
Ciancia, EM1
Canzonieri, V2
Tirelli, U2
Grushka, JR1
Ryckman, J1
Mueller, C1
Roessingh, Ade B1
Walton, JM1
St Vil, D1
Laberge, JM1
Bernard, C1
Nguyen, VH1
Puligandla, PS1
Al Balushi, Z1
Bulduc, S1
Mulleur, C1
Lallier, M1
Loriot, Y1
Mordant, P1
Deutsch, E1
Olaussen, KA1
Soria, JC2
Némati, F3
Daniel, C1
Arvelo, F2
Legrier, ME1
Froget, B1
Livartowski, A3
Assayag, F1
Bourgeois, Y2
Poupon, MF4
Decaudin, D3
Zhao, H1
Wang, Z1
Lin, F1
Sun, Y2
Chen, P1
Barnoud, R1
Collardeau-Frachon, S1
de la Roche, E1
Vasiljevic, A1
Thomson, V1
Ranchère, D1
Devouassoux, G1
Devouassoux-Shisheboran, M1
Pavageau, AH1
Croué, A1
Reguerre, Y1
Rialland, X2
Rousselet, MC1
Sugihara, T1
Fujimura, T1
Kume, H3
Homma, Y1
Machak, GN1
Polotskiĭ, BE1
Meluzova, OM1
Chernov, IS1
Aliev, MD1
Buchbinder, D1
Steinberg, G1
Linetsky, M1
Casillas, J1
Lindet, C1
Vanhuyse, M1
Thebaud, E1
Robin, YM1
Penel, N1
Lee, KW1
Kim, YJ1
Kim, JH2
Bang, SM1
Chung, JH1
Lee, JS7
Ushijima, M1
Yamakawa, Y1
Sakabe, E1
Waki, H1
Katou, K1
Contreras Ibáñez, JA1
Navas García, N1
Díaz Gómez, L1
Xu, C1
Nishi, H1
Isaka, K1
Vello Román, A1
Samprón Rodríguez, M1
Pazos Arias, B1
Romero Reinoso, C1
Peteiro Cancelo, A1
Khanfir, K1
Elhfidh, M1
Anchisi, S1
Matzinger, O1
Bieri, S1
Mirimanoff, RO1
Ozsahin, M1
Zouhair, A1
Yamagishi, A1
Sakurai, T1
Naito, S1
Tsukigi, M1
Kato, T1
Nagaoka, A1
Tomita, Y1
Iwaba, A1
Yamakawa, M1
Hong, S1
Shin, SJ1
Jung, M1
Jeong, J1
Lee, YJ1
Shin, KH2
Roh, JK1
Rha, SY1
Sueta, A1
Inoue, K2
Kuriwaki, K1
Iwase, H1
Schwitter, M1
Potocnik, P1
von Moos, R1
Frick, H1
Furrer, M1
Cathomas, R1
Jacot, W1
Pujol, JL8
Chakra, M1
Molinier, O2
Bozonnat, MC1
Gervais, R1
Quantin, X4
Ahn, JH1
Mirza, T1
Ameerally, P1
Fernandez-Pineda, I1
Bahrami, A1
Green, JF1
McGregor, LM1
Davidoff, AM1
Sandoval, JA1
Barone, C2
Germano, D2
Matano, E1
Marini, G4
Labianca, R1
Di Costanzo, F4
Bagnulo, A1
Pennucci, C1
Caroti, C1
Mencoboni, M2
Prochilo, T3
Cafferata, MA4
Ouadnouni, Y1
Smahi, M1
Bouchikh, M1
Achir, A1
Msougar, Y1
Lakranbi, M1
Benosman, A1
Onesti, E1
Fabi, A1
Mingoia, M1
Savarese, A1
Anelli, V1
Koudriavtseva, T1
Abedallaa, N1
Tremblay, L1
Baey, C1
Fabre, D1
Planchard, D2
Pignon, JP1
Guigay, J2
Pechoux, CL1
de Montpreville, VT1
Besse, B1
Giner, V12
Berchier, MC11
Lewin, D1
Bosschaerts, T2
Mouillet, G1
Monnet, E1
Milleron, B5
Puyraveau, M2
Quoix, E7
David, P1
Ducoloné, A1
Zalcman, G1
Depierre, A6
Westeel, V4
Tienghi, A1
Hall, KS1
Fagioli, F2
Picci, P1
Barbieri, E1
Eriksson, M1
Ruggieri, P1
Lindholm, P1
Prete, A1
Bisogno, G2
Tamburini, A1
Abate, ME1
Smeland, S1
Ferrari, S4
Punanov, IuA1
Gafton, GI1
Gudz', IuV1
Nabokov, VV1
Ivanova, TV1
Safonova, SA1
Levchenko, EV1
Kupatadze, DD1
Novik, VI1
Lazareva, IuR1
Krzhivitskiĭ, PI1
Petrov, VG1
Teixeira, A1
Vieira, C1
Sousa, N1
Begonha, R1
Afonso, M1
Amaro, T1
Maurício, J1
Cuneo, KC1
Riedel, RF1
Dodd, LG1
Harpole, DH1
Kirsch, DG1
Dede, DS1
Aksoy, S1
Cengiz, M1
Gullu, I1
Altundag, K1
Luo, J1
Wu, FY1
Li, AW1
Zheng, D1
Liu, JM6
Yang, Y1
Mazza, EA1
Thiriaux, J10
Florin, MC3
Efremidis, A7
Alexopoulos, CG7
Recloux, P3
Ninane, V13
Mommen, P11
Klastersky, J8
Billingham, LJ3
Bathers, S1
Burton, A1
Bryan, S1
Cullen, MH7
Lam, KC1
Yeo, W1
De Ruysscher, D2
Lievens, Y2
Van den Brande, P2
Nackaerts, K2
Vansteenkiste, J5
Ettinger, DS6
Finkelstein, DM1
Ritch, PS2
Lincoln, ST1
Blum, RH1
Oelmann, E1
Thomas, M3
Serve, H1
Kienast, J1
Zühlsdorf, M1
Mohr, M1
Klinke, F3
Dölken, G1
Macha, H1
Schmidt, EW1
Berdel, WE1
Saint-Georges, F1
Terrier, P1
Sabourin, JC1
Bonvalot, S1
De Montpreville, V1
Ruffie, P3
Li, DX1
Chen, XB1
Souquet, PJ5
Tan, EH4
Rodrigues Pereira, J1
Van Klaveren, R1
Price, A1
Gatzemeier, U7
Jaworski, M1
Burillon, JP1
Aubert, D2
Janinis, J1
Driver, D1
Mitchell, C1
Cassoni, AM1
Pringle, J1
Kilby, A1
Whelan, JS1
Crinò, L7
Kremens, B1
Gruhn, B1
Klingebiel, T1
Hasan, C1
Laws, HJ1
Koscielniak, E1
Hero, B1
Selle, B1
Niemeyer, C1
Finckenstein, FG1
Schulz, A1
Wawer, A1
Zintl, F1
Graf, N1
Lin, YC1
Lin, Y1
Lin, W1
Du, CW1
Wu, MY1
Li, DR1
Wodowski, K1
Hill, DA1
Pappo, AS2
Shochat, SJ2
Kun, LE2
Spunt, SL2
Hand, S1
Baker, J1
Smith, AP2
Macbeth, FR1
Zaniboni, A4
De Marinis, F5
Portalone, L4
Meriggi, F3
Ariganello, O1
Torri, V1
Neumaier, CE1
Rosso, R5
Veronesi, G2
Spaggiari, L2
De Pas, T3
Solli, PG1
De Braud, F2
Catalano, GP1
Leo, F2
Gebbia, V4
Galetta, D4
Caruso, M1
Verderame, F1
Pezzella, G1
Valdesi, M1
Borsellino, N1
Pandolfo, G1
Durini, E1
Rinaldi, M3
Loizzi, M1
Gebbia, N3
Valenza, R2
Tirrito, ML1
Varvara, F1
Colucci, G4
Chen, YM7
Shih, JF2
Lee, CS1
Chen, MC1
Lin, WC6
Tsai, CM7
Perng, RP9
Haro Estarriol, M1
Baldo Padró, X1
Rubio Goday, M1
Sebastián Quetglas, F1
Viñas Villaró, G1
Bernadó Turmo, L1
Socinski, MA2
Neubauer, MA1
Olivares, J1
Ketchel, S1
Tynan, M1
Moore, M2
Lee, JH1
Davis, K1
Schell, M1
Garfield, D1
Mauer, AM4
Ansari, RH1
Hoffman, PC12
Krauss, SA6
Taber, D1
Tembe, SA1
Gabrys, GT1
Cotter, T1
Schumm, LP1
Szeto, L1
Vokes, EE13
Ichiki, M3
Rikimaru, T4
Gohara, R3
Koga, T1
Kawayama, T2
Matunami, M1
Oshita, Y1
Kamimura, T1
Aizawa, H2
Snee, MP1
Unsal, M1
Erturk, D1
Danson, S1
Middleton, MR1
O'Byrne, KJ1
Clemons, M1
Ranson, M2
Hassan, J1
Anderson, H9
Burt, PA3
Fairve-Finn, C1
Stout, R10
Dowd, I1
Ashcroft, L6
Beresford, C1
Thatcher, N37
Kitajima, T1
Fujiki, R1
Shimada, A1
Mohedano Mohedano, N1
Sánchez Rovira, P1
Lozano Barriuso, A1
Fernandez Morales, M1
Medina Magan, B1
Jaen Morago, A1
Porras Quintela, I1
Dueñas Garcia, R1
Fernandez Flores, E1
Moreno Moreno, MA1
Alberola, V2
Camps, C5
Provencio, M1
Isla, D1
Rosell, R9
Vadell, C2
Bover, I1
Ruiz-Casado, A1
Azagra, P1
Jiménez, U1
González-Larriba, JL1
Diz, P1
Cardenal, F2
Artal, A3
Carrato, A1
Morales, S2
Sanchez, JJ2
de las Peñas, R1
Felip, E1
López-Vivanco, G1
Fujita, A17
Ohkubo, T1
Hoshino, H1
Takabatake, H12
Tagaki, S13
Sekine, K16
Abe, S1
Margery, J2
Le Moulec, S1
Grassin, F1
Vaylet, F2
L'her, P1
Agra, Y1
Pelayo, M1
Sacristan, M1
Sacristán, A1
Serra, C1
Bonfill, X1
Marangolo, M6
Giovanis, P1
Silvestris, N2
Piscitelli, D1
Crucitta, E1
Fiore, M1
De Lena, M1
Lorusso, V2
Song, SY1
Kim, WS2
Kim, K1
Jung, CW1
Im, YH1
Kim, HJ2
Kang, WK2
Lee, HG1
Kwon, OJ1
Rhee, CH1
Park, CH2
Kita, M1
Sasaki, Y2
Okuyama, M1
Saga, Y1
Hashimoto, H1
Kaneko, S1
Yachiku, S1
Tokumitsu, M1
Inada, F1
Ishida, H1
Merimsky, O1
Kollender, Y1
Inbar, M1
Meller, I1
Bickels, J1
Bourgeois, H2
Billiart, I1
Chabrun, V1
Chieze, S1
Lemerre, D1
Germain, T1
Ferrand, V1
Meurice, JC2
Daban, A1
Tourani, JM3
Ishizuka, O1
Satoh, T3
Mizuno, H1
Mizusawa, H1
Seki, S1
Nishizawa, O1
Van Houtte, P3
Koumakis, G6
Richez, M2
Corhay, JL2
Wackenier, P2
Lothaire, P2
Giaccone, G4
Smit, EF5
de Jonge, M1
Dansin, E1
Briasoulis, E1
Douillard, JY2
Spaeth, D1
Lacombe, D1
Baron, B1
Bachmann, P2
Fumoleau, P1
Park, SJ1
Kim, HK2
Kim, CK1
Park, SK1
Go, ES1
Kim, ME1
Hong, DS1
Hernández, R1
Juan, O1
Chrystal, K1
Cheong, K1
Harper, P1
Junker, K2
Müller, KM1
Abker, S1
Bosse, U1
Takahashi, S2
Okada, K1
Nagasawa, H1
Shimada, Y1
Sakamoto, H1
Itoi, E1
VanHoutte, P1
Chuman, H1
Corapcioglu, F1
Dillioğlugil, O1
Sarper, N1
Akansel, G1
Calişkan, M1
Arisoy, AE1
de Cremoux, P3
Sastre, X1
Judde, JG1
Tran-Perennou, C1
Fréneaux, P1
Pouillart, P2
Rawlins, JM1
Batchelor, AG1
Liddington, MI1
Towns, G1
Lorent, N1
De Leyn, P2
Verbeken, E1
Dooms, C1
Van Raemdonck, D2
Anrys, B1
Rudd, RM2
Gower, NH2
Spiro, SG5
Eisen, TG1
Harper, PG4
Littler, JA1
Hatton, M1
Johnson, PW2
Martin, WM1
Rankin, EM1
James, LE1
Gregory, WM1
Qian, W2
Lee, SM3
del Prever, AB1
Berta, M1
Bertoni, F3
Mercuri, M3
Stage, AC1
Pollock, RE1
Matin, SF1
Suzuki, M2
Matsumoto, S1
Okamoto, N1
Nishimatsu, H1
Tomita, K2
Kitamura, T2
Moro-Sibilot, D3
Mercier, M1
Breton, JL2
Debieuvre, D1
Richard, P1
Haller, MA1
Herman, D1
Level, MC2
Lebas, FX2
Lorigan, P5
Woll, PJ4
O'Brien, ME1
Ashcroft, LF1
Sampson, MR1
Stephens, RJ4
Girling, DJ4
Hopwood, P4
Dillman, RO1
Barth, NM1
VanderMolen, LA1
Allen, K1
Beutel, LD1
Chico, S1
Braun, D2
Lebeau, B5
Zak, D1
Styler, MJ1
Rosenbluth, JZ1
Brodsky, I1
Boutemy, M1
Mispelaere, D1
Krzisch, C1
Jounieaux, V1
Iwasaki, Y1
Nagata, K1
Nakanishi, M1
Natuhara, A1
Kubota, Y1
Ueda, M1
Arimoto, T3
Hara, H1
Govindan, R1
Tho, LM1
Ferry, DR2
Spada, M1
Guida, M1
Cassano, G1
Brunetti, C1
Nettis, G1
Izzi, G1
Giampaglia, M1
Kawabe, M1
Sasaki, K1
Shinoda, T1
Tanabe, S1
Handa, M1
Yamada, N1
Uesaka, T1
Morioka, K1
Ihaya, A1
Tanaka, K1
Imamura, Y1
Koutras, A1
Makatsoris, T2
Mylonakis, N3
Tzelepis, G1
Dimitrakopoulos, A1
Spyropoulos, K1
Polyzos, A2
Karabelis, A2
Kalofonos, HP4
Gordon, N1
Arndt, CA1
Hawkins, DS1
Doherty, DK1
Inwards, CY1
Munsell, MF1
Stewart, J1
Koshkina, NV1
Kleinerman, ES4
Clark, PI1
Sambrook, RJ1
Owens, R1
Daw, NC1
Billups, CA1
McCarville, MB2
Rao, BN2
Cain, AM2
Jenkins, JJ2
Neel, MD1
Meyer, WH3
Lee, HW1
Choi, JH1
Lim, HY1
Park, JS1
Kim, HC1
Kang, S1
Oh, YT1
Chun, M1
Sheen, SS1
Oh, YJ1
Park, KJ1
Hwang, SC1
Duan, X1
Jia, SF2
Koshkina, N1
Barlesi, F1
Daurès, JP2
Petrilli, AS1
de Camargo, B1
Filho, VO1
Bruniera, P1
Brunetto, AL1
Jesus-Garcia, R1
Camargo, OP1
Pena, W1
Péricles, P1
Davi, A1
Prospero, JD1
Alves, MT1
Oliveira, CR1
Macedo, CR1
Mendes, WL1
Almeida, MT1
Borsato, ML1
dos Santos, TM1
Ortega, J1
Consentino, E1
Tysome, JR1
Sandison, A1
Clarke, PM1
Booton, R3
Baka, S2
Nicolson, M1
O'Brien, M1
Dunlop, D1
O'Byrne, K1
Laurence, V1
Snee, M1
Dark, G1
Indolfi, P1
Casale, F1
Cecchetto, G1
De Salvo, G1
Donfrancesco, A1
Donofrio, V1
Martone, A1
Di Martino, M1
Di Tullio, MT1
Ferigo, N1
Cottalorda, J1
Allard, D1
Gentil-Perret, A1
Fessy, M1
Berger, C1
Stéphan, JL1
Hayakawa, T1
Sato, M1
Konaka, M1
Makino, A1
Hirohata, T1
Totsu, S1
Wada, Y1
Sato, H1
Inotsume, N1
Bendell, JC1
Lauwers, GY1
Willett, C1
Clark, JW1
Warshaw, AL1
Wain, JC1
Ryan, DP1
Rupolo, M1
Buonadonna, A1
Brollo, A1
Morra, A1
Berretta, S1
Frustaci, S1
Moreno Antón, F1
Casado Herraez, A1
Puente Vázquez, J1
Gómez Díaz, R1
Aragoncillo, P1
Díaz-Rubio García, E1
Manegold, C8
Buchholz, E3
Schott-von-Römer, K1
Nagel, S1
Blackhall, F1
Aschroft, L1
Adoun, M1
Paitel, JF1
Blanc, P1
Genet, D1
Ferru, A1
Deletage, C1
Cok, G1
Göksel, T1
Soyer, S1
Atil, H1
Güzelant, A1
Aysan, T1
Pohl, G1
Krajnik, G1
Malayeri, R1
Müller, RM1
Klepetko, W1
Eckersberger, F2
Schäfer-Prokop, C1
Pokrajac, B1
Schmeikal, S1
Maier, A1
Ambrosch, G1
Woltsche, M1
Minar, W1
Pirker, R2
Antonelli, A1
Simeone, C1
Ferrari, V1
Tardanico, R1
Cunico, SC1
Kawai, K1
Takaoka, E1
Naoi, M1
Mori, K1
Minami, M1
Shimazui, T1
Akaza, H1
Li, EX1
Zhang, YT1
Shang, JT1
Xu, Z1
Geng, Y1
Li, SM1
Shi, F1
Wu, YY1
Harada, A1
Taue, R1
Kishimoto, T1
Tanimoto, S1
Izaki, H1
Takahashi, M2
Fukumori, T1
Nishitani, MA1
Kanayama, HO1
Banna, GL1
De Giorgi, U1
Ferrari, B1
Castagna, L1
Alloisio, M1
Rosti, G5
Santoro, A3
Su, Y1
Mardynskiĭ, IuS1
Zolotkov, AG1
Kudriavtsev, DV1
Nogi, H1
Kobayashi, T1
Kawase, K1
Tabei, I1
Toriumi, Y1
Kawakami, M1
Morikawa, T1
Uchida, K1
Skubitz, KM1
Manivel, JC1
Van Cutsem, O8
Collon, T4
Whang-Peng, J7
Booten, R1
Ward, T2
Heighway, J2
Morris, J2
Pilz, L1
Drings, P19
Pelosi, G1
Catalano, G1
Gandini, S1
Burke, MJ1
Walterhouse, DO1
Jacobsohn, DA1
Duerst, RE1
Kletzel, M1
Smorenburg, CH1
van Groeningen, CJ1
Meijer, OW1
Visser, M1
Boven, E1
Saint-Blancard, P1
Hardy, K1
Bonnichon, A1
Jancovici, R1
Park, S1
Ahn, MJ1
Hong, YS2
Park, BB1
Lee, SC1
Hwang, IG1
Park, JO2
Lim, H1
Piantedosi, FV1
Caputo, F1
Mazzarella, G1
Gilli, M1
Pontillo, A1
D'Agostino, D1
Campbell, S1
Marsico, SA1
Bianco, A1
Vaslamatzis, MM1
Brunello, A1
Rossi, E1
Stefani, M1
Ghiotto, C2
Marino, D1
Crivellari, G1
Monfardini, S1
Rezaï, K1
Lokiec, F1
Grandjean, I1
Weill, S1
Bordier, V1
Ekue, R1
Garcia, M1
Han, JQ1
Han, CY1
Bi, YH1
Qiu, MZ1
Xu, F1
Wang, SS1
Luo, HY1
Wang, F1
Li, FH1
Sun, XF1
Xu, GC1
Lin, TY1
Huang, HQ1
Jiang, WQ1
Guan, ZZ2
Xu, RH1
Grosshans, DR1
Meyers, CA1
Allen, PK1
Davenport, SD1
Komaki, R3
Meyers, PA2
Schwartz, CL1
Krailo, MD1
Healey, JH1
Bernstein, ML1
Betcher, D1
Ferguson, WS2
Gebhardt, MC1
Goorin, AM2
Harris, M1
Kleinerman, E1
Link, MP2
Nadel, H1
Nieder, M1
Siegal, GP1
Weiner, MA1
Womer, RB1
Grier, HE1
Kakutani, S1
Yanada, S1
Ito, H1
Tomita, M1
Wada, T1
Hatano, T1
Kishimoto, K1
Egawa, S1
Mok, TS1
Crowley, J1
Gottfried, M1
Ramlau, R1
Krzakowski, M1
Ziolo, G1
Olechnowicz, H1
Koubkova, L1
Dahabreh, J1
Szczesna, A1
Vivanco, GL1
Carpagnano, F1
Leong, SS3
Fittipaldo, A1
De Almeida, C1
Grunenwald, D1
Leyvraz, S4
Pampallona, S3
Martinelli, G1
Ploner, F1
Perey, L4
Aversa, S1
Brunsvig, P1
Montes, A1
Lange, A3
Yilmaz, U1
Bunn, PA4
You, B1
Tranchand, B2
Girard, P2
Falandry, C1
Ribba, B1
Chabaud, S1
Court-Fortune, I3
Trillet-Lenoir, V4
Fournel, C1
Tod, M1
Freyer, G2
Arai, H1
Rino, Y1
Yamanaka, S2
Yukawa, N1
Wada, N1
Kudo, M1
Watanuki, Y1
Fukumura, H1
Nakajima, K1
Oshiro, H1
Masuda, M1
Stiefel, P3
Dirks, HP1
Grimm, V1
Kleckow, M2
Manke, HG5
Queisser, W2
Abel, U2
Heinrich, S1
Liesenfeld, A1
Havemann, K9
Gropp, C5
Seifert, W1
Thomas, C1
Mahnke, HG1
Westerhausen, M1
Wellens, W1
Konrad, RM1
Bryant, BM1
Jarman, M1
Ford, HT2
Smith, IE4
Steinke, B1
Heidemann, E1
Ostendorf, P1
Wilms, K1
Waller, HD1
Valdivieso, M10
Tenczynski, TF1
Rodriguez, V1
Burgess, MA2
Mountain, CF2
Barkley, HT4
Hersh, EM2
Bodey, GP7
Saiers, JH2
Slavik, M2
Kokron, O3
Micksche, M1
Titscher, R2
Wrba, H1
Karrer, K1
Denck, H1
Pridun, N1
Zwintz, E1
Serrou, B1
Cupissol, D2
Plagne, R1
Boutin, P1
Carcassone, Y1
Michel, FB6
Nakhosteen, JA1
Niederle, N4
Harrison, EF5
Hawke, JE2
Hunter, HL5
Costanzi, JJ5
Morgan, LR8
Plotkin, D2
Tucker, WG2
Worrall, PM2
Hokanson, J1
Holoye, PY3
Anderson, T1
Duelge, J1
Hansen, RM1
Kehl, A1
Bergholz, M1
von Heyden, HW1
Nagel, GA1
Mukouda, K1
Morikawa, E1
Hasegawa, K1
Noumi, K1
Ohmura, T1
Mishima, Y1
Kawamoto, M1
Inagaki, A1
Kamitsuna, A1
Yamakido, M1
Nishimoto, Y1
Koyama, T1
Katsuta, S1
Bakowski, MT1
Crouch, JC1
Cabanillas, F1
Keating, M1
Murphy, WK6
Frazier, H1
Chen, T1
Focan, C1
Le Hung, S1
Bays-Gallaix, R1
Frere, MH1
Demonceau, G1
Mbuyamba, P1
Claessens, JJ1
Piazza, E1
Cattaneo, MT1
Varini, M2
Joss, RA1
Cavalli, F1
Goldhirsch, A1
Mermillod, B1
Brunner, KW1
Araujo, CE1
Tessler, J1
Matthiessen, W2
Stempinski, E2
Göbel, D2
Thalmann, U2
Nobile, MT1
Brema, F1
Cinquegrana, A1
Santi, L1
Holdiness, MR2
Retsas, S1
Goldin, A1
Burkert, H2
Benjamin, RS2
Freeman, MB1
Ertel, M1
Smith, TL1
Gillen, LE1
Satomi, Y1
Clemm, C1
Hartenstein, R1
Wilmanns, W1
Donley, PJ2
Bierbaum, W1
Bremer, K1
Firusian, N1
Higi, M1
Scheulen, ME1
Schmidt, CG2
Seeber, S3
Issell, BF3
MacFadyen, BV1
Gum, ET1
Dudrick, SJ2
McNiel, NO1
König, HJ1
Hartwich, G2
Bleehen, NM2
Machin, D2
Dieckmann, KP1
Loy, V1
Küpfer, A1
Aeschlimann, C1
Wermuth, B1
Cerny, T7
Brugger, W6
Henschler, R1
Heimfeld, S1
Berenson, RJ1
Mertelsmann, R6
Carles, J3
Ariza, A1
Pellicer, I1
Fernandez-Vasalo, G1
Abad, A2
Barnadas, A3
Pettengell, R2
Dexter, TM2
Testa, NG2
Addamo, GF1
Borghini, U2
Lionetto, R1
Conte, PF4
Bruzzi, P1
Pennucci, MC3
Frommhold, H5
Pressler, K1
Hodgetts, J2
Lomax, L2
Bildet, F1
Cour-Chabernaud, V1
Carpentier, AF1
Chantelard, JV1
Henin, D1
Poisson, M1
Drinkard, LC8
Samuels, BL8
Watson, S6
Bitran, JD2
Golomb, HM10
Simmonds, PD1
Mead, GM1
Whitehouse, JM1
Crawford, J3
George, M1
Masters, GA9
Strauss, GM2
Lynch, TJ3
Elias, AD2
Jacobs, C2
Kwiatkowski, DJ2
Shulman, LN2
Carey, RW2
Grossbard, ML3
Jauss, S1
Sugarbaker, DJ1
Vicente, P1
Garciá del Muro, X1
Clerici, M2
Figoli, F3
Barduagni, M1
Carlini, P2
Ceci, G2
Cortesi, E2
Carpi, A2
Santini, A2
Molina, F2
Moreno, I4
Martínez, E1
Pifarré, A1
Font, A2
Li, S1
Skacel, Z2
Gómez-Codina, J3
Postmus, PE9
Milroy, R2
Macbeth, F1
Loehrer, PJ8
Ansari, R4
Gonin, R2
Monaco, F1
Fisher, W1
Sandler, A2
Brewster, AE1
Wolff, AC1
Neuberg, D1
Comis, RL1
Ruckdeschel, JC1
Bonomi, PD1
Johnson, DH4
de Campos, E2
Radford, J2
Steward, W2
Dougal, M1
Swindell, R4
Testa, N1
Nichols, CR2
Betticher, D1
Woodhead, M1
Weir, D1
Hanley, S1
Hardy, C1
Boros, L3
Garrow, GC2
Asbury, RF2
Chang, AY3
Hsieh, S1
Raymond, AK1
Gano, JB1
Miller, VA1
Rigas, JR2
Pisters, KM1
Grant, SC1
Pfister, DG1
Heelan, RT1
Kris, MG1
Wagner, W1
von Eiff, M3
Micke, O1
Rübe, C2
Willich, N1
Corlett, SA1
Parker, D2
Chrystyn, H1
Hatton, MQ1
Cassidy, J1
Bicknell, S1
Semple, P1
Stack, B1
Steward, WP5
Shinozaki, T1
Matsushita, M1
Kusawake, H1
Watanabe, H1
Arita, S1
Chigira, M1
Udagawa, E1
Pein, F1
Saint-Andre, JP1
Flamant, F1
Faylona, EA1
Sandler, AB2
Cumin, I1
Lacroix, H1
Mahé, M1
Dutin, JP1
Dabouis, G2
Kattan, J1
Culine, S1
Theodore, C1
Droz, JP2
Watanabe, Y1
Tanaka, H2
Ogawa, M2
Tanaka, T1
Tanizawa, M1
Cargill, RI1
Boyter, AC1
Lipworth, BJ1
Elisson, LO1
Ekberg, L1
Bureau, G6
Michel, J3
Küstner, U2
Kroll, F2
Prendiville, J4
Hicks, F1
Leahy, B1
Burt, P3
Somma-Mauvais, H1
Farisse, P1
Viallat, JR2
Pocard, M1
Azorin, JF1
Delepine, N1
Delepine, G1
Tremblay, B1
Destable, MD1
Thongprasert, S5
Phromwas, N1
Atikachi, B1
Jiemsripong, K1
Moro, D2
Orfeuvre, H1
Nagy-Mignotte, H1
Mousseau, M1
Blanc-Jouvan, F1
Schaerer, R1
Brambilla, C1
Hayot, M1
Rouanet, P2
Le Chevalier, T5
Hsieh, RK1
Asbury, R1
Perez, EA2
Sowray, PC1
Gardner, SL1
Gandara, DR2
Lorrigan, P1
Izraeli, S1
Adamson, PC1
Blaney, SM1
Balis, FM1
Mornex, F1
Chauvin, F2
Fournel, P2
Voloch, A1
Perol, M2
Laennec, E1
Piperno, D1
Boyer, J1
Ardiet, JM1
Jiamsriponges, K1
González Barón, M3
Feliu, J3
Espinosa, E1
García Girón, C3
Blanco, E1
Garrido, P3
Colmenarejo, A1
Ordóñez, A4
Moyano, A1
de la Gándara, I1
van der Graaf, WT1
Haaxma-Reiche, H2
Burghouts, JT3
Pratt, CB2
Parham, DM1
Fleming, ID1
Rosen, G1
Forscher, C1
Lowenbraun, S1
Eilber, F1
Eckardt, J1
Holmes, C1
Fu, YS1
Kosmidis, P2
Skarlos, DV2
Samantas, E3
Beer, M1
Theocharis, D1
Zachariadis, E1
Gioti, A1
Papadakis, E1
Poulakis, N2
Krigel, RL2
Palackdharry, CS3
Padavic, K1
Haas, N1
Kilpatrick, D1
Langer, C1
Comis, R1
Evans, WK4
Stewart, DJ1
Shepherd, FA7
Logan, D4
Goss, G2
Maroun, JA1
Wierzbicki, R1
Warner, E4
Latreille, J6
Dahrouge, S2
Tibaldi, C6
Chella, A2
Angeletti, CA2
Romanini, A1
Andrei, A2
Algeri, R2
Silvano, G3
Chastang, C2
Jacoulet, P1
Paillot, N2
Janicot, H2
Lombard, JN1
Maestre, J3
Milla, A1
Wolf, M8
Hans, K8
Becker, H5
Hässler, R1
von Bültzingslöwen, F2
Goerg, R2
Klaasen, HA1
Dannhäuser, J1
Holle, R6
Pfab, R2
Isai, H1
Minase, T2
Arcangeli, G1
Milano, S2
Simoncini, E1
Marpicati, P1
Kurowski, V2
Wagner, T3
Hibi, S1
Naya, M1
Takaya, K1
Morimoto, M1
Kataoka, Y1
Todo, S1
Imashuku, S1
Otsuka, T1
Matsui, N1
Ohta, H1
Hattori, M1
Nakamura, T1
Kirkpatrick, A3
Splinter, TA4
Cameron, JC1
Johnson, BE1
Teresi, ME1
Murry, DJ1
Cornelius, AS1
Millward, MJ1
Cantwell, BM5
Munro, NC1
Robinson, A1
Corris, PA1
Harris, AL6
Graziano, SL2
Herndon, JE3
Richards, F2
DiFino, S1
Modeas, C1
Duggan, DB1
Green, MR3
Radford, JA2
Berrocal, A1
Barón, JM1
Meyer, T1
Herrmann, C1
Hiddemann, W1
Schauer, A1
Köpf-Maier, P1
Sass, G1
Lobo-Sanahuja, F1
García, I1
Santamaría, S1
Barrantes, JC1
Bohas, CH1
Fortune, IC1
Chatte, G1
Gridelli, C2
Rossi, A1
Incoronato, P1
Bruni, GS1
Scognamiglio, F1
Ruffolo, P1
Rinaldi, L1
Bianco, AR1
Satoh, H2
Yano, H2
Ishikawa, H1
Hasegawa, S2
Majello, E1
Sohda, T1
Wahid, NA1
Neugut, AI1
Hibshoosh, H1
Brunetti, JC1
Fountain, KS1
Rubin, M1
Urban, T2
Bedin, A1
Baud, M2
Chouaid, C1
Febvre, M2
Sergysels, R1
Koch, P1
Johnson, N1
van Schaik, J1
Andersen, S1
Blatter, J3
Bosanquet, N1
Copley-Merriman, K1
Vandebroek, J1
Mariën, S1
Roex, L1
Bertrand, P1
Bockaert, J1
De Beukelaar, T1
Deman, R1
De Muynck, P1
Ulrichts, H1
Crump, M1
Stewart, D4
Tomiak, E1
Eisenhauer, E3
Fisher, B1
Lokich, J1
Anderson, N1
Moore, C1
Bern, M1
Coco, F1
Dow, E1
Soler, P1
Arpin, D1
Bohas, C1
Riou, R2
Ecochard, D1
Gautier, V1
Zinaï, A1
Valone, FH1
Rege, VB1
Clamon, G1
Scagliotti, GV3
Ricardi, U1
Maranzano, E1
Morandi, MG1
Meacci, L1
Emiliani, E1
Bolzicco, G1
Masiero, P1
Gentile, A1
Tonato, M4
Fountzilas, G2
Pavlidis, N2
Kattis, K1
Skarlos, D1
Pawinski, A1
Lentz, MA1
van Glabbeke, M1
van Zandwijk, N4
Schnaars, Y1
Zatloukal, P1
Dolensky, J1
Jackevicius, A1
Petruzelka, L1
Zorzi, F1
Ottoni, DB1
Di Fabio, D1
Mombelloni, G1
Zarogoulidis, K2
Ziogas, E2
Papagiannis, A2
Charitopoulos, K1
Dimitriadis, K1
Economides, D1
Maglaveras, N1
Vamvalis, C2
Bosquée, L3
Pasini, F2
Humblet, Y3
Hamdan, O1
Cetto, GL1
Palmer, AJ1
Brandt, A1
Scagliotti, G1
Groen, HJ3
Gozzelino, F2
Curran, D1
Sahmoud, T1
Vallejo, C1
Romero, A1
Perez, J1
Cuevas, M1
Lacava, J1
Sabatini, C1
Dominguez, M1
Rodriguez, R1
Barbieri, M1
Romero Acuña, L1
Romero Acuña, J1
Langhi, M1
Amato, S1
Salvadori, M1
Ortiz, E1
Machiavelli, M1
Leone, B1
Rodenhuis, S1
Boerrigter, L1
Top, B1
Slebos, RJ1
Mooi, WJ2
van't Veer, L1
Paul, K2
Bacci, G2
Briccoli, A2
Donati, D1
Monti, C1
Zanoni, A1
Forni, C2
Manfrini, M1
Salomaa, ER1
Liippo, K1
Ellmen, J1
Komi, J1
Planting, AS3
de Wit, R2
van der Burg, ME2
Stoter, G2
Verweij, J3
Hsieh, A1
Mick, R1
Guaspari, A1
Witschi, H1
Espiritu, I1
Peake, JL1
Wu, K1
Maronpot, RR1
Pinkerton, KE1
Fetscher, S4
Engelhardt, R4
Hasse, J4
Wenger, M2
Lange, W4
Hastürk, S1
Kurt, B1
Kocabas, A2
Orüç, O1
Burgut, R2
Katschinski, DM1
Wiedemann, GJ1
Mentzel, M1
Mulkerin, DL1
Touhidi, R1
Robins, HI1
Wu, MF4
Chou, CM1
Yang, KY3
Brüggemann, SK1
Kisro, J1
Eberhard, W2
Wilke, HJ2
Chomy, F2
Chomy, P2
Khayat, D2
Mosconi, AM2
Celik, I1
Başçil, N1
Yalçin, S1
Güllü, IH1
Kars, A1
Barişta, I1
Tekuzman, G1
Morere, JF1
Piperno-neumann, S1
Brunet, A1
Boaziz, C1
Kohn, M1
Bouillet, T1
Breau, JL1
Murad, AM1
Guimaraes, RC1
Amorim, WC1
Morici, AC1
Ferreira-Filho, AF1
Schwartsmann, G1
Corgna, E1
Porrozzi, S1
Palladino, MA1
Darwish, S1
Minotti, V1
Semik, M1
Bokemeyer, C1
Franzke, A1
Schöber, C1
Arseniev, L1
Metzner, B1
Link, H1
Schmoll, HJ1
Masters, G1
Rizzi, A1
Alghisi, A1
Pascarella, A1
Bozzola, G1
Mutti, S1
Herbst, R1
Leong, T1
Lynch, C1
Skarin, AT1
Chap, LI1
Mirra, J1
Ippolito, V1
Rentschler, R1
Rosen, P1
Paris, A1
Reme-Saumon, M3
Khial, F3
Godard, P2
Yang, SL1
Ishii, T1
Tatezaki, S1
Yonemoto, T1
Umeda, T2
Kitoh, M1
Chou, CW1
Li, AF1
Tie, CM1
Chi, KH1
Riccardi, F1
Cariello, S1
Masutani, M1
Akusawa, H1
Kadota, A1
Ohchi, Y1
Takahashi, N2
Tanigawa, S1
Koya, Y1
Horie, T1
Glisson, B3
Palmer, J1
Fossella, F3
Shin, DM2
Perez-Soler, R2
Hong, WK4
Bunnell, CA1
Thompson, L1
Buswell, L1
Berkowitz, R1
Muto, M1
Sheets, E1
Kurie, J1
Schea, R1
Vadhan-Raj, S1
Maurer, K1
Heitger, A1
Schwaighofer, H1
Fink, FM1
Niederweiser, D1
Goren, MP1
Anthony, LB1
Hande, KR1
Brade, WP2
Frazier, MW1
Bush, DA1
Li, JT1
von Pawel, J2
Woll, P1
Koschel, G3
Clancy, L1
Pfeifer, W1
Fennelly, J1
Frisch, J1
Hirota, T1
Takeuchi, M1
Iwata, A1
Kitagawa, S1
Sato, T1
Konno, K1
Sawada, K1
Kobayashi, S1
Hamaguchi, N1
Agata, H1
Katano, N1
Fujimoto, T1
Gasbarrini, A1
Fabbri, N1
Cesari, M1
Campanacci, M1
Zacharias, C5
Vansteenkiste, JF2
De Leyn, PR1
Deneffe, GJ1
Lievens, YN1
Nackaerts, KL1
Van Raemdonck, DE1
van der Schueren, E1
Lerut, TE1
Demedts, MG1
Fahantidou, E1
Dermitzakis, G1
Gioulekas, D1
Salvati, F1
Antilli, A1
Barbera, S1
Romano, F1
Migliorino, MR1
Noseda, MA1
Crippa, M1
Ferrara, G2
Raimondi, M1
Fioretti, M1
Bandera, M1
Galeasso, G1
Cacciani, GC1
Lepidini, G1
Sunseri, G1
Lanfranco, C1
Wyka, D1
Golomb, H1
Pannacciulli, I1
Castello, G1
Lerza, R1
Botta, M1
Arboscello, E1
Bogliolo, G1
Wu, HW4
Inserra, A1
Zangari, A1
Ciprandi, G1
Boldrini, R1
Boglino, C1
Donnellan, P1
Armstrong, J1
Rowan, S1
Fennelly, D1
Lynch, V1
McDonnell, T1
McNicholas, W1
Crown, J1
Tjan-Heijnen, VC1
Biesma, B1
Festen, J3
Cox, A1
Wagener, DJ1
Tsang, KW1
Lam, WK1
Ip, M1
Kito, M1
Rey, F1
Astoul, P1
Marqueste, L1
Petite, JM1
Boutin, C1
Harris, MB1
Gieser, P1
Ayala, A1
Holbrook, T1
Shevlin, PM2
Muers, MF3
Peake, MD4
Hosker, HS2
Stead, ML2
Poulter, KM3
Brown, JM3
Soh, LT1
Ang, PT3
Spaas, P1
Specenier, P1
Demedts, M1
Ali, MA2
Kraut, MJ2
Herskovic, AM1
Du, W1
Kalemkerian, GP2
Preti, P2
Poggi, G1
Cuomo, AM2
Robustelli della Cuna, FS2
Zambelli, A1
Pavesi, L1
Han, JY1
Choi, BG1
Moon, H1
Lee, KS2
Lafontaine, T1
Maeda, Y1
Oyama, H1
Shishido, T1
Kin, T1
Izutani, T1
Yonese, J1
Fukui, I1
Nakagawa, K2
Okumura, S1
Hiratsuka, H1
Lococo, A1
Campisi, C1
Lalli, A1
Di Lullo, L1
De Filippis, S2
Vaccarili, M1
Zappalà, A1
Corrao, G1
Rea, S2
Pectasides, D1
Kalofonos, C1
Klouvas, G1
Panoussaki, E1
Tsiakopoulos, E1
Baumöhl, J3
Levitan, N1
Dowlati, A1
Craffey, M1
Tahsildar, H1
MacKay, W1
McKenney, J1
Remick, SC1
Wasserfallen, JB1
Rollier, P1
Kandioler-Eckersberger, D1
Kappel, S1
Mittlböck, M1
Dekan, G1
Ludwig, C1
Janschek, E1
Wolner, E1
Czyzewski, EA1
Goldman, S1
Mundt, AJ1
Nachman, J1
Rubin, C1
Hallahan, DE1
Philip, PA1
Rea, D1
Mitchell, K1
Carmichael, J2
Talbot, DC1
Deneffe, G1
Coosemans, W1
Lerut, T1
Igami, Y1
Yamamoto, R1
Okubo, Y1
Mitui, T1
Kinoshita, M1
Oizumi, K2
Wee, J2
Fong, KW2
Khoo, KS2
Fossella, FV3
Rigas, J1
Tognoni, A2
Cadenotti, L1
Pensa, F2
Vaira, F2
Vigani, A2
Bancalari, L2
Cordani, S1
Maggiani, R2
Canessa, PA1
Pronzato, P3
Victoria, L1
McCulloch, TM1
Callaghan, EJ1
Bauman, NM1
Woodroffe, CM3
Chetiyawardana, AD3
Joshi, R2
Cook, JE1
Trask, C1
Bessell, E1
Connolly, CK1
Tobias, J1
Souhami, RL4
Ricci, S1
Ceribelli, A1
Bianco, R1
Sassi, M2
Barni, S1
Ravaioli, A1
Adamo, V1
Cruciani, G1
Masotti, A1
Peters, R1
van de Velde, H1
Weynants, P1
Canon, JL1
Rosier, JF1
Javier Sánchez, J1
Padilla, J1
Cantó, A1
Roig, J1
Scinto, AF1
Ferraresi, V1
Milella, M1
Tucci, E1
Santomaggio, C1
Pasquali-Lasagni, R1
Del Vecchio, MR1
Campioni, N1
Nardi, M1
Cognetti, F1
Martin, C1
Balaña, C1
Langer, CJ1
Twu, NF1
Juang, CM1
Yeng, MS1
Lu, CJ1
Lai, CZ1
Chao, KC1
Belani, CP1
Corsi, DC1
Pozzo, C1
Cassano, A1
Alvaro, G1
Colloca, G1
Landriscina, M1
Astone, A1
Yoshizawa, H1
Tanaka, J1
Kagamu, H1
Ito, K1
Shimbo, T1
Chou, D1
Wakabayashi, M1
Suzuki, E1
Sakai, K1
Arakawa, M1
Gejyo, F1
Vergnenègre, A1
Thomas, P1
Robinet, G1
Pibarot, M1
Paillotin, D1
Vernejoux, JM1
Thiberville, L2
Lena, H1
Kleisbauer, JP1
Gimonet, JF1
Tan, T1
Eng, P1
Hsu, A1
Tan, YK1
Chua, EJ1
Ong, YY1
Rosselli, M1
Pompili, P1
Guerriero, G1
Campoccia, S1
Cionini, L1
Conte, P1
Perry, MC1
Ihde, DC3
Grethein, SJ1
Atkins, JN1
Vadell-Nadal, C1
Nogué-Aliguer, M1
Fabregat-Mayol, X1
Saigí-Grau, E1
Gallén-Castillo, M1
Ruotsalainen, T1
Halme, M1
Isokangas, OP1
Pyrhönen, S1
Mäntylä, M1
Pekonen, M1
Sarna, S1
Joensuu, H1
Mattson, K1
DeVore, R1
Kerr, RN1
Natale, RR1
Dunphy, F1
Kalman, L1
Miller, V1
Gandara, D1
Karp, D1
Vokes, E1
Kris, M1
Gamza, F1
Hammershaimb, L1
Takigawa, N2
Segawa, Y3
Kishino, D1
Fujiwara, K1
Ida, M1
Eguchi, K2
Takamori, S1
Hayashi, A1
Tayama, K1
Mitsuoka, M1
Fujimoto, K1
Horiuchi, M1
Hayabuchi, N1
Shirouzu, K1
Bisagni, G1
Moretti, G1
Rondini, E1
Zadro, A1
Franciosi, V1
Pazzola, A1
Vignoli, R1
Banzi, MC1
Pajetta, V1
Scott, C1
Movsas, B1
Wagner, H1
Tsavaris, NB3
Sepsas, E2
Malamos, NA2
Vadiaka, M4
Dosios, T1
Antonopoulos, MJ1
Ligneau, B1
Ardiet, C1
Rebattu, P1
Boissel, JP1
Schmerber, J1
Vanhees, SL1
Paridaens, R1
Jaillon-Abraham, C1
Coscas, Y1
Andrieu, JM1
Sayit, E1
Aktoğu, S1
Ertay, T1
Capa, G1
Erkmen, G1
Ozbilek, E1
Büyükşirin, M1
Durak, H1
Fukuoka, S1
Koufos, C1
Gurney, EM1
Napp, VV1
Hepburn, PM1
Gérinière, L1
Takita, H2
Pitoniak, RF1
Simms, T1
Davies, R1
Ahn, JB1
Ko, WK1
Lee, JG1
Shim, KY1
Jeung, HC1
Yoo, NC1
Kim, BS1
Kim, SK2
Woo, IS1
Park, YS1
Kwon, SH1
Park, YL1
Lee, JA1
Park, MJ1
Hyun, IG1
Jung, KS1
Bae, HS1
Oh, DH1
Ahn, YC1
Poquette, CA1
Brandao, L1
Czownicki, Z1
Pasz, P1
Michałek, A1
Zientek, J1
Zientek, A1
Koźlik, H1
Dingemans, AC1
van Ark-Otte, J1
Span, S1
van der Valk, P1
Fiasella, L1
Canessa, P1
Arnau Obrer, A2
Martín Díaz, E2
Pérez Alonso, D2
Regueiro Mira, F2
Cervera Juan, A2
Granell Gil, M2
Roch Pendería, S1
Cantó Armengod, A2
Panopoulos, C1
Stavroyianni, N2
Kourelis, T1
Malamos, N1
Antonopoulos, M1
Luthra, K1
Wozniak, AJ1
Behera, D1
Aggarwal, AN1
Sharma, SC1
Gupta, D1
Jindal, SK1
Cañizares Carretero, M1
Roch Tejerina, S1
Szopiński, J1
Ponarska, A1
Rogińska, E1
Rogala, E1
Rowińska-Zakrzewska, E1
van Putten, JW1
Kerbush, T1
van Rijswijk, R1
Beijnen, JH2
Sleijfer, DT1
Kerbusch, T1
vanPutten, JW1
Huitema, AD1
Mathĵt, RA1
Kobylińska, K1
Koralewski, P1
Sobik, B1
Gasiorek, M1
Kobylińska, M1
Rixe, O1
Le Guen, Y1
Touboul, E1
Granata, C1
Gambini, C1
Carlini, C1
Repetto, P1
Torre, M1
Mazzola, C1
Mattioli, G1
Jasonni, V1
Baiardi, P1
Torazzo, R1
Robustelli della Cuna, G1
Montalar, J1
Maestu, I1
García, R1
Yuste, AL1
Torregrosa, D1
Segura, A1
Hosomi, Y2
Shibuya, M2
Erkisi, M1
Erkurt, E1
Zeren, H1
Tunali, C1
Neumaier, C1
Tumolo, S1
Toffoli, G1
Saracchini, S1
Lo Re, G1
Bruschi, G1
Boccieri, MG1
Chevret, S1
Lemarié, E1
Gouva, S1
Bréchot, JM1
Terrioux, P1
Clavier, J1
Foucher, P1
Monchâtre, M1
Coëtmeur, D1
Leclerc, P1
Blanchon, F1
Rodier, JM1
Villeneuve, A1
Postovsky, S1
Beck, D1
Ben-Izhak, O1
Arush, MW1
Onyenadum, A1
Dimitropoulos, D1
Rokana, S1
Hanna, NH1
Sandier, AB1
Jung, SH1
Lane, K1
Chu, DT1
Zhang, XR1
Li, JL1
Qu, FL1
Ito, T1
Mochida, A1
Saito, K1
Nishi, K1
Sasaki, S1
Hisada, T1
Morinari, H1
Nakahara, K1
Tahara, M1
Masuda, S1
Yakumaru, K1
MacRae, R1
Grimard, L1
Hsu, E1
Nizalik, E1
Halton, JM1
Ueoka, H5
Kiura, K3
Tabata, M2
Moritaka, T3
Hiraki, S3
Harada, M1
Tanimoto, M1
Calderoni, A1
von Briel, C1
Aebi, S1
Solenthaler, M1
Betticher, DC1
Körner, F2
Lund, S1
Jonas, U1
Zaren, HA1
Freireich, EJ1
Copeland, EW1
Gagliano, R1
Loukas, D1
Panettiere, FJ2
Hokanson, JA1
Cohen, MH2
Chretien, PB1
Fossieck, BE2
Makuch, R2
Johnston, AV1
Shackney, SE2
Matthews, MJ2
Lipson, SD1
Kenady, DE1
Minna, JD2
Johnston-Early, A1
Richman, S1
Gutterman, JU1
Constanzi, JJ1
Greco, C2
Corsi, A2
Caputo, M1
Cavallari, A1
Calabresi, F2
Neidhardt, B1
Lutz, H1
Schnitker, J1
Brock, N2
Fichtner, E1
Glazman-Kuśnierczyk, H1
Matuszyk, J2
Radzikowski, C4
Nakabayashi, T3
Miyamoto, H3
Fujikane, T3
Shimizu, T3
Yasuda, S2
Akita, H2
Sakai, E1
Onodera, S2
Ohsaki, Y1
Kawakami, Y3
Rynard, S1
Songer, J1
Pennington, K1
Einhorn, L1
Zamora, P1
Garcia de Paredes, ML1
Chacon, JI1
Palmen, FM1
Carney, DN2
Vendrik, C2
Roozendaal, K2
Williams, SD1
Eberhardt, W1
Shirinian, M2
Dhingra, HH2
Goss, PE2
Maroun, J3
Lind, M4
Berendsen, HH1
Jassem, E1
Bonfrer, JM1
van Tinteren, H2
Bischoff, H1
Fischer, JR1
Löchner, S1
Peukert, M1
Schmähl, A1
García Gómez, R1
García Arroyo, R1
Meana García, A1
Martínez del Prado, P1
González del Val, R1
Pérez Manga, G1
Isobe, H1
Asakawa, M5
Suzuki, A5
Monnet, I1
Chariot, P1
Voisin, S1
Saltiel, JC1
de Cremoux, H1
Estrada-Aguilar, J1
Greenberg, H1
Walling, A1
Schroer, K1
Black, T1
Morse, S1
Hvizdala, E1
Hojo, K1
Kumasaka, Y1
Nishiyama, S1
Higashihara, T1
Oku, Y1
Okada, M1
Kajiyama, K1
Arai, N1
Annoh, S1
Kaneko, H1
Umeda, M1
Tsukahara, T1
Shirai, T1
Thomas, F1
Subirana, R1
Baldeyrou, P2
Arriagada, R3
Chazard, M1
Tursz, T1
Gurney, H2
de Campos, ES1
Dodwell, D1
Kamthan, A2
Lind, MJ6
Gomm, S1
Simmonds, AP1
Twelves, CJ1
Goldman, J1
Ash, CM2
Geddes, D1
Tobias, JS3
Pritsch, M1
Schroeder, M6
Flechtner, H2
Heim, M4
Hruska, D1
Mende, S2
Avery, L1
McKay, CP1
Wyatt, RJ1
Hancock, ML1
Hoskin, PJ1
Parton, D1
Yarnold, JR2
Cherryman, G1
Weiss, RB2
Heckmayr, M2
Hossfeld, DK3
Kaukel, E2
Neuhauss, R2
von Rohr, A1
McIntosh, R1
Ohnoshi, T5
Ueda, N1
Fujii, M2
Machida, K1
Kawahara, S3
Kozuka, A1
Maasberg, M2
Mariani, GL1
Addamo, G1
Venturini, M1
Kamei, H1
Kimura, I1
Kumar, L1
Bhargava, VL1
Sasaki, H2
Mori, T1
Nakajima, S2
Inoue, Y3
Honda, R3
Miles, DW2
Earl, HM2
Rudd, R2
James, L1
Trask, CW1
Gomm, SA1
Cuthbert, A1
Chang, J1
Burmester, H1
Hall, P1
Carroll, KB3
Fujita, H1
Kiyokawa, N1
Takada, K1
Kyo, K1
Ishimoto, K1
Yabuta, K1
Mizuno, T1
Fukuoka, M1
Negoro, S1
Masuda, N1
Furuse, K1
Kawahara, M1
Kodama, N1
Ikegami, H1
Nakamura, S1
Nishio, H1
Anderson, NR1
Tandon, DS1
Elias, A1
Ryan, L1
Aisner, J1
Antman, KH1
Baker, WJ1
Fistel, SJ1
Jones, RV1
Dorr, RT1
ten Bokkel Huinink, WW1
Wanders, J1
Simonetti, G1
Dubbelman, R1
Franklin, H1
McVie, JG1
Currie, DC1
Drake, JS1
Glisson, BS1
Dhingra, HM2
Umsawasdi, T2
Levy, JK1
Jeffries, D1
Raber, MN1
Abad-Esteve, A2
Fernandez, C1
Ribelles, N2
Culubret, M1
Woodcock, A1
Perren, TJ1
Ashley, SA1
Woodiwiss, J1
Forgeson, GV1
Matsutomo, S1
Genba, K1
Itami, S1
Horikoshi, N1
Mukaiyama, T1
Fukutani, H1
Hirano, A1
Mizunuma, N1
Trillet, V1
Champel, F1
Bernard, JP1
Brune, J1
Clavel, M1
Emonot, A1
Guérin, JC1
Kalb, JC1
Paccagnella, A1
Favaretto, A1
Brandes, A1
Fornasiero, A1
Volpi, A1
Pappagallo, G1
Festi, G1
Cipriani, A1
Vinante, O1
Laumen, R1
Jungbluth, H1
Häussinger, K1
Otto, M1
Krieger, H1
Falkson, G1
Chasen, MR1
Falkson, HC1
Margison, JM3
Wilkinson, PM3
Kamthan, AG1
Bronchud, MH1
Ranson, MR1
Olazabal, A1
Canela, M1
Bidoli, P2
Spinazzè, S2
Casali, P1
Bedini, AV2
Guzzon, A1
Rossi, JF1
Dubois, JB1
Mary, H1
Shimokata, K1
Yamamoto, M1
Saka, H1
Sakai, S1
Kawachi, H1
Eschenbach, C1
Maroske, D1
Winkler, K1
Harms, V1
Dombrowski, H1
Victor, N2
Bronchud, M1
Scarffe, JH1
Crowther, D1
Souza, LM1
Alton, NK1
Numata, T1
Nishii, K1
Yonei, T2
Yamashita, H2
Ishii, J2
Nourissat, C1
Patricot, LM1
Brunat-Mentigny, M1
Tachon, G1
Manoukian, A1
Kuśnierczyk, H2
Cataldo, I1
Bonadonna, G1
Chetiyawardana, SD1
Joshi, RC1
Payne, C1
Campbell, C1
Moussalli, H1
Hardman, PD1
Green, JA1
Errington, RD1
Myint, S1
Warenius, HM1
Thatcher, D1
Morgenstern, G1
Carr, T1
Chadwick, G1
Jones, R1
Craig, P1
Barber, PV1
Wolstenholme, RJ1
Barnes, P1
Deiraniya, A1
Dommes, M1
Fusco, V1
Gulisano, M1
Baracco, F1
Capaccio, A1
Pastorino, G1
Nosenzo, M1
Felletti, R1
Fabiano, F1
Tamura, T2
Tamai, M1
Egawa, T1
Bozzino, JM2
Corris, P1
Tsujii, H1
Irie, G1
Dalesio, O1
Palmen, FJ1
Burghouts, J1
Planting, A1
Pastran, Z1
Spielmann, M1
Rouesse, J1
Stalleicken, D1
Klasen, H1
Bülzebruck, H2
Djawid, N1
Ruchalla, E1
Tessen, HW1
Paschke, R1
Worst, P1
Brust, J1
Lange, OF1
Banks, J1
Anderson, EG1
Hoff, AM1
Naitoh, T1
Suyama, T1
Kameyama, M1
Ohtsuka, M1
Yoshizawa, Y1
Radenbach, D1
Zschaber, R1
Birch, R1
Kramer, BS1
Greco, FA1
Fergusson, RJ1
Wolf, CR1
Balkwill, FR1
Smyth, JF1
Höfeler, H1
Höffken, K1
Schoetensack, B1
Wandl, U1
Kath, R1
Müller, M1
Tsukagoshi, S1
Frankmann, C1
McMurtrey, MJ1
Jeffries, DG1
Welch, SR1
Smith, DB2
Webb, K1
Hilton, A1
Rahman, A1
Klapsing, J1
Viktor, N1
Girón, CG1
Jalón, JI1
Barón, MG1
Pooley, J1
Meanwell, CA2
Mould, JJ1
Blackledge, G2
Lawton, FG1
Stuart, NS1
Kavanagh, J1
Latief, TN1
Sakurai, M1
Saijo, N1
Shinkai, T1
Sano, T1
Suemasu, K1
Jett, JR1
Blake, AE1
Kelly, KA1
Honigsberger, L1
Li, GC1
Li, JQ1
He, YJ1
Zalupski, M1
Baker, LH1
Barclay, J1
Chopra, MP1
Fitzgerald, MD1
Zamboglou, N1
Fürst, G1
Pape, H1
Bannach, B1
Molls, M1
Schmitt, G1
Spitzer, G1
Farha, P1
Dicke, K1
Zander, A1
Vellekoop, L1
Chiuten, D1
Paprocka, M2
Budzyński, W1
Rak, J1
Kinas, R1
Misiura, K1
Stec, W1
Herdrich, K1
Hoefer, H1
Scheef, W1

Clinical Trials (26)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
PEI REGIMEN: A THERAPEUTIC OPTION IN SMALL CELL LUNG CANCER? A MONOINSTITUTIONAL EXPERIENCE OF 46 CONSECUTIVE CASES[NCT02324296]46 participants (Actual)Observational1998-12-31Completed
Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment[NCT00824083]950 participants (Actual)Observational2009-07-31Completed
Chemotherapy-induced Necrosis in Ewing Sarcoma: Which is the Best Scoring Tool[NCT03968471]474 participants (Actual)Observational2019-05-13Completed
EUROPEAN INTERGROUP COOPERATIVE EWING'S SARCOMA STUDY [EICESS 92][NCT00002516]Phase 30 participants Interventional1992-07-31Active, not recruiting
A Phase II Study Using Autologous Young Tumor-Infiltrating Lymphocytes Derived From Patients With Non-Small Cell Lung Cancer Following Non-Myeloablative Lymphocyte Depleting Preparative Regimen[NCT02133196]Phase 285 participants (Anticipated)Interventional2014-10-23Recruiting
Phase III Trial Comparing 2 Chemotherapy Schedules (Preoperative vs Pre and Postoperative) in Stage I and II NSCLC[NCT00198354]Phase 3530 participants (Actual)Interventional2001-05-31Completed
Observational Study on Treatment of Skeletal Ewing Sarcoma at Diagnosis[NCT04845893]100 participants (Anticipated)Observational2021-06-01Recruiting
A Phase Ⅱ Single-arm Clinical Trial to Investigate the Efficacy and Safety of Vinorelbine-ifosfamide Regimen as Third-line Treatment in Refractory or Recurrent Extensive Small Cell Lung Cancer Patients[NCT01752517]60 participants (Anticipated)Observational2012-12-31Recruiting
A Phase 1, Open-Label, Dose Escalation Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Combined Oral C-Met/ALK Inhibitor (PF-02341066) and Pan-Her Inhibitor (PF-0299804) in Patients With Advanced Non-Small Cell Lung Cancer[NCT01441128]Phase 120 participants (Actual)Interventional2011-09-01Terminated
Open Label Phase II Study on Glufosfamide Administered as a 60 Minute Infusion Every 3 Weeks in Advanced Non Small Cell Lung Cancer[NCT00005055]Phase 239 participants (Actual)Interventional2000-01-31Completed
RANDOMISED CLINICAL TRIAL OF IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITH MID-CYCLE VINCRISTINE (VICE) VERSUS STANDARD PRACTICE CHEMOTHERAPY IN PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER (SCLC) AND GOOD PERFORMANCE STATUS[NCT00002822]Phase 3400 participants (Anticipated)Interventional1996-03-31Completed
A Phase I Trial and Pharmacokinetic Study of the Oral Platinum Analog Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors[NCT01259479]Phase 19 participants (Actual)Interventional2010-12-03Completed
MISTOSUS: Iscador® P (Mistletoe) Immunotherapy To Improve Event Free Survival In Patients With Relapsed Osteosarcoma After Resection Of Pulmonary Metastases[NCT05726383]Phase 232 participants (Anticipated)Interventional2023-12-15Not yet recruiting
Multicenter Observational Study on the Treatment of Patients With Localized Osteosarcoma[NCT04890067]120 participants (Anticipated)Observational2021-07-30Recruiting
Phase II Multicenter Study Evaluating the Efficacy of Carboplatin-Etoposide Combination in Hormone-resistant Prostate Cancers With Neuroendocrine Differentiation.[NCT00973882]Phase 260 participants (Actual)Interventional2005-04-30Completed
A Phase Ⅱ Randomized Clinical Trial Comparing Vinorelbine-ifosfamide With Gefitinib as Third-line Treatment in Advanced EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients[NCT01749072]Phase 2120 participants (Anticipated)Interventional2012-12-31Recruiting
Efficacy and Tolerance Adjuvant High-Dose Thiotepa With Peripheral Stem Cell Rescue Associated With Conventional Chemotherapy in Children and Adults With Relapsed Osteosarcoma[NCT00978471]Phase 244 participants (Actual)Interventional2009-07-31Completed
Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)[NCT02734069]132 participants (Anticipated)Observational2016-02-29Recruiting
(PRO#11307) Phase III Randomized Study of Autologous Stem Cell Transplantation With High-dose Melphalan Versus High-dose Melphalan and Bortezomib in Patients With Multiple Myeloma 65 Year or Older[NCT01453088]Phase 263 participants (Actual)Interventional2010-06-24Terminated (stopped due to Lack of Accrual)
Tandem Autologous Hematopoietic Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma[NCT01241708]Phase 3146 participants (Actual)Interventional2010-04-08Completed
A Phase II Trial of Pemetrexed (Alimta [Registered Trademark]) Combined With Sirolimus (Rapamycin, Rapamune [Registered Trademark]) in Subjects With Relapsed or Refractory NSCLC[NCT00923273]Phase 1/Phase 242 participants (Actual)Interventional2008-02-29Terminated (stopped due to Premature closure - investigator left the National Institutes of Health.)
A Study on the Efficacy and Safety of Anlotinib Combined With Docetaxel in the Treatment of Wild-type Advanced Non-squamous Non Small Cell Lung Cancer Patients With Progress After Immunotherapy Plus Chemotherapy as First-line Treatment[NCT04619537]Phase 242 participants (Anticipated)Interventional2020-10-08Recruiting
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies[NCT00703625]Phase 126 participants (Actual)Interventional2008-03-08Completed
A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodg[NCT00479167]Phase 21 participants (Actual)Interventional2007-05-31Terminated (stopped due to Lack of accrual and interest in study)
A Phase Ⅱ Randomized Controlled Trial to Compare Gefitinib With Docetaxel as Second-line Therapy for Advanced or Metastatic Non-squamous NSCLC Patients With Wild-type EGFR[NCT01755923]Phase 260 participants (Anticipated)Interventional2012-12-31Recruiting
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable Non-Small-Cell Lung Cancer.[NCT02259621]Phase 245 participants (Anticipated)Interventional2014-09-30Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Overall Survival Rate

(NCT01453088)
Timeframe: 1 year

InterventionParticipants (Count of Participants)
Auto Transplant High Dose Melphalan27
Auto Transplant High Dose Melphalan+Bortezomib27

Progression Free Survival Rate

Progression free survival of elderly patients with multiple myeloma treated with either high-dose melphalan versus high-dose melphalan and bortezomib at 3 years (NCT01453088)
Timeframe: Participants will be followed post transplant for a minimum of 3 years, and after that may be monitored as part of the study indefinitely

InterventionParticipants (Count of Participants)
Auto Transplant High Dose Melphalan13
Auto Transplant High Dose Melphalan+Bortezomib11

Phase I: Maximum Tolerated Dose (MTD) of Pemetrexed

The phase I component of the study are to determine the safety and tolerability of pemetrexed in human subjects with non small cell lung cancer (NSCLC), and to determine the maximum tolerated dose. (NCT00923273)
Timeframe: 5 weeks

Interventionmg/m^2 (Number)
Treatment Level 1: 3mg Load500
Treatment Level 2: 6mg Load500
Treatment Level 3: 6mg Load500
Treatment Level 4: 10mg Load500
Treatment Level 5: 15mg Load500

Phase I: Maximum Tolerated Dose (MTD) of Sirolimus

The phase I component of the study are to determine the safety and tolerability of sirolimus in human subjects with non small cell lung cancer (NSCLC), and to determine the maximum tolerated dose. (NCT00923273)
Timeframe: 5 weeks

Interventionmg/m^2 (Number)
Treatment Level 1: 3mg Load10
Treatment Level 2: 6mg Load10
Treatment Level 3: 6mg Load10
Treatment Level 4: 10mg Load10
Treatment Level 5: 15mg Load10

Number of Participants With Serious and Non-Serious Adverse Events

Here is the count of participants with serious and non-serious adverse events assessed by the Common Terminology Criteria for Adverse Events (CTCAE v3.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life-threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT00923273)
Timeframe: Date treatment consent signed to date off study, approximately 45 months

,,,,
InterventionParticipants (Count of Participants)
Subjects from phase I8subjects prior peme & 12 subjects peme naive
Treatment Level 1: 3mg Load40
Treatment Level 2: 6mg Load30
Treatment Level 3: 6mg Load30
Treatment Level 4: 10 mg Load720
Treatment Level 5: 15mg Load50

Phase II: Clinical Response Rate

Clinical response is assessed by the Response Evaluation Criteria in Solid Tumors (RECIST). Complete response (CR) is disappearance of all target lesions. Partial response (PR) at least a 30% decrease in the sum of the longest diameter (LD) of target lesions, taking as reference the baseline sum LD. Stable disease (SD) is neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD, taking as reference the smallest sum LD since the treatment started. Progressive disease (PD) is at least a 20% increase in the sum of the LD of target lesions, taking as reference the smallest sum LD recorded since the treatment started or the appearance of one or more new lesions. (NCT00923273)
Timeframe: 21 weeks

InterventionParticipants (Count of Participants)
Complete responsePartial responseStable diseaseProgressive diseaseNot evaluable
Treatment Level 4: 10mg Load051327

Reviews

92 reviews available for ifosfamide and Cancer of Lung

ArticleYear
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
    Anticancer research, 2023, Volume: 43, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Ce

2023
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
    Current oncology (Toronto, Ont.), 2019, Volume: 26, Issue:4

    Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide;

2019
Successful treatment of synchronous chemoresistant pulmonary metastasis from pleomorphic rhabdomyosarcoma with stereotaxic body radiation therapy: A case report and a review of the literature.
    Cancer treatment and research communications, 2021, Volume: 26

    Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Resistance, Neoplasm; Female; Huma

2021
Historical perspective on the introduction and use of chemotherapy for the treatment of osteosarcoma.
    Advances in experimental medicine and biology, 2014, Volume: 804

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; C

2014
Long-term survival in metastasized leiomyosarcoma: a case report and review of the literature.
    Tumori, 2015, Sep-09, Volume: 101, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Disease-Fre

2015
Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Apr-01, Volume: 35, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality

2017
Multidisciplinary management of metastatic sarcoma.
    The Surgical clinics of North America, 2008, Volume: 88, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality

2008
Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: a systematic overview.
    Lung cancer (Amsterdam, Netherlands), 2009, Volume: 64, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat

2009
Leiomyosarcoma of the parotid gland in an HIV-positive patient: therapeutic approach, clinical course and review of the literature.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biomar

2009
Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature.
    Journal of pediatric surgery, 2009, Volume: 44, Issue:5

    Topics: Abscess; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Celecoxib; Ch

2009
Are RAS mutations predictive markers of resistance to standard chemotherapy?
    Nature reviews. Clinical oncology, 2009, Volume: 6, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat

2009
Leiomyosarcoma of the tongue with multiple metastases: a case report and review of literature.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:7

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy

2012
Isolated subcutaneous metastasis of osteosarcoma 5 years after initial diagnosis.
    Journal of pediatric surgery, 2011, Volume: 46, Issue:10

    Topics: Abdominal Wall; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas

2011
Leptomeningeal carcinomatosis in aggressive germ non-seminoma testicular tumor: a case report and review of literature.
    Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Fatal O

2012
A chemosensitive pediatric extraosseous osteosarcoma: case report and review of the literature.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin; Female; Human

2003
Chemotherapy versus best supportive care for extensive small cell lung cancer.
    The Cochrane database of systematic reviews, 2003, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Humans; Ifosfamide; Lomustine

2003
Ifosfamide in small cell lung cancer.
    Oncology, 2003, Volume: 65 Suppl 2

    Topics: Antineoplastic Agents, Alkylating; Carcinoma, Small Cell; Humans; Ifosfamide; Lung Neoplasms; Surviv

2003
Ifosfamide in non-small cell lung cancer.
    Oncology, 2003, Volume: 65 Suppl 2

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc

2003
[Pulmonary rhabdomyosarcoma generated during treatment of testicular tumor].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2003, Volume: 94, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Embryonal; Cisplatin; Combined Mod

2003
Palliative treatment for advanced or metastatic osteosarcoma.
    The Israel Medical Association journal : IMAJ, 2004, Volume: 6, Issue:1

    Topics: Amputation, Surgical; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic A

2004
Chemotherapy of small cell lung cancer: state of the art.
    Current opinion in oncology, 2004, Volume: 16, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Smal

2004
Osteosarcoma occurring in osteogenesis imperfecta.
    Virchows Archiv : an international journal of pathology, 2004, Volume: 444, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality

2004
[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Carboplatin; Cisplatin;

2004
In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy.
    International journal of cancer, 2005, Feb-20, Volume: 113, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Carcinoma, Small Cel

2005
Bilateral metastatic renal synovial sarcoma.
    Urology, 2005, Volume: 65, Issue:2

    Topics: Amputation, Surgical; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Female; Forearm;

2005
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
    Clinical advances in hematology & oncology : H&O, 2005, Volume: 3, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Mo

2005
Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials.
    Lung cancer (Amsterdam, Netherlands), 2006, Volume: 51, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Carcinoma, Non-

2006
Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review.
    The Journal of laryngology and otology, 2006, Volume: 120, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Da

2006
Giant cell tumor of the uterus: case report and response to chemotherapy.
    BMC cancer, 2007, Mar-14, Volume: 7

    Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal

2007
[Clinical features of patients with metastasis in phalanges as first symptom of primary lung cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcino

2007
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
    Cancer treatment reviews, 1983, Volume: 10, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm

1983
New agents in non-small cell lung cancer.
    Cancer treatment reviews, 1984, Volume: 11, Issue:3

    Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Anti

1984
Ifosfamide in experimental tumor systems.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Ifosfamide; Lethal Dose

1982
Ifosfamide: European perspective.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administrat

1982
The anticancer spectrum of ifosfamide.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Mal

1982
Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
    Hematology/oncology clinics of North America, 1995, Volume: 9, Issue:4

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Chemoth

1995
Response of metastasized sex cord gonadal stromal tumor of the testis to cisplatin-based chemotherapy.
    The Journal of urology, 1994, Volume: 151, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifos

1994
The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
    Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinica

1995
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth

1995
Oral therapy for small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12 Suppl 3

    Topics: Administration, Oral; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto

1995
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.
    Thorax, 1995, Volume: 50 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth

1995
The role of ifosfamide in germ cell tumors and small cell lung cancer.
    Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Ger

1995
Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
    Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Trials

1995
Translocation t(11;19) (q23;p13) in a child with myelomonocytic leukemia following 2 years after chemotherapy for pneumoblastoma.
    Medical and pediatric oncology, 1993, Volume: 21, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chromosomes, Human, Pair 11; Chrom

1993
[A case of small cell lung cancer associated with fulminant hepatitis B].
    Nihon Kyobu Shikkan Gakkai zasshi, 1994, Volume: 32, Issue:9

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; E

1994
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
    Seminars in oncology, 1995, Volume: 22, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clini

1995
[Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin].
    Bulletin du cancer, 1994, Volume: 81, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Fem

1994
Intensive combined-modality therapy in small cell lung cancer.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Ad

1994
Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990.
    Cancer treatment and research, 1993, Volume: 62

    Topics: Amputation, Surgical; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Th

1993
Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical

1994
Ifosfamide-induced hyperpigmentation.
    Cancer, 1993, May-01, Volume: 71, Issue:9

    Topics: Child, Preschool; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Mesna; Pigm

1993
Ifosfamide in the treatment of small cell lung cancer.
    Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo

1996
Ifosfamide in non-small cell lung cancer.
    Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm

1996
The role of ifosfamide in small cell lung cancer.
    Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Humans; Ifosfamide; Lung Neop

1996
The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 1996, Volume: 51, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat

1996
Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer.
    Seminars in oncology, 1998, Volume: 25, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinica

1998
A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
    Seminars in oncology, 1998, Volume: 25, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as T

1998
Ifosfamide and docetaxel in non-small cell lung cancer.
    Seminars in oncology, 1998, Volume: 25, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Pha

1998
Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
    Seminars in oncology, 1998, Volume: 25, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as

1998
Combination studies with gemcitabine in the treatment of non-small-cell lung cancer.
    British journal of cancer, 1998, Volume: 78 Suppl 3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1998
Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer.
    Seminars in oncology, 1999, Volume: 26, Issue:1 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat

1999
Docetaxel (Taxotere) in non-small cell lung cancer: ongoing studies in Heidelberg and future plans.
    Seminars in oncology, 1999, Volume: 26, Issue:3 Suppl 11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as T

1999
Malignant triton tumor of the head and neck: A case report and review of the literature.
    Head & neck, 1999, Volume: 21, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Cisplatin; Combined Modality

1999
Ifosfamide in non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10 Suppl 5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Deoxycy

1999
Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer.
    Seminars in oncology, 1999, Volume: 26, Issue:5 Suppl 16

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm

1999
New options in the treatment of non-small cell lung cancer.
    Anti-cancer drugs, 1999, Volume: 10 Suppl 1

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc

1999
Chemotherapy in metastatic non-small-cell lung cancer.
    Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:7 Suppl 5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell

2000
Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Humans; Hyponatrem

2000
Second-line chemotherapy for non-small-cell lung cancer.
    Current oncology reports, 2000, Volume: 2, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung

2000
[Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
    Revue de pneumologie clinique, 2000, Volume: 56, Issue:5

    Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineopl

2000
Review of two phase III randomized trials of single-agent docetaxel in previously treated advanced non--small cell lung cancer.
    Seminars in oncology, 2001, Volume: 28, Issue:3 Suppl 9

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung

2001
[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc

2001
Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2001, Volume: 34 Suppl 4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Ca

2001
Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: case report and review of the literature.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:4

    Topics: Adenocarcinoma, Clear Cell; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin;

2001
The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences.
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical

2002
Brain metastases in Wilms' tumor: case report and literature review.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Ther

2002
Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC).
    Cancer chemotherapy and pharmacology, 2002, Volume: 49 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycy

2002
[ Early anti-cancer drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun

2002
Non-small-cell lung cancer (NSCLC): chemotherapy in advanced disease. Our experience in ten years.
    American journal of clinical oncology, 1992, Volume: 15, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical

1992
Clinical trials with ifosfamide: the Indiana University experience.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Humans; Ifosfamide; Indiana;

1992
Ifosfamide in non-small cell lung cancer: a review.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Th

1992
Overview of ifosfamide in small cell lung cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Protocols; Humans; I

1992
Novel approaches with ifosfamide in small cell lung cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Protocols; Humans; I

1992
Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
    Seminars in oncology, 1990, Volume: 17, Issue:4 Suppl 7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Humans; Ifosfamide; Lung N

1990
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
    Cancer, 1990, Apr-15, Volume: 65, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1990
Overview of ifosfamide in small cell and non-small cell lung cancer.
    Seminars in oncology, 1990, Volume: 17, Issue:2 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel

1990
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
    Presse medicale (Paris, France : 1983), 1990, Apr-07, Volume: 19, Issue:14

    Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clin

1990
Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: a meta-analytic review.
    Journal of surgical oncology, 1990, Volume: 45, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modal

1990
Ifosfamide in small cell lung cancer.
    Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans;

1989
Ifosfamide in the treatment of non-small cell lung cancer.
    Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Th

1989
Ifosfamide.
    Journal of the National Cancer Institute, 1988, Jun-15, Volume: 80, Issue:8

    Topics: Breast Neoplasms; Drug Evaluation, Preclinical; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphoma

1988
Ifosfamide--pharmacology, safety and therapeutic potential.
    Cancer treatment reviews, 1985, Volume: 12, Issue:1

    Topics: Animals; Biotransformation; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evalu

1985

Trials

325 trials available for ifosfamide and Cancer of Lung

ArticleYear
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
    Acta oncologica (Stockholm, Sweden), 2017, Volume: 56, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Female; Follow-U

2017
Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.
    Medical oncology (Northwood, London, England), 2017, Nov-01, Volume: 34, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool;

2017
A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting.
    Cancer chemotherapy and pharmacology, 2018, Volume: 81, Issue:2

    Topics: Aged; Amylases; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; E

2018
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin.
    British journal of cancer, 2013, Apr-30, Volume: 108, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung;

2013
Modulation of peripheral immune responses by paclitaxel-ifosfamide-cisplatin chemotherapy in advanced non-small-cell lung cancer.
    Journal of cancer research and clinical oncology, 2013, Volume: 139, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2013
An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC.
    Anticancer research, 2013, Volume: 33, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small

2013
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.
    American journal of clinical oncology, 2016, Volume: 39, Issue:2

    Topics: Administration, Inhalation; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin;

2016
Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Annals of surgical oncology, 2015, Volume: 22, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool;

2015
[Combined Chemotherapy with Vinorelbine and Ifosfamide as Third-line Treatment and Beyond of Advanced Non-small Cell Lung Cancer].
    Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2015, Volume: 18, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease

2015
Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models.
    Cancer biology & therapy, 2016, 04-02, Volume: 17, Issue:4

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Humans; Ifosfamide; Lung Neoplasms; Mice; Nitroimidazoles;

2016
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
[Treatment of relapsed osteosarcoma. Role of chemotherapy using ifosamide and carboplatin].
    Voprosy onkologii, 2010, Volume: 56, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chem

2010
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).
    British journal of cancer, 2012, Feb-14, Volume: 106, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2012
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working
    Lung cancer (Amsterdam, Netherlands), 2012, Volume: 77, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2012
Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino

2012
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Belg

2002
Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2002, Volume: 37, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cos

2002
Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
    Lung cancer (Amsterdam, Netherlands), 2002, Volume: 37, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemo

2002
Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.
    Oncology, 2002, Volume: 63, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Carcinom

2002
[Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2002, Volume: 21, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

2002
GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L

2002
[Comparison of effects of three chemotherapy regimens for advanced non-small cell lung cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2002, Volume: 21, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel

2002
Outpatient intensive chemotherapy for small cell lung cancer: five years experience of modified 'ICE' ifosfamide carboplatin and etoposide.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2002, Volume: 14, Issue:5

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small

2002
Phase II study of Taxol combined With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancer.
    American journal of clinical oncology, 2003, Volume: 26, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

2003
Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospe
    Lung cancer (Amsterdam, Netherlands), 2003, Volume: 39, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell;

2003
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.
    Lung cancer (Amsterdam, Netherlands), 2003, Volume: 39, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy

2003
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2003, Volume: 40, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Femal

2003
Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

2003
Phase II study of irinotecan and ifosfamide in patients with advanced non-small cell lung cancer.
    Oncology, 2003, Volume: 64, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell

2003
Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Saudi medical journal, 2003, Volume: 24, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug

2003
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
    Cancer, 2003, Aug-01, Volume: 98, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; C

2003
Combination chemotherapy with irinotecan and ifosfamide as second-line treatment of refractory or sensitive relapsed small cell lung cancer: a phase II study.
    Chemotherapy, 2003, Volume: 49, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co

2003
Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer: phase II study.
    American journal of clinical oncology, 2003, Volume: 26, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2003
Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-01, Volume: 21, Issue:17

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2003
Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer.
    British journal of cancer, 2003, Sep-15, Volume: 89, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma

2003
Phase I study with dose escalation of gemcitabine and cisplatin in combination with ifosfamide (GIP) in patients with non-small-cell lung carcinoma.
    American journal of clinical oncology, 2004, Volume: 27, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2004
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino

2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group.
    European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Child; Child, Presch

2004
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L

2004
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jan-01, Volume: 23, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antine

2005
Combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in patients with metastatic urothelial cancer: a preliminary report.
    Japanese journal of clinical oncology, 2005, Volume: 35, Issue:2

    Topics: Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bo

2005
Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
    Journal of the National Cancer Institute, 2005, Apr-06, Volume: 97, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carc

2005
Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
    Journal of the National Cancer Institute, 2005, May-04, Volume: 97, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dos

2005
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2005, Volume: 49, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2005
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.
    American journal of clinical oncology, 2005, Volume: 28, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carbo

2005
Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer.
    Chest, 2005, Volume: 128, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com

2005
Chemotherapy for metastatic NSCLC: current status and future direction.
    Nature clinical practice. Oncology, 2005, Volume: 2, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino

2005
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
    Oncology reports, 2005, Volume: 14, Issue:6

    Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-

2005
A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer.
    Oncology, 2005, Volume: 69, Issue:4

    Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, No

2005
Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter ran
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Nov-20, Volume: 23, Issue:33

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino

2005
Metastatic osteosarcoma.
    Cancer, 2006, Jan-15, Volume: 106, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chil

2006
Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2005, Volume: 63, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcinoma, Non-Sm

2005
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Mar-01, Volume: 24, Issue:7

    Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Br

2006
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino

2006
Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study.
    American journal of clinical oncology, 2006, Volume: 29, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2006
Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2006, Volume: 54, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Carcinoma, Non-Small-Cell Lung

2006
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera

2006
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol

2007
Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006, Volume: 1, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small

2006
Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com

2007
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party.
    British journal of cancer, 2007, Jun-04, Volume: 96, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol

2007
Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study.
    Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycy

2008
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell;

2007
Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
    Cancer, 2008, Feb-01, Volume: 112, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cogni

2008
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Feb-01, Volume: 26, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Feb-01, Volume: 26, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Feb-01, Volume: 26, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Feb-01, Volume: 26, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2008
Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth

2008
A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Journal of the National Cancer Institute, 2008, Apr-16, Volume: 100, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co

2008
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
    Lung cancer (Amsterdam, Netherlands), 2008, Volume: 62, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Ca

2008
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.
    Lancet (London, England), 1980, Sep-27, Volume: 2, Issue:8196

    Topics: Acrolein; Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Female; Hematuria; Hu

1980
[Chemotherapy of nonseminomatous testicular tumors. The results of a pilot study with reduced cis-platin dosage].
    Onkologie, 1983, Volume: 6, Issue:3

    Topics: Bleomycin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans;

1983
Chemoimmunotherapy of small cell bronchogenic carcinoma with VP-16-213, ifosfamide, vincristine, adriamycin, and Corynebacterium parvum.
    Cancer, 1981, Jul-15, Volume: 48, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Bacterial Vaccines; Brain; Carcinoma, Small Cell; Clinical Trial

1981
[Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small cell carcinoma of the lung. A clinical study].
    Onkologie, 1982, Volume: 5, Issue:2

    Topics: Adult; Aged; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combin

1982
Parenteral intravenous nutrition (PIVN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma.
    Cancer treatment reports, 1981, Volume: 65 Suppl 5

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marr

1981
Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Actuarial Analysis; Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cl

1982
Use and safety of high-dose ifosfamide.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyc

1982
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
    Cancer treatment reviews, 1983, Volume: 10, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm

1983
Randomised trial comparing sequential methotrexate (or 5-FU), vinblastine and ifosfamide to vincristine, adriamycin and ifosfamide in advanced lung cancer.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Do

1983
New agents in non-small cell lung cancer.
    Cancer treatment reviews, 1984, Volume: 11, Issue:3

    Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Anti

1984
Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:2

    Topics: Administration, Oral; Adult; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Therapy, Combina

1983
Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors.
    Tumori, 1984, Oct-31, Volume: 70, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Ifosfa

1984
Ifosfamide: European perspective.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administrat

1982
Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
    Cancer treatment reports, 1981, Volume: 65 Suppl 5

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bon

1981
New drug found active against lung cancers.
    Hospitals, 1982, Jun-16, Volume: 56, Issue:12

    Topics: Clinical Trials as Topic; Cyclophosphamide; Humans; Ifosfamide; Lung Neoplasms

1982
[Chemotherapy in advanced sarcomas (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1981, Sep-11, Volume: 106, Issue:37

    Topics: Cisplatin; Doxorubicin; Drug Therapy, Combination; Humans; Ifosfamide; Lung Neoplasms; Sarcoma; Vinc

1981
Protective effect of N-acetylcysteine on the urotoxicity produced by oxazaphosphorine without interference with anticancer activity.
    European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:1

    Topics: Acetylcysteine; Antineoplastic Agents; Cyclophosphamide; Hematuria; Humans; Ifosfamide; Lung Neoplas

1982
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
    British journal of cancer, 1993, Volume: 68, Issue:6

    Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carcinoma, Small Cel

1993
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
    Blood, 1994, Sep-01, Volume: 84, Issue:5

    Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Ble

1994
Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion, Autologous; Carboplatin; C

1995
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.
    British journal of cancer, 1995, Volume: 71, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1995
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Seminars in oncology, 1995, Volume: 22, Issue:1 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis

1995
Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma

1995
Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.
    Seminars in oncology, 1995, Volume: 22, Issue:2 Suppl 5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Ad

1995
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.
    Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 9

    Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-C

1995
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, No

1995
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12 Suppl 1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Eto

1995
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined

1995
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth

1995
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.
    Thorax, 1995, Volume: 50 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth

1995
Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell;

1995
Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1995, Volume: 34, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell;

1995
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma,

1995
Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small C

1995
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
    Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinom

1995
Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer.
    Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1995
Combination therapy with ifosfamide and liposome-encapsulated muramyl tripeptide: tolerability, toxicity, and immune stimulation.
    Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy, 1995, Volume: 17, Issue:3

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Adolescent; Adult; Aged; Antineoplastic C

1995
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Eto

1995
Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.
    American journal of clinical oncology, 1995, Volume: 18, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Resp

1995
[Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1995, Volume: 171, Issue:7

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Carcinoma, Bronc

1995
Pharmacokinetics of ifosfamide and its enantiomers following a single 1 h intravenous infusion of the racemate in patients with small cell lung carcinoma.
    British journal of clinical pharmacology, 1995, Volume: 39, Issue:4

    Topics: Aged; Carcinoma, Small Cell; Female; Half-Life; Humans; Ifosfamide; Infusions, Intravenous; Lung Neo

1995
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:5

    Topics: Administration, Oral; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcino

1995
Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.
    Cancer investigation, 1995, Volume: 13, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms

1995
Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
    Seminars in oncology, 1995, Volume: 22, Issue:1 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit

1995
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
    Seminars in oncology, 1995, Volume: 22, Issue:1 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Epi

1995
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
    Seminars in oncology, 1995, Volume: 22, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clini

1995
Hoosier Oncology Group studies in extensive and recurrent small cell lung cancer.
    Seminars in oncology, 1995, Volume: 22, Issue:1 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo

1995
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer.
    Acta oncologica (Stockholm, Sweden), 1994, Volume: 33, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female

1994
Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer.
    Chest, 1994, Volume: 106, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva

1994
Phase II study of ifosfamide, carboplatin, and etoposide in patients with advanced non-small cell lung cancer.
    American journal of clinical oncology, 1994, Volume: 17, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1994
Phase I study of high-dose cisplatin, ifosfamide, and etoposide.
    Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru

1994
Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT).
    Lung cancer (Amsterdam, Netherlands), 1993, Volume: 10, Issue:1-2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit

1993
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1994
Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990.
    Cancer treatment and research, 1993, Volume: 62

    Topics: Amputation, Surgical; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Th

1993
Synovial sarcoma. Uniform response of metastases to high dose ifosfamide.
    Cancer, 1994, May-15, Volume: 73, Issue:10

    Topics: Adolescent; Adult; Female; Humans; Ifosfamide; Infusions, Parenteral; Lung Neoplasms; Male; Mesna; N

1994
A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer. A study of the Hellenic Co-operative Oncology Group for Lung Cancer Trials.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1994
Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1994
Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1994
An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth

1994
A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva

1994
Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth

1994
Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dr

1994
MICE: a new active combination for non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:13

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1993
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Wor
    British journal of cancer, 1993, Volume: 68, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cause of Death;

1993
Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyc

1993
Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
    Oncology, 1993, Volume: 50 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell

1993
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study.
    British journal of cancer, 1993, Volume: 67, Issue:5

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm

1993
A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.
    Cancer, 1993, Jul-01, Volume: 72, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1993
A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.
    British journal of cancer, 1993, Volume: 67, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small

1993
Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
    American journal of clinical oncology, 1993, Volume: 16, Issue:4

    Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-C

1993
Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Seminars in oncology, 1996, Volume: 23, Issue:2 Suppl 5

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co

1996
Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Seminars in oncology, 1996, Volume: 23, Issue:2 Suppl 5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti

1996
Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Dose-Response

1996
Treatment of stage III-IV non-small-cell lung carcinoma with vinorelbine in combination with ifosfamide plus MESNA: a study by the Southern Italy Oncology Group (GOIM).
    American journal of clinical oncology, 1996, Volume: 19, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Humans; Ifosfa

1996
Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co

1996
[Evaluation of chemotherapy for stage IV non-small cell lung cancer employing a regression tree type method for quality-adjusted survival analysis to determine prognostic factors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1996
Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1996, Volume: 14, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined

1996
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Disease-Free Sur

1996
Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago.
    Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female;

1996
Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 13, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell;

1995
Intensified VICE regimen may improve SCLC survival.
    Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Sur

1996
Phase I study of paclitaxel (Taxol) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer. A study of the National Cancer Institute of Canada Clinical Trials Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung;

1996
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Th

1996
Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
    The Journal of infusional chemotherapy, 1996,Winter, Volume: 6, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Antineoplastic Combined Che

1996
The limits of chemotherapy dose intensification using granulocyte colony stimulating factor alone in extensive small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1996, Volume: 14, Issue:2-3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, D

1996
r-metHuG-CSF support to ifosfamide, cisplatin, etoposide chemotherapy in non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1996, Volume: 14, Issue:2-3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru

1996
A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
    Lung cancer (Amsterdam, Netherlands), 1996, Volume: 14, Issue:2-3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Admi

1996
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma,

1996
[Phase I study of cisplatin, ifosfamide and CPT11 with granulocyte colony-stimulating factor support in advanced non-small cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell

1996
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytog

1996
Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm

1996
Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial.
    Lung cancer (Amsterdam, Netherlands), 1996, Volume: 15, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com

1996
Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.
    Bone marrow transplantation, 1996, Volume: 18 Suppl 1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined

1996
Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytog

1996
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Carbopl

1996
Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.
    American journal of clinical oncology, 1996, Volume: 19, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co

1996
Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.
    Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co

1996
Ifosfamide combined with toremifene in the treatment of non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1996, Volume: 16, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administr

1996
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1996
Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
    Seminars in oncology, 1997, Volume: 24, Issue:1 Suppl 2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carci

1997
Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
    Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Carcinoma, Bronchoge

1997
Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Ad

1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carc

1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; C

1997
Ifosfamide, cisplatin and etoposide (ICE) combined chemotherapy with recombinant human granulocyte colony-stimulating factor support in small cell lung cancer.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo

1997
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia.
    Cancer letters, 1997, May-19, Volume: 115, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Breast Neoplasms; Carboplatin; Car

1997
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.
    Japanese journal of clinical oncology, 1997, Volume: 27, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Drug Admin

1997
A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer.
    Seminars in oncology, 1997, Volume: 24, Issue:3 Suppl 8

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Comb

1997
Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer.
    Seminars in oncology, 1997, Volume: 24, Issue:3 Suppl 8

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, No

1997
Vinorelbine and ifosfamide for unresectable non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1997, Volume: 18, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administr

1997
Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer.
    Breast cancer research and treatment, 1997, Volume: 45, Issue:1

    Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; F

1997
A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1997
[Neoadjuvant combined therapy in stage IIIA if non-small-cell bronchial cancer].
    Deutsche medizinische Wochenschrift (1946), 1997, Aug-15, Volume: 122, Issue:33

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co

1997
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.
    Cancer, 1997, Oct-01, Volume: 80, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Granu

1997
Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer.
    Seminars in oncology, 1997, Volume: 24, Issue:4 Suppl 12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Ad

1997
Paclitaxel, ifosfamide, and carboplatin for the treatment of stages IIIB and IV non-small cell lung cancer: preliminary results.
    Seminars in oncology, 1997, Volume: 24, Issue:4 Suppl 12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1997
Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Seminars in oncology, 1997, Volume: 24, Issue:4 Suppl 12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1997
Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    British journal of cancer, 1997, Volume: 76, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1997
A phase III randomized trial of cisplatin plus vindesine versus cisplatin plus vindesine plus mitomycin C versus cisplatin plus vindesine plus ifosfamide for advanced non-small-cell lung cancer.
    Respirology (Carlton, Vic.), 1996, Volume: 1, Issue:1

    Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cel

1996
Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Cancer, 1998, Jan-15, Volume: 82, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineo

1998
A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors.
    Cancer, 1998, Feb-01, Volume: 82, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Fe

1998
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
    International journal of radiation oncology, biology, physics, 1998, Jan-15, Volume: 40, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cohor

1998
Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Cross-Over Studies; Humans; If

1998
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dou

1998
Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
    Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chem

1998
Ifosfamide-based three-drug combination regimens in non-small cell lung cancer.
    Seminars in oncology, 1998, Volume: 25, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Granulo

1998
Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancer.
    Seminars in oncology, 1998, Volume: 25, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Femal

1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1998
Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth

1998
Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 19, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female;

1998
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
    British journal of cancer, 1998, Volume: 77, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1998
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic

1998
Cisplatin inhibits erythroid committed progenitor (BFU-E) mobilization in peripheral blood.
    European journal of haematology, 1998, Volume: 61, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemot

1998
Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1998, Volume: 61, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino

1998
New chemotherapy combinations with docetaxel in the treatment of patients with non-small cell lung cancer.
    Seminars in oncology, 1998, Volume: 25, Issue:3 Suppl 8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1998
Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small-cell lung cancer: a phase II study.
    American journal of clinical oncology, 1998, Volume: 21, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1998
Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Mo

1998
Modified ice study: a phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 21, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combi

1998
Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 22, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru

1998
Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 22, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophospha

1998
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC).
    Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1998
Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC).
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:12

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun

1998
Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
    Chest, 1999, Volume: 115, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1999
Carboplatin, ifosfamide, and vinorelbine in the treatment of advanced non-small-cell lung cancer: a phase II study.
    American journal of clinical oncology, 1999, Volume: 22, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1999
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.
    American journal of clinical oncology, 1999, Volume: 22, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cra

1999
A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 22, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite Stimulants; Ca

1998
Phase I study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in advanced non-small cell lung cancer.
    Oncology, 1999, Volume: 56, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co

1999
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Workin
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:3

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined

1999
A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1999, Volume: 11, Issue:2

    Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemot

1999
Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1999, Volume: 15, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combine

1999
[Period of time patients with advanced non-small cell lung cancer could remain at home during CIC--therapy (cisplatin + ifosfamide + CPT-11)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell

1999
Phase I study of a combination of irinotecan and ifosfamide in advanced primary lung cancer.
    The Kurume medical journal, 1999, Volume: 46, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Humans; Ifosfamid

1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis

1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up report.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat

1999
Vinorelbine, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Acta oncologica (Stockholm, Sweden), 1999, Volume: 38, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1999
The use of docetaxel (Taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens.
    Seminars in oncology, 1999, Volume: 26, Issue:3 Suppl 11

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Ifosfamide; Lung Neoplasms

1999
A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancer.
    Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1999
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1999
Modifying the ICE regimen for better prognosis small cell lung cancer--an update.
    Lung cancer (Amsterdam, Netherlands), 1999, Volume: 25, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans;

1999
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:11

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcin

1999
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-

1999
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined M

1999
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial.
    Lung cancer (Amsterdam, Netherlands), 1999, Volume: 26, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth

1999
Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study.
    British journal of cancer, 1999, Volume: 81, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1999
Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer.
    Oncology, 2000, Volume: 58, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Co

2000
A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer.
    Bone marrow transplantation, 2000, Volume: 25, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com

2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party.
    European journal of cancer (Oxford, England : 1990), 1999, Volume: 35, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1999
[High-dose ifosfamide in patients with stage IV non-small cell lung cancer: phase II trial from the Groupe français de pneumo-cancérologie (GFPC)].
    Bulletin du cancer, 1999, Volume: 86, Issue:12

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Female; Humans; Ifos

1999
Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.
    Acta oncologica (Stockholm, Sweden), 1999, Volume: 38, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1999
Ifosfamide, vinorelbine and gemcitabine in advanced non-small cell lung cancer. A phase I study.
    European journal of cancer (Oxford, England : 1990), 1999, Volume: 35, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycy

1999
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer.
    American journal of clinical oncology, 2000, Volume: 23, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epi

2000
Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Seminars in oncology, 2000, Volume: 27, Issue:1 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532.
    Lung cancer (Amsterdam, Netherlands), 2000, Volume: 28, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic

2000
A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2000, Volume: 28, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2000
Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineopla

2000
Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study.
    Anti-cancer drugs, 2000, Volume: 11, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free

2000
Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2000, Volume: 83, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dos

2000
A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA (N2) non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2000, Volume: 29, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2000
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: a phase II study of the italian oncology group for clinical research (GOIRC).
    International journal of cancer, 2000, Sep-01, Volume: 87, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2000
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:16

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoth

2000
A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.
    Cancer, 2000, Aug-15, Volume: 89, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2000
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy.
    Lung cancer (Amsterdam, Netherlands), 2000, Volume: 29, Issue:2

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Pro

2000
Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancer.
    Oncology, 2000, Volume: 59, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Ci

2000
Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study.
    British journal of clinical pharmacology, 2000, Volume: 50, Issue:4

    Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung

2000
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
    British journal of cancer, 2000, Volume: 83, Issue:9

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-S

2000
Feasibility and preliminary results of intensive chemotherapy and extensive irradiation in selected patients with limited small-cell lung carcinoma--results of three consecutive phase II programs.
    Acta oncologica (Stockholm, Sweden), 2000, Volume: 39, Issue:4

    Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide

2000
Effect of chemotherapy on pulmonary epithelial permeability in lung cancer.
    Nuclear medicine and biology, 2000, Volume: 27, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Gas Analysis; Carcinoma, Non-Small-Cell Lung;

2000
Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-01, Volume: 19, Issue:1

    Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell

2001
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2000, Volume: 30, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2000
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.
    British journal of cancer, 2001, Jan-05, Volume: 84, Issue:1

    Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma

2001
Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-01, Volume: 19, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Carboplatin; Carcinoma

2001
Effect of vinorelbine, ifosfamide, and cisplatin combination chemotherapy in advanced non-small-cell lung cancer.
    American journal of clinical oncology, 2000, Volume: 23, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2000
A phase II study of VP-16-fosfamide-cisplatin combination chemotherapy plus early concurrent thoracic irradiation for previously untreated limited small cell lung cancer.
    Japanese journal of clinical oncology, 2000, Volume: 30, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combi

2000
[Use of etoposide, ifosfamide and cisplatin (EIP) for treatment of inoperable non-small cell lung cancer].
    Pneumonologia i alergologia polska, 2000, Volume: 68, Issue:9-10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Eto

2000
Radiation induced chemotherapy sensitization in trimodality therapy of stage III non small cell lung cancer. A preliminary report.
    Journal of experimental & clinical cancer research : CR, 2000, Volume: 19, Issue:4

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L

2000
Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.
    European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2001
A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer.
    Cancer investigation, 2001, Volume: 19, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclo

2001
Combination chemotherapy for extensive small cell lung cancer -- experience from India.
    Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administrat

2001
[The effect of small cell lung cancer extension on secretion of interleukin-2 (IL-2) and interferon gamma (IFM gamma) in whole blood culture stimulated with mitogens].
    Pneumonologia i alergologia polska, 2001, Volume: 69, Issue:1-2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epiru

2001
Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carb

2001
Pharmacokinetics and toxicity of oral (-)-(S)-bromofosfamide in lung cancer patients.
    Arzneimittel-Forschung, 2001, Volume: 51, Issue:7

    Topics: Administration, Oral; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Blood Cell Count; B

2001
Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2001, Volume: 34, Issue:2

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun

2001
Anticipated administration of GM-CSF in the treatment of non small cell lung cancer.
    Journal of experimental & clinical cancer research : CR, 2001, Volume: 20, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2001
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
    British journal of cancer, 2001, Nov-16, Volume: 85, Issue:10

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Proto

2001
Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC).
    British journal of cancer, 2001, Nov-16, Volume: 85, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycy

2001
Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jan-01, Volume: 20, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2002
The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fem

2001
A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.
    International journal of cancer, 2002, Mar-01, Volume: 98, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2002
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small

2002
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors.
    Lung cancer (Amsterdam, Netherlands), 2002, Volume: 36, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Squ

2002
Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.
    Lung cancer (Amsterdam, Netherlands), 2002, Volume: 36, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi

2002
Protection against chemotherapy toxicity by IV hyperalimentation.
    Cancer treatment reports, 1978, Volume: 62, Issue:8

    Topics: Bacterial Vaccines; Carcinoma, Squamous Cell; Doxorubicin; Evaluation Studies as Topic; Humans; Ifos

1978
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
    JAMA, 1979, Apr-27, Volume: 241, Issue:17

    Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combinati

1979
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
    Cancer treatment reports, 1979, Volume: 63, Issue:2

    Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin

1979
Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
    Cancer treatment reports, 1978, Volume: 62, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Bacterial Vaccines; Body Weight; Carcinoma, Squamous Cell; Clinical Tri

1978
Advances in cancer management--an essay on the application of basic science principles.
    Texas reports on biology and medicine, 1979, Volume: 38

    Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Clinical Trials as Topic; Cytological Tec

1979
Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
    Arzneimittel-Forschung, 1976, Volume: 26, Issue:10

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Breast Neoplasms; Child; Clinical Trials as Topic; Cyclopho

1976
[Randomized trial of cisplatin plus ifosfamide versus cisplatin plus vindesine for non-small cell lung cancer (NSCLC)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru

1992
Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancer.
    Cancer, 1992, Feb-01, Volume: 69, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female;

1992
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyc

1992
Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Car

1992
A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer.
    Oncology, 1992, Volume: 49, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo

1992
A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etopo

1992
Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report.
    Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1992
Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis

1992
Carboplatin in small cell lung cancer: the Royal Marsden Hospital experience.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1992
[Cisplatin etoposide versus cisplatin/etoposide/ifosfamide combination chemotherapy in small-cell lung cancer: a multicenter randomized controlled study. Hokkaido Study Group of Treatment for Small-Cell Lung Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; F

1991
Sequential chemotherapy in good-prognosis patients with small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:2

    Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Thera

1991
Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide

1991
A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
    American journal of clinical oncology, 1991, Volume: 14, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1991
Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.
    Acta medica Okayama, 1991, Volume: 45, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell

1991
A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer.
    Journal of cancer research and clinical oncology, 1991, Volume: 117 Suppl 4

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small

1991
[Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:4 Pt 2

    Topics: Adenocarcinoma; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, No

1990
High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.
    British journal of cancer, 1991, Volume: 63, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Non-S

1991
Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders.
    Journal of cancer research and clinical oncology, 1991, Volume: 117, Issue:5

    Topics: Adult; Aged; Double-Blind Method; Female; Hematuria; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna

1991
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
    Cancer, 1990, Apr-15, Volume: 65, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1990
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
    Presse medicale (Paris, France : 1983), 1990, Apr-07, Volume: 19, Issue:14

    Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clin

1990
Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.
    Cancer, 1990, Jun-15, Volume: 65, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce

1990
[Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
    Pneumologie (Stuttgart, Germany), 1990, Volume: 44 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide

1990
Ifosfamide, cisplatin, vinblastine combination chemotherapy in the treatment of advanced non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1990, Volume: 27, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1990
The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Clinical Trials as

1987
Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophospha

1989
Treatment of small cell lung cancer with induction chemotherapy followed by late intensification.
    Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cyc

1989
Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clini

1987
Two carboplatin-containing regimens for small cell lung cancer: preliminary results of a randomized phase II trial.
    Cancer treatment reviews, 1988, Volume: 15 Suppl B

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Evaluation;

1988
[Results of 2 multicenter therapy studies in inoperable non-small cell bronchial cancer].
    Onkologie, 1988, Volume: 11, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical

1988
Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
    Cancer treatment reports, 1986, Volume: 70, Issue:7

    Topics: Acetylcysteine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic

1986
Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
    Cancer, 1987, Mar-15, Volume: 59, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide;

1987
Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Humans; Ifos

1986
Two randomized trials for alternating polychemotherapy of small cell lung cancer.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clini

1986
"Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial".
    Cancer treatment reports, 1987, Volume: 71, Issue:4

    Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carc

1987
The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
    Japanese journal of clinical oncology, 1986, Volume: 16, Issue:2

    Topics: Adult; Aged; Clinical Trials as Topic; Cystitis; Female; Hemorrhage; Humans; Ifosfamide; Lung Neopla

1986
High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma,

1986
Ifosfamide--pharmacology, safety and therapeutic potential.
    Cancer treatment reviews, 1985, Volume: 12, Issue:1

    Topics: Animals; Biotransformation; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evalu

1985
[Treatment of oat cell metastazing bronchial carcinoma with isofosfamide. Results of a prospective randomized study].
    Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology, 1974, Issue:5-6

    Topics: Aged; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Humans; If

1974
[Treatment of bronchogenic cancer and lung metastases of solid tumors with ifosfamid (author's transl)].
    Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology, 1974, Issue:1

    Topics: Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Female; Humans

1974

Other Studies

330 other studies available for ifosfamide and Cancer of Lung

ArticleYear
Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features.
    BMC medical imaging, 2022, 07-26, Volume: 22, Issue:1

    Topics: Epirubicin; Humans; Ifosfamide; Lung Neoplasms; Retrospective Studies; Sarcoma; Soft Tissue Neoplasm

2022
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study.
    Lung cancer (Amsterdam, Netherlands), 2023, Volume: 176

    Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Ifosfamide; Lung Neoplasms; Mesna; Progressi

2023
[Advanced Bladder Cancer with Multiple Pulmonary Metastases Treated with Paclitaxel/Ifosfamide/Nedaplatin Therapy : Two Case Reports].
    Hinyokika kiyo. Acta urologica Japonica, 2023, Volume: 69, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxy

2023
Complete remission of a case of high-grade myxofibrosarcoma with lung metastases after modified MAID regimen chemotherapy.
    Journal of chemotherapy (Florence, Italy), 2020, Volume: 32, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Fibrosarcoma; Human

2020
[Lung Metastasis from High-grade Uterine Endometrial Stromal Sarcoma;Report of a Case].
    Kyobu geka. The Japanese journal of thoracic surgery, 2020, Volume: 73, Issue:8

    Topics: Aged; Endometrial Neoplasms; Female; Heparin; Humans; Ifosfamide; Lung Neoplasms; Sarcoma, Endometri

2020
Durable Complete Remission of PD-L1 Positive NUT Carcinoma Treated With Concurrent Chemotherapy and Radiation.
    The Permanente journal, 2020, Volume: 25

    Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Carcinoma; Etoposide; Hu

2020
Multimodality treatment including whole pleura radiation therapy for DICER1-associated pediatric pleuropulmonary blastoma.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Mo

2021
Neurofibromatosis type 1 and disseminated malignant peripheral nerve sheath tumor.
    QJM : monthly journal of the Association of Physicians, 2017, Sep-01, Volume: 110, Issue:9

    Topics: Antineoplastic Agents; Cafe-au-Lait Spots; Disease Management; Doxorubicin; Humans; Ifosfamide; Lung

2017
Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report.
    Medicine, 2017, Volume: 96, Issue:51

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Endostatins; Etoposide; Human

2017
Autologous stem-cell transplant for metastatic renal medullary carcinoma.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Doxoru

2018
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma.
    Lung cancer (Amsterdam, Netherlands), 2018, Volume: 122

    Topics: Adult; Aged; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Midd

2018
[RETROPERITONEAL LIPOSARCOMA WITH MULTIPLE RECURRENCE OF LUNG METASTASES TREATED BY MULTIMODAL THERAPY CENTERING ON THE OPERATION: A CASE REPORT].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2018, Volume: 109, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etopo

2018
The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report.
    Medicine, 2019, Volume: 98, Issue:17

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Endostatins; Epirubicin; Hear

2019
Complete remission of giant malignant phyllodes tumor with lung metastasis: A case report.
    Medicine, 2019, Volume: 98, Issue:22

    Topics: Antineoplastic Agents; Axilla; Breast Neoplasms; Doxorubicin; Female; Humans; Ifosfamide; Lung Neopl

2019
MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma: A case report.
    Medicine, 2019, Volume: 98, Issue:25

    Topics: Adult; Ameloblastoma; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine;

2019
[A case of Ifosfamide-induced dysuria which could be avoided by changing the regimen of mesna].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dysuria; Female; Humans; Ifosfamid

2013
Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:2

    Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neopla

2013
Successful treatment of recurrent pediatric inflammatory myofibroblastic tumor in a single patient with a novel chemotherapeutic regimen containing celecoxib.
    Journal of pediatric hematology/oncology, 2013, Volume: 35, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Child; Humans; Ifosfamide; Lung Neoplasms

2013
Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
    American journal of clinical oncology, 2015, Volume: 38, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin

2015
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carb

2013
Targeted imaging of α(v)β(3) expressing sarcoma tumor cells in vivo in pre-operative setting using near infrared: a potential tool to reduce incomplete surgical resection.
    Bone, 2014, Volume: 62

    Topics: Animals; Diagnostic Imaging; Humans; Ifosfamide; Integrin alphaVbeta3; Lung Neoplasms; Preoperative

2014
Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases.
    Anti-cancer drugs, 2014, Volume: 25, Issue:10

    Topics: Adult; Antineoplastic Agents; Axilla; Combined Modality Therapy; Dioxoles; Epirubicin; Fatal Outcome

2014
Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2014
    Bulletin of the World Health Organization, 2014, Nov-01, Volume: 92, Issue:11

    Topics: Adolescent; Adult; Animals; Antineoplastic Agents; Arachidonic Acids; Asbestos; Asbestosis; Attitude

2014
Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
    World journal of surgical oncology, 2014, Nov-11, Volume: 12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant;

2014
Extraskeletal myxoid chondrosarcoma of the thigh in a child: a case report.
    Journal of orthopaedic surgery (Hong Kong), 2014, Volume: 22, Issue:3

    Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Chondrosar

2014
Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study.
    Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; China; Dox

2015
Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases.
    Journal of translational medicine, 2015, Apr-24, Volume: 13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Fem

2015
A retrospective analysis of lung metastasis in 64 patients with alveolar soft part sarcoma.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015, Volume: 17, Issue:10

    Topics: Adolescent; Adult; Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chem

2015
Trabectedin clinical cases: use according to indication in diverse clinical scenarios.
    Future oncology (London, England), 2015, Volume: 11, Issue:11 Suppl

    Topics: Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; C

2015
Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma

2015
Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast.
    World journal of surgery, 2016, Volume: 40, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neopla

2016
Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma.
    Anticancer research, 2015, Volume: 35, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Etoposide; H

2015
Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
    Medicine, 2016, Volume: 95, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin

2016
Primary proximal epithelioid sarcoma of the lung successfully treated with pneumonectomy and adjuvant chemotherapy.
    BMJ case reports, 2016, Apr-04, Volume: 2016

    Topics: Adult; Chemotherapy, Adjuvant; Doxorubicin; Hemoptysis; HIV Infections; Humans; Ifosfamide; Lung Neo

2016
A Child with Rapid-onset Respiratory Distress after Chemotherapy, Lung Irriadiation, General Anaesthesia, and Blood Transfusion.
    Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:11

    Topics: Abdominal Neoplasms; Acute Lung Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Chil

2015
A Pediatric Case of Metastatic Conventional Parosteal Osteosarcoma Treated With Multidrug Chemotherapy.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cispla

2016
Perioperative Morbidity and Mortality Associated With Bleomycin in Primary Mediastinal Nonseminomatous Germ Cell Tumor.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 12-20, Volume: 34, Issue:36

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant

2016
Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 76

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothera

2017
Pleomorphic malignant fibrous histiocytoma: response of bone, lung, and brain metastases to chemotherapy.
    Radiation medicine, 2008, Volume: 26, Issue:8

    Topics: Acetabulum; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Brain; B

2008
Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report.
    Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti

2009
Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
    Journal of the National Cancer Institute, 2009, Jan-07, Volume: 101, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemot

2009
Gastrointestinal hemorrhage as the first manifestation of metastatic extragonadal choriocarcinoma.
    Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Choriocarcinoma

2009
Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma.
    Anti-cancer drugs, 2009, Volume: 20, Issue:1

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas

2009
Desmoplastic small round cell tumor in children: a new therapeutic approach.
    Journal of pediatric surgery, 2009, Volume: 44, Issue:5

    Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Ca

2009
Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
    Anti-cancer drugs, 2010, Volume: 21, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etopo

2010
Therapeutic effect of pirarubicin-based chemotherapy for osteosarcoma patients with lung metastasis.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Membe

2010
[Lung metastases of epithelioid sarcoma revealed by bilateral spontaneous pneumothorax: a pathological diagnosis].
    Annales de pathologie, 2010, Volume: 30, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Doxorubicin; Drainage; Fatal Outc

2010
[A rare tumour with a distinctive histological appearance].
    Annales de pathologie, 2010, Volume: 30, Issue:2

    Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemo

2010
Successful treatment of metastatic malignant fibrous histiocytoma of the kidney.
    Urologia internationalis, 2010, Volume: 85, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Dacarbazine; Doxorub

2010
Moyamoya in a child treated with interferon for recurrent osteosarcoma.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:6

    Topics: Antineoplastic Agents; Bone Neoplasms; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral

2010
Pulmonary blastoma in adult: dramatic but transient response to doxorubicin plus ifosfamide.
    Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Drug Administration Sch

2011
Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Dacarbazine; Doxorub

2011
[A case of recurrent high-grade endometrial stromal sarcoma controlled by a combination of Ifosfamide, adriamycin, and cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:10

    Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endomet

2010
Mestastatic gastric cancer from malignant fibrous histiocytoma.
    Revista espanola de enfermedades digestivas, 2011, Volume: 103, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Dio

2011
A case of uterine cervical carcinosarcoma recurrence who obtained a clinically complete response by ifosfamide, doxorubicin and cisplatin.
    European journal of gynaecological oncology, 2011, Volume: 32, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Doxorubicin; Female; Huma

2011
[Nephropathy following administration of angiogenesis inhibitors].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:2

    Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl

2011
Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.
    Swiss medical weekly, 2011, Volume: 141

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modali

2011
[Successful treatment of a case of advanced adult Wilms' tumor with pre-surgical chemotherapy, irradiation and radical nephrectomy].
    Hinyokika kiyo. Acta urologica Japonica, 2011, Volume: 57, Issue:4

    Topics: Adult; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplasti

2011
Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
    Oncology, 2011, Volume: 80, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2011
Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: report of a case.
    Surgery today, 2011, Volume: 41, Issue:8

    Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Female; Humans; Ifosfamide; Lung Neopla

2011
Dyspnoea and a lung mass in a young female 2 weeks after Caesarean delivery.
    The European respiratory journal, 2011, Volume: 38, Issue:2

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms

2011
Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.
    Lung cancer (Amsterdam, Netherlands), 2012, Volume: 75, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Female; Humans; I

2012
[A rare tumor of the chest wall: the synovial sarcoma].
    The Pan African medical journal, 2011, Volume: 9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chest Pain; Comb

2011
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuro

2012
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl

2012
[Organ-preserving interventions in combined therapy of children and adolescents with osteosarcoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Transplantation; Ch

2012
[Biphasic pulmonary blastoma with germ cell differentiation: a challenge in diagnosis and treatment].
    Acta medica portuguesa, 2011, Volume: 24 Suppl 3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cisplatin; Etoposide; Huma

2011
Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Oct-01, Volume: 30, Issue:28

    Topics: Antineoplastic Agents, Alkylating; Female; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Neoadjuv

2012
Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patients.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamo

2012
Comparison of vinorelbine, ifosfamide and cisplatin (NIP) and etoposide and cisplatin (EP) for treatment of advanced combined small cell lung cancer (cSCLC) patients: a retrospective study.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin;

2012
[Treatment and prognosis of stage IV alveolar soft part sarcoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Dacarbazine;

2012
Response to chemotherapy in a child with primary bronchopulmonary leiomyosarcoma.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Child, Preschool; Dactinomycin;

2002
Chemotherapy induced complete remission in malignant phyllodes tumor of the prostate metastasizing to the lung.
    The Journal of urology, 2002, Volume: 168, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Ifosfamide; Lung Neoplas

2002
Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2002, Volume: 64, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined

2002
[Pulmonary carcinosarcoma with jejunal metastasis: complete response to chemotherapy].
    Revue de pneumologie clinique, 2002, Volume: 58, Issue:4 Pt 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Doxorubicin; Humans; Ifos

2002
A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; C

2002
Neo-adjuvant chemotherapy in early stages of non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2002, Volume: 38 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva

2002
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
    Bone marrow transplantation, 2002, Volume: 30, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modal

2002
Preoperative chemotherapy is essential for conservative surgery of Askin tumors.
    The Journal of thoracic and cardiovascular surgery, 2003, Volume: 125, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplas

2003
[Primary pulmonary synovial sarcoma: a report and diagnosis of 2 cases].
    Archivos de bronconeumologia, 2003, Volume: 39, Issue:3

    Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherap

2003
Modified Ifosphamide/CarboPlatin/Etoposide.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2003, Volume: 15, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Human

2003
[Maintenance chemotherapy for small-cell lung cancer. A new publication].
    Revue de pneumologie clinique, 2003, Volume: 59, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administratio

2003
Unusual response to second-line single-agent gemcitabine in locally advanced primary leiomyosarcoma of the lung: a case report.
    Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:5

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug

2003
Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
    Japanese journal of clinical oncology, 2003, Volume: 33, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2003
[A difficult case of advanced testicular choriocarcinoma effectively treated by chemotherapy and resection of lung metastasis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma

2004
A case of renal synovial sarcoma: complete remission was induced by chemotherapy with doxorubicin and ifosfamide.
    The Korean journal of internal medicine, 2004, Volume: 19, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Ifosfamide; Kidn

2004
Ifosfamide-induced psychosis.
    Acta oncologica (Stockholm, Sweden), 2004, Volume: 43, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Humans; Ifosfamide; Lung Ne

2004
[Cellular changes in non-small cell lung cancer after neoadjuvant therapy].
    Der Pathologe, 2004, Volume: 25, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Ce

2004
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Lung cancer (Amsterdam, Netherlands), 2004, Volume: 45, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; C

2004
Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
    Urology, 2004, Volume: 64, Issue:4

    Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carbopla

2004
Tumor excision and reconstruction of the upper cervical spine: a multidisciplinary approach.
    Plastic and reconstructive surgery, 2004, Volume: 114, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axis, Cervical Vertebra; Bone Transplantation

2004
Long-term survival in high-grade axial osteosarcoma with bone and lung metastases treated with chemotherapy only.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child, Preschool; Cispl

2005
Is the tolerance to MIP chemotherapy different between English and other European populations?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-01, Volume: 23, Issue:25

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III a

2005
Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French trial database.
    Chest, 2005, Volume: 128, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Databases

2005
[Evaluation of combined chemotherapy with vinorelbine, ifosfamide and cisplatin in the treatment of metastatic non-small cell bronchial carcinoma].
    Revue des maladies respiratoires, 2005, Volume: 22, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcin

2005
Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety?
    Postgraduate medical journal, 2005, Volume: 81, Issue:961

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; I

2005
[Yolk sac tumor of the anterior mediastinum and pulmonary metastases; report of a case].
    Kyobu geka. The Japanese journal of thoracic surgery, 2005, Volume: 58, Issue:12

    Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Mod

2005
Fas expression in lung metastasis from osteosarcoma patients.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2005
The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysi
    Neoplasma, 2006, Volume: 53, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined

2006
Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases.
    Cancer, 2006, Mar-15, Volume: 106, Issue:6

    Topics: Administration, Intranasal; Animals; Antineoplastic Agents, Alkylating; Bone Neoplasms; Combined Mod

2006
Prognostic factors in pleuro-pulmonary blastoma.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, P

2007
Successful treatment via chemotherapy and surgical resection of a femoral hemangiopericytoma with pulmonary metastasis.
    Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modalit

2006
[Comparison of ramosetron and azasetron for prevention of acute and delayed cisplatin-induced emesis in lung cancer patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:5

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bi

2006
[Current data concerning neoadjuvant chemotherapy].
    Revue de pneumologie clinique, 2006, Volume: 62 Spec no 1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti

2006
Pancreatoblastoma in a teenage patient.
    Clinical advances in hematology & oncology : H&O, 2006, Volume: 4, Issue:2

    Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol

2006
Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:2

    Topics: Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fat

2006
Cardiac metastasis from uterine leiomyosarcoma.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Deoxycytidin

2006
Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2006, Volume: 53, Issue:2

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Ch

2006
[Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
    Tuberkuloz ve toraks, 2006, Volume: 54, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide

2006
Durable and complete remission of a metastatic bladder sarcomatoid carcinoma with chemotherapic and surgical treatments.
    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2006, Volume: 78, Issue:2

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell;

2006
A case of metastatic testicular cancer complicated by tumour lysis syndrome and choriocarcinoma syndrome.
    Japanese journal of clinical oncology, 2006, Volume: 36, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Drug A

2006
[Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; F

2006
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report].
    Hinyokika kiyo. Acta urologica Japonica, 2006, Volume: 52, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera

2006
[Efficacy of adriamycin, etoposide plus ifosfamide on small cell lung cancer--a retrospective analysis of 69 cases treated in Centre Hospitalo-Universitaire de Bordeaux].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:12

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubi

2006
[Role of radiotherapy of lung cancer].
    Voprosy onkologii, 2006, Volume: 52, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

2006
Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a case.
    Surgery today, 2007, Volume: 37, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dactin

2007
Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006, Volume: 1, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinica

2006
Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Etoposide;

2007
Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined M

2007
Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
    The Netherlands journal of medicine, 2007, Volume: 65, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality

2007
[Three-year survival after treatment of a primary pulmonary angiosarcoma].
    Revue de pneumologie clinique, 2007, Volume: 63, Issue:1

    Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Diseas

2007
Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2007, Volume: 58, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Therapy, Co

2007
Chemotherapy improves low performance status lung cancer patients.
    The European respiratory journal, 2007, Volume: 30, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female

2007
Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.
    Drugs & aging, 2007, Volume: 24, Issue:11

    Topics: Abdominal Neoplasms; Aged; Antidotes; Antineoplastic Agents, Alkylating; Antineoplastic Combined Che

2007
Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide.
    BMC pharmacology, 2007, Oct-27, Volume: 7

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Carcinoma, Non-Small-

2007
[Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemothe

2007
Salvage combination chemotherapy with docetaxel, ifosfamide and cisplatin (DIP): successful treatment of a case with metastatic testicular immature teratoma.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Humans; Ifosfamide; Lun

2008
[A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin].
    Hinyokika kiyo. Acta urologica Japonica, 2008, Volume: 54, Issue:1

    Topics: Adult; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic

2008
Big question, small answer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Admi

2008
Diseases desperate grown.
    Journal of the National Cancer Institute, 2008, Apr-16, Volume: 100, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Sur

2008
[A case of primary lung adenocarcinoma accompanied by Ewing's sarcoma successfully treated with ifosfamide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Humans; Ifosfamide; Lung Neoplasms; Male; Middle

2008
[Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin].
    Deutsche medizinische Wochenschrift (1946), 1984, Jul-06, Volume: 109, Issue:27

    Topics: Adenocarcinoma; Adult; Aged; Alopecia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; C

1984
[3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
    Onkologie, 1984, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Ca

1984
Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
    Veterinary and human toxicology, 1981, Volume: 23, Issue:Suppl 1

    Topics: Acetylcysteine; Adenocarcinoma; Administration, Oral; Carcinoma; Carcinoma, Small Cell; Carcinoma, S

1981
[Prevention of recurrence of small-cell lung cancer by adjuvant polychemotherapy (author's transl)].
    Wiener klinische Wochenschrift, 1982, Apr-02, Volume: 94, Issue:7

    Topics: Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Human

1982
Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
    Cancer treatment reviews, 1982, Volume: 9 Suppl

    Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug

1982
Small cell lung cancer. Serial bronchofiberscopy and photographic documentation--the bridge sign.
    Chest, 1983, Volume: 83, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcino

1983
Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Administrati

1982
[Toxic-allergic lung edema following cyclophosphamide and ifosfamide therapy. Case report].
    Onkologie, 1983, Volume: 6, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin

1983
[Ifosfamide in the treatment of small cell carcinoma of the lung].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:5

    Topics: Adult; Aged; Carcinoma, Small Cell; Cyclophosphamide; Cystitis; Drug Administration Schedule; Drug T

1983
Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
    The American journal of medicine, 1984, Volume: 76, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Bronch

1984
Pharmacokinetic studies in lung cancer patients.
    Cancer, 1984, Sep-15, Volume: 54, Issue:6 Suppl

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Carmustine; Cisplatin; Cyclophospha

1984
Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubic

1983
Electron-capture--gas chromatographic analysis of ifosfamide in human plasma and urine.
    Journal of chromatography, 1983, Jul-08, Volume: 275, Issue:2

    Topics: Cyclophosphamide; Fluorocarbons; Humans; Ifosfamide; Lung Neoplasms; Phosphoramide Mustards

1983
Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapy.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Ifosfamide;

1983
N-acetylcysteine: its bioavailability and interaction with ifosfamide metabolites.
    Seminars in oncology, 1983, Volume: 10, Issue:1 Suppl 1

    Topics: Acetates; Acetylcysteine; Biological Availability; Carcinoma, Bronchogenic; Chemical Phenomena; Chem

1983
Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.
    Seminars in oncology, 1983, Volume: 10, Issue:1 Suppl 1

    Topics: Acetylcysteine; Acrolein; Adenocarcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Cystitis; Dose

1983
[Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide].
    Deutsche medizinische Wochenschrift (1946), 1983, May-27, Volume: 108, Issue:21

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophos

1983
[Pulmonary metastasis of renal cell carcinoma].
    Gan no rinsho. Japan journal of cancer clinics, 1983, Volume: 29, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Agents; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil;

1983
The value of ifosfamide in the polychemotherapy of metastasized testicular cancer pretreated with chemotherapy.
    Arzneimittel-Forschung, 1982, Volume: 32, Issue:12

    Topics: Adolescent; Adult; Alkylating Agents; Cisplatin; Cyclophosphamide; Drug Therapy, Combination; Humans

1982
The control of ifosfamide-induced hematuria with N-acetylcysteine in patients with advanced carcinoma of the lung.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Acetylcysteine; Administration, Oral; Cyclophosphamide; Female; Hematuria; Humans; Ifosfamide; Lung

1982
Toxicity of single- vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multi-center study.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Alopecia; Brain; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Hematuria; Humans;

1982
Serum zinc levels in lung cancer patients.
    Cancer, 1981, Apr-01, Volume: 47, Issue:7

    Topics: Adult; Aged; Bacterial Vaccines; Carcinoma, Squamous Cell; Copper; Doxorubicin; Humans; Ifosfamide;

1981
The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma.
    International journal of clinical pharmacology, therapy, and toxicology, 1981, Volume: 19, Issue:11

    Topics: Administration, Oral; Adult; Biological Availability; Carcinoma, Bronchogenic; Cyclophosphamide; Fem

1981
[Cytostatic treatment of hypernephroid renal carcinoma (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1980, Dec-26, Volume: 105, Issue:52

    Topics: Adenocarcinoma; Bone Neoplasms; Cyclophosphamide; Female; Humans; Ifosfamide; Kidney Neoplasms; Lung

1980
Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue.
    Lancet (London, England), 1994, Mar-26, Volume: 343, Issue:8900

    Topics: Administration, Oral; Adolescent; Antidotes; Bone Neoplasms; Brain Diseases; Drug Overdose; Female;

1994
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1993, Volume: 10, Issue:3-4

    Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemothe

1993
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
    Journal of neuro-oncology, 1994, Volume: 21, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dacti

1994
A complicated case of metastatic teratoma. Growing teratoma syndrome and cerebral metastasis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Brain Neoplasms; Cispl

1995
[Spontaneous pneumothorax in response to chemotherapy of metastatic germinal tumor].
    Anales de medicina interna (Madrid, Spain : 1984), 1995, Volume: 12, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etopos

1995
Ifosfamide, carboplatin and etoposide for good prognosis small cell lung cancer: are four courses inadequate? West of Scotland Lung Cancer Group.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Eto

1995
[Combination effect of pirarubicin, ifosfamide, and vincristine sulfate in the treatment of advanced synovial sarcoma--report of a case].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Buttocks; Cystitis; Doxorubicin; Female; Hemo

1995
[Efficacy of the combination of mitomycin, ifosfamide and cisplatin with irradiation for the treatment of cerebral metastasis in non small cell lung carcinoma].
    Bulletin du cancer, 1995, Volume: 82, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-C

1995
Reversible myocardial ischaemia following vincristine containing chemotherapy.
    Respiratory medicine, 1994, Volume: 88, Issue:9

    Topics: Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Myocardia

1994
Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell;

1994
[Epileptic seizures and treatment with ifosfamide-mesna].
    Revue neurologique, 1994, Volume: 150, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Epilepsy; Fatal Outcome; H

1994
[Peri-operative chemotherapy during resection of pulmonary metastases of sarcoma].
    Bulletin du cancer, 1994, Volume: 81, Issue:2

    Topics: Adult; Combined Modality Therapy; Female; Humans; Ifosfamide; Infusions, Intravenous; Intraoperative

1994
Acute pancreatitis after ifosfamide therapy.
    Cancer, 1994, Sep-01, Volume: 74, Issue:5

    Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; H

1994
Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC).
    Lung cancer (Amsterdam, Netherlands), 1993, Volume: 10, Issue:1-2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epiru

1993
Teniposide for meningeal carcinomatosis of small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1993, Volume: 10, Issue:3-4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyc

1993
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:3

    Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell;

1994
[A case of malignant fibrous histiocytoma of jejunal origin with marked response to cisplatin, ifosfamide and adriamycin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Doxorubicin; Histiocytom

1993
Lung irradiation for Ewing's sarcoma with pulmonary metastases at diagnosis: results of the CESS-studies.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1993, Volume: 169, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophos

1993
Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.
    Cancer chemotherapy and pharmacology, 1993, Volume: 33, Issue:1

    Topics: Acetaldehyde; Adult; Aged; Carcinoma, Bronchogenic; Chromatography, Gas; Chromatography, High Pressu

1993
[Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Do

1993
Osteosarcoma with deeply eosinophilic rhabdomyoblast cells in a lung metastatic focus. A case report.
    Clinical orthopaedics and related research, 1993, Issue:293

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Femoral Neoplasms;

1993
Ifosfamide neurotoxicity. A challenge for nurses, a potential nightmare for patients.
    Cancer nursing, 1993, Volume: 16, Issue:1

    Topics: Brain Diseases; Carcinoma, Small Cell; Central Nervous System; Female; Humans; Ifosfamide; Lung Neop

1993
Management of small-cell lung cancer.
    Clinics in chest medicine, 1993, Volume: 14, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell;

1993
[Pathology and clinical aspects of peripheral neuroectodermal tumors].
    Deutsche medizinische Wochenschrift (1946), 1993, Oct-08, Volume: 118, Issue:40

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Dexamethasone; Doxorubicin; Dru

1993
Antitumor activity of treosulfan in human lung carcinomas.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti

1996
Case report: pulmonary blastoma in children--response to chemotherapy.
    Medical and pediatric oncology, 1996, Volume: 26, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Moda

1996
Disease extent and response to chemotherapy in non-small cell lung cancer.
    Acta oncologica (Stockholm, Sweden), 1996, Volume: 35, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo

1996
Response of small cell carcinoma of pancreas to a small cell lung cancer regimen: a case report.
    Cancer investigation, 1996, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cy

1996
Gemcitabine: clinical and economic impact in inoperable non-small cell lung cancer.
    Anti-cancer drugs, 1995, Volume: 6 Suppl 6

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Smal

1995
Histopathological grading of response to induction chemotherapy in non-small cell lung cancer: a preliminary study.
    Lung cancer (Amsterdam, Netherlands), 1996, Volume: 15, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy,

1996
Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Gene Ex

1997
Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
    Cancer, 1997, Jan-15, Volume: 79, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Di

1997
Gemcitabine shows promise as combination agent in NSCLC.
    Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:9

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcin

1996
The carcinogenicity of environmental tobacco smoke.
    Carcinogenesis, 1997, Volume: 18, Issue:3

    Topics: Adenocarcinoma; Adenoma; Administration, Inhalation; Animals; Antineoplastic Agents; Biomarkers; But

1997
Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide.
    Cancer research, 1997, Jul-01, Volume: 57, Issue:13

    Topics: Acetaldehyde; Carcinoma, Non-Small-Cell Lung; Cell Survival; Cells, Cultured; Dose-Response Relation

1997
Ifosfamide-based chemotherapy for recurrent or metastatic hemangiopericytoma.
    Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Fema

1997
Miliary osteosarcomatosis with associated hypocalcemia.
    American journal of clinical oncology, 1997, Volume: 20, Issue:5

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antine

1997
[Efficacy of systemic chemotherapy in adenocarcinoma of the lung with pleuritis carcinomatosa].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:13

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin

1997
Concomitant brain radiotherapy and high-dose ifosfamide in brain relapses of lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Cranial

1997
Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1997, Volume: 60, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Humans; Ifos

1997
[The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:14

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Child; Drug Administration Sch

1997
Prolonged survival in a nasopharyngeal carcinoma patient with multiple metastases: a case report and review of the literature.
    Japanese journal of clinical oncology, 1997, Volume: 27, Issue:5

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl

1997
Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms' tumor.
    Bone marrow transplantation, 1997, Volume: 20, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxo

1997
[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms;

1998
[Pilot study of cisplatin, ifosfamide and irinotecan (CPT-11) with granulocyte colony-stimulating factor support (CIC-regimen) in relapsed small-cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Ci

1998
Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:14

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Erythrop

1997
[Peripheral neuroectodermal tumors of the chest wall. Description of a case].
    Minerva chirurgica, 1998, Volume: 53, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin;

1998
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyc

1998
Response of dermatomyositis co-existing with non-small cell lung cancer to chemotherapy.
    Respiratory medicine, 1998, Volume: 92, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dermatomy

1998
[Chemotherapy for pulmonary metastases of soft tissue sarcoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administra

1998
Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Singapore medical journal, 1998, Volume: 39, Issue:8

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating;

1998
[Successful management for chemorefractory testicular cancer with brain and lung metastases. A case report].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1998, Volume: 89, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carcinoma, Embryonal;

1998
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 22, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1998
Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin;

1999
The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer.
    The Journal of thoracic and cardiovascular surgery, 1999, Volume: 117, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Case-Control Studies

1999
Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
    Prescrire international, 1998, Volume: 7, Issue:34

    Topics: Adult; Antineoplastic Agents, Alkylating; Breast Neoplasms; Child; Clinical Trials as Topic; Cycloph

1998
Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
    International journal of radiation oncology, biology, physics, 1999, Jun-01, Volume: 44, Issue:3

    Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow

1999
Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1999, Volume: 26, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-C

1999
Treatment of primary pure angiosarcoma of ovary with multiple lung metastases: a case report.
    European journal of gynaecological oncology, 1999, Volume: 20, Issue:5-6

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fema

1999
Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cell Division; Cispl

2000
[Combination chemotherapy consisting of ifosfamide and vindesine for non-small cell lung cancer in the elderly].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2000, Volume: 38, Issue:4

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L

2000
Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer.
    Oncology, 2000, Volume: 59, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carcinom

2000
Induction chemotherapy for locoregional lung cancer using paclitaxel combination. A preliminary report.
    Journal of experimental & clinical cancer research : CR, 2000, Volume: 19, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small

2000
Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer : cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support.
    Chest, 2001, Volume: 119, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Tri

2001
Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre

2001
[A case of primary malignant hemangiopericytoma of the lung with marked response to combination chemotherapy with cisplatin, ifosfamide and gemcitabine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:3

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineopl

2001
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:2

    Topics: Amino Acid Substitution; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP-Bin

2001
A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer.
    Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deo

2001
[Surgical treatment of non-small cell lung cancer with mediastinal node invasion. A retrospective study].
    Archivos de bronconeumologia, 2001, Volume: 37, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small

2001
[Surgery and combined therapy for non-small cell lung cancer with invasion of the mediastinal nodes. A retrospective study].
    Archivos de bronconeumologia, 2001, Volume: 37, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small

2001
Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients.
    Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Carcinoma, Small Cell; Drug Resist

2001
[Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
    Revue des maladies respiratoires, 2001, Volume: 18, Issue:4 Pt 1

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl

2001
[Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer].
    Revue des maladies respiratoires, 2001, Volume: 18, Issue:4 Pt 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

2001
Pleuropulmonary blastoma.
    European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 2001, Volume: 11, Issue:4

    Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Child, Preschool; Dactinomycin; Disease-Free Survival

2001
Three conventional-drug combination (ifosfamide, carboplatin, etoposide--ICE regimen) in advanced non-small cell lung cancer (NSCLC).
    Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

2001
Docetaxel and non small-cell lung cancer: new indication. One of several non curative chemotherapies.
    Prescrire international, 2001, Volume: 10, Issue:52

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical

2001
Managing poor performance non-small-cell lung cancer patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; I

2001
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2002, Volume: 40, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin;

2002
[Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1975, Aug-22, Volume: 117, Issue:34

    Topics: Adult; Antineoplastic Agents; Bleomycin; Cell Transformation, Neoplastic; Child; Child, Preschool; D

1975
Chemotherapy in testicular tumors.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1977, Issue:60

    Topics: Bleomycin; Castration; Cell Division; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; D

1977
Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules.
    Cancer, 1978, Volume: 41, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Bone Marrow; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophos

1978
Advances in the chemotherapy and immunotherapy of lung cancer.
    Texas medicine, 1979, Volume: 75, Issue:2

    Topics: Humans; Ifosfamide; Immunotherapy; Lung Neoplasms

1979
Cyclophosphamide and iphosphamide against Lewis lung carcinoma: evaluation of toxic and therapeutic effects.
    Tumori, 1979, Apr-30, Volume: 65, Issue:2

    Topics: Animals; Cyclophosphamide; Ifosfamide; Lethal Dose 50; Lung Neoplasms; Male; Mice; Mice, Inbred C57B

1979
[Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
    Medizinische Klinik, 1978, Sep-08, Volume: 73, Issue:36

    Topics: Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease;

1978
Comparative effects of cyclophosphamide and isophosphamide on Lewis lung carcinoma.
    British journal of cancer, 1978, Volume: 38, Issue:5

    Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Ifosfamide; Lung Neoplasms; Mice; Neopl

1978
Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
    Immunopharmacology and immunotoxicology, 1992, Volume: 14, Issue:4

    Topics: Animals; Bromine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ifosfamide; Le

1992
[Advances in the treatment of non-small cell lung cancer].
    Pathologie-biologie, 1992, Volume: 39, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined

1992
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital.
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:8 Suppl

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1992
Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1

    Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcin

1992
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1

    Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma

1992
Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcino

1992
Oral ifosfamide-mesna: a clinical investigation in advanced non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:9

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dreams; Drug Administration Schedule; Female; Humans; Ifosfami

1992
[Chemotherapy with cisplatin, adriamycin, etoposide and ifosfamide in microcytic lung carcinoma].
    Medicina clinica, 1992, Sep-19, Volume: 99, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxor

1992
Primary treatment of pelvic osteosarcoma. Report of five cases.
    Cancer, 1992, Mar-01, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemot

1992
[A case of adenocarcinoma of lung cancer with multiple brain metastasis and lymphangitis carcinomatosa responding well to chemotherapy with carboplatin, etoposide and ifosfamide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:14

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin;

1992
[Elderly non-Hodgkin's lymphoma presenting with pulmonary squamous cell carcinoma as a complication of chemotherapy for malignant lymphoma].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1992, Volume: 29, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cyclophosphamide; Hu

1992
A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma.
    Cancer, 1991, Jun-15, Volume: 67, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma,

1991
Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:5

    Topics: Adenocarcinoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm

1991
A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:2

    Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Ifosfamide; Interferon

1991
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cis

1991
Ifosfamide, Fanconi's syndrome, and rickets.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Chronic Kidney Disease-Mineral an

1991
Intercalated radio-chemotherapy in small cell lung cancer: toxicity and implications for future regimens.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1991, Volume: 20, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com

1991
Ifosfamide vs cyclophosphamide in cancer therapy.
    Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:5

    Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cyclophosphamide; Female; Genital Neoplasms,

1991
Phase II study with mitomycin, ifosfamide and carboplatin in inoperable non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; D

1991
Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human lung cancer cell lines.
    Journal of cancer research and clinical oncology, 1991, Volume: 117 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel

1991
A pilot study of mitomycin, ifosfamide and cisplatin as outpatient combination chemotherapy for advanced non-small cell lung cancer.
    Tumori, 1991, Dec-31, Volume: 77, Issue:6

    Topics: Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun

1991
Chemotherapy in recurrent and advanced cervical cancer.
    Gynecologic oncology, 1991, Volume: 40, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplati

1991
[Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce

1991
Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxor

1991
[Successful treatment of metastatic and refractory osteosarcoma by ifosfamide, carboplatin and vindesine: case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Drug Admini

1991
[Cisplatin, ifosfamide and vindesine in the chemotherapy of squamous cell carcinoma of the lung].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Squamous Cell; Cisplatin; Dr

1991
Ifosfamide extrapyramidal neurotoxicity.
    Cancer, 1991, Jul-01, Volume: 68, Issue:1

    Topics: Adenocarcinoma; Basal Ganglia Diseases; Humans; Ifosfamide; Lung Neoplasms; Lymphoma, Large B-Cell,

1991
Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma.
    Seminars in oncology, 1990, Volume: 17, Issue:2 Suppl 4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Ther

1990
Interstitial pneumonitis associated with ifosfamide therapy.
    Cancer, 1990, May-15, Volume: 65, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide

1990
Dose-finding studies with carboplatin, ifosfamide, etoposide, and mesna in non-small cell lung cancer.
    Seminars in oncology, 1990, Volume: 17, Issue:1 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell

1990
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1990
Ifosfamide with mesna uroprotection in the management of lung cancer.
    American journal of clinical oncology, 1990, Volume: 13, Issue:2

    Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans

1990
Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Female; Huma

1990
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com

1990
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
    Seminars in oncology, 1990, Volume: 17, Issue:2 Suppl 4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1990
[Phase II study of ifosfamide and vindesine combination of non-small cell lung cancer in elderly patients and patients with reduced renal function].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:5

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung

1990
[Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:5

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun

1990
[Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
    Pneumologie (Stuttgart, Germany), 1990, Volume: 44 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administration

1990
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer.
    Investigational new drugs, 1990, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small

1990
The effect of age on the pharmacokinetics of ifosfamide.
    British journal of clinical pharmacology, 1990, Volume: 30, Issue:1

    Topics: Adult; Aged; Aging; Body Water; Carcinoma, Non-Small-Cell Lung; Half-Life; Humans; Ifosfamide; Lung

1990
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Eto

1990
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26, Issue:5

    Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sma

1990
Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma.
    American journal of clinical oncology, 1990, Volume: 13, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1990
Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1990
[Successful treatment of several metachronous pulmonary metastases of a chondroblastic osteosarcoma].
    Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood, 1985, Volume: 40, Issue:4

    Topics: Amputation, Surgical; Bleomycin; Child; Chondroblastoma; Cyclophosphamide; Dactinomycin; Female; Hum

1985
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.
    Behring Institute Mitteilungen, 1988, Issue:83

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Colony-Stimulating Factors; D

1988
[Beneficial effect of cisplatin based combination chemotherapy on adenocarcinoma of the lung].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; D

1989
[Desmoid fibroma of the scapula. Recurrence with pulmonary metastasis].
    Revue de chirurgie orthopedique et reparatrice de l'appareil moteur, 1989, Volume: 75, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Female; Fibroma

1989
Comparative evaluation of acute toxicity and antitumor activity of IF-XXV preparation and holoxan.
    Archivum immunologiae et therapiae experimentalis, 1989, Volume: 37, Issue:5-6

    Topics: Animals; Female; Ifosfamide; Lethal Dose 50; Leukemia L1210; Lung Neoplasms; Male; Mice; Mice, Inbre

1989
European experience with ifosfamide in non-small cell lung cancer.
    Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dr

1989
Pilot study with adriamycin and ifosfamide in small cell lung cancer.
    Tumori, 1989, Feb-28, Volume: 75, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Fem

1989
Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:2

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun

1989
A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).
    British journal of cancer, 1989, Volume: 60, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemo

1989
Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.
    British journal of cancer, 1989, Volume: 60, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Com

1989
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chromat

1989
High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
    Cancer, 1989, Apr-01, Volume: 63, Issue:7

    Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Ma

1989
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer.
    Cancer, 1987, Nov-15, Volume: 60, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit

1987
Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce

1987
[Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce

1988
The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modalit

1988
[The role of radiotherapy in small cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 2-1

    Topics: Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Ifosfamide;

1988
Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Ev

1988
Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.
    British journal of cancer, 1988, Volume: 58, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1988
[Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
    Onkologie, 1988, Volume: 11 Suppl 2

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun

1988
[Hepatotoxicity with etoposide-ifosfamide combination therapy].
    Onkologie, 1988, Volume: 11, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cel

1988
Concurrent chemo-radiotherapy in small cell lung cancer.
    Antibiotics and chemotherapy, 1988, Volume: 41

    Topics: Adult; Aged; Carcinoma, Small Cell; Carmustine; Combined Modality Therapy; Female; Humans; Ifosfamid

1988
Ifosfamide/mesa and encephalopathy.
    Lancet (London, England), 1985, Mar-30, Volume: 1, Issue:8431

    Topics: Brain Diseases; Carcinoma, Small Cell; Cyclophosphamide; Female; Humans; Ifosfamide; Lung Neoplasms;

1985
Ifosfamide as single-agent chemotherapy in inoperable non-small-cell lung cancer.
    Lancet (London, England), 1985, Aug-31, Volume: 2, Issue:8453

    Topics: Adult; Aged; Carcinoma; Cyclophosphamide; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged

1985
Failure of response to ifosfamide in squamous cell bronchogenic carcinoma.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:2

    Topics: Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Drug Resistance; Humans; Ifosfamide; Lung Neoplas

1989
A phase II study of high dose ifosfamide in metastatic colorectal cancer.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:1

    Topics: Adult; Aged; Colorectal Neoplasms; Drug Evaluation; Female; Humans; Ifosfamide; Liver Neoplasms; Lun

1989
[A case of retrocecal appendicitis occurrence during effective chemotherapy in lung cancer].
    Gan no rinsho. Japan journal of cancer clinics, 1989, Volume: 35, Issue:3

    Topics: Abscess; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Appendicitis; Bone Marrow;

1989
[Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
    Strahlentherapie, 1985, Volume: 161, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic

1985
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
    Onkologie, 1985, Volume: 8, Issue:4

    Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug

1985
Augmentation of cytotoxicity of chemotherapy by human alpha-interferons in human non-small cell lung cancer xenografts.
    Cancer research, 1986, Volume: 46, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin;

1986
[Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].
    Deutsche medizinische Wochenschrift (1946), 1986, Dec-19, Volume: 111, Issue:51-52

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administration Schedule;

1986
[Ifomide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:1

    Topics: Animals; Bone Neoplasms; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Leukemia, Experimental;

1987
Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
    Cancer, 1987, Jan-15, Volume: 59, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcino

1987
Ifosfamide by bolus as treatment for advanced non-small cell lung cancer.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2

    Topics: Adult; Aged; Carcinoma, Small Cell; Drug Administration Schedule; Female; Humans; Ifosfamide; Inject

1986
Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell;

1986
Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
    Cancer treatment reports, 1987, Volume: 71, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat

1987
False-positive ketonuria during ifosfamide and mesna therapy.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:2

    Topics: False Positive Reactions; Female; Humans; Ifosfamide; Ketone Bodies; Lung Neoplasms; Male; Mercaptoe

1986
Phase II study of ifosfamide in cervical cancer.
    Cancer treatment reports, 1986, Volume: 70, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Central Nervo

1986
Prediction of ifosfamide/mesna associated encephalopathy.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Electroencephalography; Female; Huma

1986
Ifosfamide and Mesna in advanced malignancies.
    Chinese medical journal, 1988, Volume: 101, Issue:3

    Topics: Adult; Aged; Carcinoma, Bronchogenic; Female; Hematuria; Humans; Ifosfamide; Lung Neoplasms; Lymphom

1988
Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group.
    Cancer, 1988, Jan-01, Volume: 61, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Ifosfamide;

1988
[Results of whole lung irradiation and chemotherapy in comparison with partial lung irradiation in metastasizing, undifferentiated soft tissue sarcomas].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1988, Volume: 164, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; F

1988
Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
    Archivum immunologiae et therapiae experimentalis, 1986, Volume: 34, Issue:3

    Topics: Animals; Cyclophosphamide; Ifosfamide; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Mice;

1986
Bioavailability of ifosfamide in patients with bronchial carcinoma.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:3

    Topics: Administration, Oral; Aged; Biological Availability; Carcinoma, Bronchogenic; Female; Humans; Ifosfa

1986
Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
    Journal of immunopharmacology, 1986, Volume: 8, Issue:4

    Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Ifosfamide;

1986